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ABSTRACT OF DISSERTATION 
 
 
 
UNDERSTANDING CARBOHYDRATE RECOGNITION MECHANISMS IN 
NON-CATALYTIC PROTEINS THROUGH MOLECULAR SIMULATION 
 
 Non-catalytic protein-carbohydrate interactions are an essential element of 
various biological events. This dissertation presents the work on understanding 
carbohydrate recognition mechanisms and their physical significance in two groups of 
non-catalytic proteins, also called lectins, which play key roles in major applications such 
as cellulosic biofuel production and drug delivery pathways. A computational approach 
using molecular modeling, molecular dynamic simulations and free energy calculations 
was used to study molecular-level protein-carbohydrate and protein-protein interactions. 
Various microorganisms like bacteria and fungi secret multi-modular enzymes to 
deconstruct cellulosic biomass into fermentable sugars. The carbohydrate binding 
modules (CBM) are non-catalytic domains of such enzymes that assist the catalytic 
domains to recognize the target substrate and keep it in proximity. Understanding the 
protein-carbohydrate recognition mechanisms by which CBMs selectively bind substrate 
is critical to development of enhanced biomass conversion technology. We focus on 
CBMs that target both oligomeric and non-crystalline cellulose while exhibiting various 
similarities and differences in binding specificity and structural properties; such CBMs 
are classified as Type B CBMs. We show that all six cellulose-specific Type B CBMs 
studied in this dissertation can recognize the cello-oligomeric ligands in bi-directional 
fashion, meaning there was no preference towards reducing or non-reducing end of 
ligand for the cleft/groove like binding sites. Out of the two sandwich and twisted forms 
of binding site architectures, twisted platform turned out to facilitate tighter binding also 
exhibiting longer binding sites. The exterior loops of such binding sites were specifically 
identified by modeling the CBMs with non-crystalline cellulose showing that high- and 
low-affinity binding site may arise based on orientation of CBM while interacting with 
non-crystalline substrate. These findings provide various insights that can be used for 
further understanding of tandem CBMs and for various CBM based biotechnological 
applications.  
 
 The later part of this dissertation reports the identification of a physiological 
ligand for a mammalian glycoprotein YKL-40 that has been only known as a biomarker 
in various inflammatory diseases and cancers. It has been shown to bind to oligomers of 
chitin, but there is no known function of YKL-40, as chitin production in the human body 
has never been reported. Possible alternative ligands include proteoglycans, 
polysaccharides, and fibers such as collagen, all of which make up the mesh comprising 
the extracellular matrix. It is likely that YKL-40 is interacting with these alternative 
polysaccharides or proteins within the body, extending its function to cell biological roles 
such as mediating cellular receptors and cell adhesion and migration. We considered the 
feasibility of polysaccharides, including cello-oligosaccharides, hyaluronan, heparan 
sulfate, heparin, and chondroitin sulfate, and collagen-like peptides as physiological 
ligands for YKL-40. Our simulation results suggest that chitohexaose and hyaluronan 
preferentially bind to YKL-40 over collagen, and hyaluronan is likely the preferred 
physiological ligand, as the negatively charged hyaluronan shows enhanced affinity for 
YKL-40 over neutral chitohexaose. Collagen binds in two locations at the YKL-40 
surface, potentially related to a role in fibrillar formation. Finally, heparin non-
specifically binds at the YKL-40 surface, as predicted from structural studies. Overall, 
YKL-40 likely binds many natural ligands in vivo, but its concurrence with physical 
maladies may be related to the associated increases in hyaluronan. 
KEYWORDS: protein-carbohydrate interaction, cellulose, glycosaminoglycan, collagen, 
molecular dynamics, free energy perturbation. 
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Chapter 1  – Introduction 
1.1 Carbohydrate-binding proteins 
 Proteins are the most abundant macromolecules in mammals, and are the most 
diverse biomolecules in the living organisms [1, 2]. Proteins play many different roles in 
the chemical and biological events of a cell from its birth to death, functioning as 
enzymes, structural proteins, transporters, energy storage proteins, motor proteins, 
antibodies in immune response, and regulatory proteins, etc.. They are mostly known to 
work synergistically with either other proteins or biomolecules like carbohydrates [3]. 
Carbohydrates are the most abundant macromolecules in plant cells, where cell walls 
consist of long polysaccharides [4, 5]. However, various sizes of carbohydrates, 
oligosaccharides and short polysaccharides, are also found along the cell plasma 
membrane and in the extra-cellular matrix of all living organisms, both independently as 
well as in the form of protein-conjugates like glycoproteins. Naturally, the interaction 
between proteins and carbohydrates in biological processes has a significant role, 
reportedly in metabolic activities, cell recognition and signaling, catalysis, and 
inflammation [6-11]. Such interactions also affect industrial processes, and enzymatic 
degradation of cellulosic biomass to produce bioethanol is one of the most important 
process among them, as we will discuss further.  
Carbohydrate-binding proteins can be primarily categorized into two broad 
classes: carbohydrate-active enzymes and catalytically inactive proteins. The latter class 
of this protein population is commonly referred to as lectins, which can recognize and 
bind carbohydrates with high specificity and high to moderate affinity, but without any 
catalytic activity [3, 12-14].  
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Figure 1.1 *HQHUDl classification of protein-carbohydrate interaction and groups of 
lectins based on their area of existence/function.  
These non-catalytic carbohydrate-binding proteins, lectins, can be further divided 
into groups such as carbohydrate-binding antibodies, selectins (lectins in the cell 
membranes), intra-cellular lectins, extra-cellular lectins, and carbohydrate binding 
modules (CBMs) [3, 15, 16]. Every group of lectins exhibits further variation in structural 
and functional properties making it very challenging to generalize the overall non-
catalytic protein-carbohydrate partnership. In this dissertation, I focus on case studies of 
two of these non-catalytic carbohydrate-binding proteins, investigating (1) the molecular-
level recognition mechanisms of Type B carbohydrate binding modules that can 
differentially bind to oligomeric and non-crystalline cellulose, and (2) the binding 
mechanisms of the mammalian glycoprotein YKL-40, which is an extra-cellular lectin 
primarily known as a biomarker whose functionality remains largely unknown.  
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1.2 Motivation 
1.2.1 Sustainable cellulosic bioethanol 
 Over the last few decades, it has been acknowledged that ethanol produced from 
lignocellulosic biomass has great potential to become an excellent DOWHUQDWLYHOLTXLGIXHO
for the transportation sector [17-20]. Even though there are other upcoming green 
technologies like electric and fuel-cell vehicles, lignocellulosic biomass-derived ethanol 
is much needed, as unlike other technologies, it has great potential to achieve target 
reductions in greenhouse gas emissions [21-23]. In the journey toward developing OLTXLG
biofuels, researchers have studied various aspects of this field, pointing out advances as 
well as challenges in building a sustainable cellulosic bioenergy enterprise [24-27]. The 
biochemical conversion of cellulose to fermentable sugars is considered to be one of the 
most promising approaches, particularly when compared to other thermochemical routes 
[28, 29]. Lignocellulosic biomass comprises a majority of plant cell walls and can be 
biochemically converted to ethanol in five general steps: i) biomass handling ii) 
pretreatment, iii) enzymatic hydrolysis, iv) fermentation, and v) ethanol recovery. The 
enzymatic hydrolysis step is both a rate determining as well as expensive step [30, 31]. 
The highly crystalline nature of cellulose makes it recalcitrant to facile deconstruction 
and challenging for enzymes to access the strong glycosidic linkages connecting the 
soluble glucose monomers [29].  
Nature uses multi-PRGXODUJO\FRVLGHK\GURODVH*+HQ]\PHVWRKHOSRYHUFRPH
biomass recalcitrance. Multi-modulaU*+VFDQWDNHPDQ\IRUPVEXWJHQHUDOO\FRQVLVWRI
at least one catalytic domain (CD) appended by linker peptides to one or more 
carbohydrate binding modules (CBM) [32, 33] (Figure 1.2). 
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Figure 1.2 Stick representation of cello-oligomer showing ȕ-1-4 glycosidic linkages 
between glucose monomers with reducing and non-reducing ends (top panel). Multi-
modular glycoside hydrolase exhibiting a catalytic domain connected by linker peptides 
to carbohydrate binding modules (bottom panel).  
 The CD is responsible for catalytic activity, cleaving the glycosidic linkages of 
cellulose. The non-catalytic CBMs assist the CD in targeting the substrate and serves as 
the primary biological means of protein-carbohydrate recognition [16]. To attain the goal 
of efficient biomass conversion, a significant amount of prior research has focused on 
catalytic domains, as they are directly involved in the cleavage of glycosidic linkages and 
can offer obvious gains in enzymatic performance. On the other hand, researchers have 
just begun to explore and realize the carbohydrate recognition capabilities of CBMs in 
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optimization of efficient biomass conversion. The specificity of CBMs may also be 
harnessed for multitudes of other biotechnological applications, including, for example, 
bioprocessing, targeting, cell immobilization, protein engineering, diagnostics, and fiber 
modification [34, 35]. 7KHUHIRUH ZH DGGUHVV IXQGDPHQWDO TXHVWLRQV VXUURXQGLQJ how 
these carbohydrate binding modules specifically recognize their carbohydrate substrates 
as a means to develop enhanced CBM-based biotechnology. 
1.2.2 Lectin-mediated targeted drug delivery  
 *LYHQ their substantial involvement in various biological processes, lectins have 
been extensively studied in medicinal chemistry as drug targets or as carriers to target and 
deliver drugs to their site of action [36, 37]. Vice versa, carbohydrates in their various 
forms (mono/oligo/poly-saccharide) have been used as drug carriers or labels and have 
also been the target of drug molecules, especially the glycosaminoglycans [38]. 
Accordingly, the intertwined relationship between lectins and carbohydrates is an 
invaluable asset in the field of targeted drug delivery [39].  
Different cells are known to express different glycan arrays, and natural 
combination of monosaccharides with various sets of substitutions and isomorphs can 
result in a vast range of different chemical structures, eaFKFRPELQDWLRQEHLQJDXQLTXH 
sugar code [36, 40]. In other words, malignant cells, like tumor cells, express different 
glycans or glycoproteins compared to their benign counterparts, making malignant cells 
potential targets of lectins [41]. Such appears to be the case with mammalian 
glycoprotein YKL-40, which is overproduced by the human body in conjunction with 
cancers and chronic inflammatory ailments, making it a well known biomarker of many 
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diseases [42]. However, experimental efforts to understand the biological role and 
mechanism of YKL-40 have been hindered by the difficulty associated with isolating the 
various contributions from the cellular environment. To date, it is unclear what YKL-40 
interacts with in the human body, but it has been reported to bind in vitro to chito-
oligosaccharides and collagen [43-45]. Better understanding of the different mechanisms 
by which such lectins can target specific carbohydrates can add a new dimension to 
engineering lectin-mediated drug delivery pathways and enhance our understanding of 
inflammatory disease and cancer progression. Here, we focus on identifying the potential 
physiological binding partners of this infamous biomarker lectin by screening the most 
likely carbohydrate ligand candidates found within the extra-cellular matrix and 
investigating the associated molecular-level binding mechanisms.  
1.3 Research background 
1.3.1 Carbohydrate binding modules 
 The catalytic domains of the carbohydrate-active enzymes, e.g., cellulases or 
cellulosome enzyme complexes, can have a single or multiple smaller CBM domains that 
aid in function; the domains are connected by linker peptides and typically hold 
complementary specificity towards carbohydrate substrates [33, 46-48] (Figure 1.2). Prior 
to 1999 [49], CBMs were known as cellulose binding domains (CBDs) because almost all 
of those initially characterized were specific to cellulose. As more enzymes with non-
catalytic domains binding carbohydrates other than cellulose were observed through 
advances in biochemical and structural characterization (NMR and X-UD\WHFKQLTXHVWKH
nomenclature shifted to a more general terminology of Carbohydrate Binding Modules 
(CBMs) [49]. There are three proposed functions of CBMs in biomass deconstruction: i) 
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maintaining proximity to substrates, ii) targeting specific regions, and iii) disrupting 
surface crystallinity [16, 50]. Experimental results confirm that maintaining proximity to 
substrate contributes to increasing enzyme concentration at the surface, resulting in 
enhanced enzymatic deconstruction of polysaccharides [51-58]. Their function in 
targeting distinct regions, specificity towards orientation of substrate [59-62], and 
apparent variable functional capacity on chemically invariant substrates [63-66] are 
appealing targets for enhanced biotechnology development and, accordingly, from the 
perspective of understanding fundamental protein-carbohydrate binding mechanisms. The 
disruption of substrate surface crystallinity by CBMs has been reported by relatively few 
biochemical studies [67-71], and similar results have not observed for other CBMs [50, 
51, 56, 72]. Thus, this latter proposed CBM function has not been widely accepted as a 
general function by the community.  
Finally, cellulosic substrates are comprised of glucose monomers linked together 
through E-1,4 glycosidic bonds and span a range of degree of polymerizations. ȕ-1-4-
glycan-specific CBMs appear to bind either crystalline or non-crystalline/amorphous and 
oligomeric cellulose [16]. Competition isotherms suggest CBMs do not compete for 
binding sites on these variable crystalline surfaces despite similar substrate specificities 
[66, 73]. 7KHVH IXQFWLRQDO IHDWXUHV DORQJZLWK VWUXFWXUDO DQG VHTXHQFH VLPLODULW\ KDYH
led to the classification scheme of different CBMs [16]. 
1.3.1.1 Terminology of CBMs 
 Classification of CBMs is based on similarity LQ ERWK SURWHLQ VHTXHQFH DQG
IXQFWLRQ&%0µIDPLOLHV¶are defined according to WKHSURWHLQVHTXHQFHDQGIROG, while 
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µW\SHV¶ DUH LOOXVWUDWLYH RI WKHLU IXQFWLRQDO DFWLYLW\ [16]. CBMs largely appear to bind 
either crystalline or non-crystalline/amorphous and oligomeric substrates. As of August 
2017, there are 81 CBM families FDWHJRUL]HG EDVHG RQ DPLQR DFLG VHTXHQFH LQ WKH
Carbohydrate Active Enzymes (CAZy) database (http://www.cazy.org/Carbohydrate-
Binding-Modules.html) [74] . The current protocol for abbreviation of a CBM from a 
given family is CBM#, where # is its family number. Also, the name of the native 
microorganism <Genus species> producing the CBM may be added as prefix, i.e., 
GsCBM#.  
$OWKRXJKIDPLOLHVDUHGLYLGHGEDVHGRQSURWHLQVHTXHQFHVRPHSURWHLQIROGVDUH
FRPPRQ DFURVV VHYHUDO IDPLOLHV 7KH ȕ-sandwich fold is the most common, shared by 
more than 30 families. The CBMs are also grouped into three types (A, B, and C) based 
on functional similarity and binding site topology (Figure1.2). Type A CBMs consist of 
those with affinity towards crystalline substrate and have planar binding sites. Type B 
CBMs are specific to free-single-glycan chain polysaccharides, have groove or cleft-like 
binding site, and bind µinternally¶ on single free glycan chains. And Type C CBMs bind 
the termini of glycans with a simplified lectin-like binding site that can accommodate 
only mono-/di-/tri-saccharides at the terminal end of a glycan chain [16, 75] (Figure 1.3). 
Families generally belong to one of the types, for example CBMs from families 4, 17, 
and 28 are all Type B CBMs, but there are exceptions, e.g., in family 2 and 3, that 
illustrate the functional diversity of these carbohydrate-binding proteins and difficulty in 
developing a cohesive categorization scheme [76, 77]. Before going into the details of 
specific CBM families, LWLVDOVRHTXally important to define the chemical nature of their 
substrate.  
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Figure 1.3 Classification of CBMs in three types (A, B, and C) based on binding site 
topology and morphology of target substrate. Type A CBMs have a planar binding site 
and target crystalline substrate. Type B CBMs have cleft or groove shaped binding sites 
and target single free glycan chains. Type C CBMs have a binding site that bind to glycan 
chain termini, i.e. reducing or non-reducing ends. 
1.3.1.2 Substrates of CBMs - different target morphologies  
 Nature has developed plant cell walls as a complex network containing different 
high molecular weight polysaccharides to reinforce strength and provide protection 
against microbial and animal attack [29, 78]. These polysaccharides primarily include 
cellulose, hemicellulose, and pectin, in varying percentages depending on the plant. The 
secondary cell wall also contains lignin, which strengthens and waterproofs the cell wall. 
Cellulose, the most abundant biopolymer on Earth, is the unbranched polymer of 
UHSHDWLQJȕ-1-4-linked glucans and is the primary component of plant cell walls [4, 79]. 
Several polymer chains are stacked upon each other and are held together through a 
network of hydrogen bonds in either parallel or anti-parallel chains constituting 
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microfibrils of crystalline cellulose; such variations in chain directions and hydrogen 
bonding patterns between chains/sheets define various polymorphs of cellulose [80]. Two 
polymorphs, cellulose IȽ and IȾǡ are naturally produced by plants and both exhibit only 
intralayer hydrogen bonding with parallel-oriented chains [81, 82]. Cellulose II and III 
are synthetic cellulose polymorphs that have been obtained through chemical 
pretreatment of cellulose I, and exhibit antiparallel chains with both intra- and inter-layer 
hydrogen bonding [83, 84]. The average number of monomeric glucose units in the 
polymeric chains is called as the degree of polymerization (DP) of that cellulosic 
substrate. The DP and polymorphism of substrate varies with source as well as pre-
treatment conditions of the biomass. For example, microcrystalline cellulose (e.g., 
Avicel) has a DP between 150 and 300, cotton and other plant fibers can have a DP in the 
range of 800-10,000, and secondary cell wall cellulose has a much higher DP, up to 
15,000 [5, 85]. Apart from crystalline cellulose, other cellulosic forms, such as para-
crystalline (pseudo-ordered), amorphous/non-crystalline, and soluble cellulose, have also 
been observed, although not essentially in its native structure [80]. This variation in 
crystallinity and polysaccharide construction is thought to significantly contribute to 
microbial UHFDOFLWUDQFH )LJXUH UHTXLULQJ WKH secretion of many different enzymes 
ZLWKTXLWHYDULHGVSHFLILFLW\WRHIIHFWLYHO\GHFRQVWUXFWSODQWFell wall components [29, 86, 
87]. 
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Figure 1.4 Illustration of different possible morphologies of cellulose after biomass 
pretreatment. (A) Surface representation of perfectly crystalline microfibril of cellulose 
Iȕ. (B and C) Non-crystalline cellulose with disruptions in the microfibril; non-crystalline 
regions at the end and in the middle, respectively. (D) Highly amorphous bunch of 
polysaccharides of cellulose (E) Independent insoluble polysaccharide chain of cellulose 
(F) Soluble cello-oligosaccharides from cellohexaose to monomeric glucose.  
 Crystalline cellulose is well characterized, including the network of hydrogen-
bonding interactions, as the structure of both the nDWLYHFHOOXORVH ,ĮDQG ,ȕ DOORPRUSKV
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and various other polymorphs have been identified through nuclear magnetic resonance 
(NMR) spectroscopy [88], atomic force microscopy (AFM) [89] and X-ray diffraction 
(XRD) [81, 82]. On the other hand, 3-dimentional structure determination of non-
crystalline cellulose is not straightforward, leaving us with relatively little understanding 
as to the non-crystalline forms of cellulose that lie between truly crystalline and highly 
amorphous phases [90, 91]. Characterization of the amorphous cellulose regenerated 
from dissolution of microcrystalline cellulose in SO2-diethylamine-dimethylsulfoxide 
with XRD, Fourier-transform infrared microscopy (FTIR) and differential scanning 
microscopy (DSC) could only confirm that it is a cellulose with a decreased degree of 
polymerization and crystallinity index [92]. Thus, the pretreated cellulosic biomass is 
thought to consist of a substantial amount of non-crystalline cellulose, including kinks or 
twists in microfibrils and/or voids, such as surface micropores, large pits, and capillaries, 
having either no specific structural properties or highly undistinguishable structural 
characteristics [33]. Soluble oligomers are the smallest forms of cellulose, known as 
cello-ROLJRVDFFKDULGHVZLWKD'3OHVVWKDQRUHTXDOWo 6 (Figure1.3) [93]. The origin of 
the plant biomass and pretreatment strategy are prime variables determining the target 
cellulose morphologies subjected to enzymatic hydrolysis. Certainly, cellulose 
crystallinity exists within a continuum, where clear delineations between regions are 
difficult to discern. However, with findings such as regional CBM specificity with non-
crystalline cellulose substrates [64, 65], it is increasingly evident that CBMs hold the 
potential to probe such regions and provide insights to the structural complexity of the 
non-crystalline cellulose [94].  
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1.3.1.3 Cellulose-specific Type B CBMs 
 All Type B CBMs characterized up to now exhibit the most common protein fold 
among CBMs [16], termed the ȕ-sandwich fold, which consists of WZRȕ-sheets each of 
which contain WKUHH WR VL[ ȕ-strands. The characteristic groove-like nature of Type B 
CBM binding sites is akin to the active sites of glycoside hydrolase catalytic domains, 
where hydrogen bonding interactions along with aromatic stacking mechanisms are 
responsible for ligand binding [95]. The length of these binding sites can accommodate 
free-single-glycan chains, generally with at least 3 and a maximum of 6 monomers in a 
row. The depth of these grooves varies from being able to enclose the whole width of a 
pyranose ring ( > 6 Å) to merely a shallow cleft (1-2 Å) [16]. The relatively solvent-
exposed binding site allows these Type B CBMs to expand their specificity to a large 
range of substrate morphologies, excepting pure crystalline polysaccharides and very 
small sugars (mono-/di-/tri-saccharides).  
The Type B CBMs from families 4, 17, and 28 have been shown to bind both 
soluble cello-oligomers and non-crystalline cellulose, but never crystalline cellulose [51, 
52, 54, 73, 96-98]. Despite having the VDPH ȕ-sandwich fold and groove-like binding 
sites, CBMs from these three families have further individual characteristics that enable 
them to differentially bind non-crystalline cellulose in an uncompetitive mode [64, 99, 
100]. Structural and thermodynamic studies of Type B CBMs have been conducted to 
gain insight into the CBM-carbohydrate recognition process, bringing to light additional 
TXHVWLRQV as mentioned ahead. For example, variations in thermodynamic binding 
signatures for CBMs within these same families have been observed despite the strong 
structural DQG VHTXHQFH similarities [64, 101, 102]. Mutagenic studies of key residues 
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comprising the binding site report individual contributions to binding affinities [99, 100], 
but comprehensive characterization of such contributions across several Type B CBMs is 
needed to identify their roles in the carbohydrate recognition process. An NMR study 
reported the counterintuitive finding that family 4 CBMs are able to bind oligomers in 
multiple orientations [61], although structural-level carbohydrate binding mechanisms 
were obscured; the crystal structures of ligand-bound CBMs from families 17 and 28 
report only a single ligand orientation [62]. Additionally, the motivation for microbial 
evolution of these carbohydrate binding modules from individual entities to tandem 
systems is the long-term TXHVWLRQWKDWQHHGHGWREHDGGUHVVHG (Details in Section 1.3.1.5). 
Formation of these multivalent carbohydrate-binding proteins can significantly enhance 
ligand-binding affinity relative to individual modules [51, 64, 102-104], although this is 
not a given [98].  
 *LYHQDOOWKHVHRSHQTXHVWLRQVIRU consideration, along with the fact that we have 
an abundance of unexplained experimental phenomena, which could benefit from 
theoretical investigations, our focus lies on understanding the carbohydrate recognition 
mechanisms of family 4, 17, and 28 CBMs. We have conducted a comprehensive 
examination of carbohydrate recognition in six different Type B CBMs (two from each 
family 4, 17, and 28) having specificity for both cello-oligomers and non-crystalline 
cellulose, along with two tandem CBMs (Figure 1.5). One tandem CBM is a blend of two 
family 4 CBMs, whereas a second tandem CBM consists one from each family 17 and 
28, as they would be naturally secreted by the associated microorganisms [105, 106]. 
Details of each CBM are described below based on the studies reporting their structural 
biology and characterizations of soluble cello-oligomeric binding. Further information 
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about the non-crystalline binding characterizations for these CBMs is then provided 
collectively in the next section.  
 
Figure 1.5 The study addresses carbohydrate recognition in six Type B CBMs, two from 
each of the three families – 4, 17, and 28. Two tandem CBMs were included in this work. 
The letters preceding the CBM# represent the name of bacteria that produces that CBM. 
Cf – Cellulomonas fimi, Cc – Clostridium cellulovorans, Bsp – Bacillus sp. 1139, Cj – 
Clostridium josui. Structures of CfCBM4-1 (light pink 3'% *8), CcCBM17 (light 
blue, PDB 1J84) and CjCBM28 (light green, PDB 3ACI) are shown for comparison.  
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1.3.1.3.1 Family 4 CBMs 
 CfCBM4-1 and CfCBM4-2, selected to represent family 4, are two N-terminal 
binding domains from Cellulomonas fimi ȕ-1,4-glucanase C (CenC/Cel9B) [105]. The 
two CBMs naturally occur in tandem and are linked to the Cel9B catalytic domain 
through a four-amino acid peptide linker. Through various methods to detect 
carbohydrate-binding specificity, CfCBM4-1 appears to preferentially bind cellulosic 
substrates, with cellopentaose and cellohexaose binding with similar affinities [98, 107]. 
Quantitative evaluation of binding affinity by Isothermal Titration Calorimetry (ITC) 
suggested that CfCBM4-1 binds cello-oligomers in an enthalpically-driven fashion, based 
on favorable change in enthalpy compensated by negative change in entropy [98]. 
Prevalent polar interactions, especially hydrogen bonding, appear to be central for 
specificity towards the cello-oligosaccharides [99, 108, 109]. Structural studies with both 
NMR spectroscopy and X-ray crystallography revealed that CfCBM4-1 binds cello-
oligomers in a binding groove formed on the IDFHRI LWVȕ-sandwich fold. This binding 
groove is comprised of oppositely facing hydrophobic residues sandwiching the relatively 
hydrophobic pyranoside rings [62, 108] (Figure 1.5). On the sides, several polar and 
hydrophilic residues are involved in binding, as identified through mutagenesis [99]; 
however, the role of orientation of cello-oligomers and their side chains in hydrogen 
bonding was unclear. We identify the critical binding modes with which cello-oligomers 
bind CfCBM4-1 in a directionless fashion, details of which are discussed in Chapter 3. 
 In addition to being a tandem CBM partner, CfCBM4-2 shares a very similar 
tertiary structure and sugar binding properties with CfCBM4-1 [110]. Though very 
similar, the CfCBM4-2 binding cleft is not identical to that of CfCBM4-1. Detailed 
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comparison reveals that a few binding site residues that interact with the bound ligand in 
CfCBM4-1 are substituted. The NMR structure captures CfCBM4-2 in its apo state, and 
thus, the absence of ligand interactions could likely be the reason behind the larger width 
of its binding groove relative to that of CfCBM4-1. Based on our molecular dynamics 
study of CfCBM4-2 docked with cellopentaose in the binding JURRYH LW LV TXLHW
intriguing to observe that the width reduces to approximately that of CfCBM4-1 during 
the HTXLOLEUDWLRQ period and remains almost the same over the remainder of the 
simulation (details in Chapter 3). We have further analyzed the variability in 
thermodynamic signature between these two family 4 CBMs in Chapter 4. The two 
CBM4s are naturally found in a side-by-side orientation, prevented from end-to-end 
orientation as a result of the lack of a flexible peptide linker [110]. We anticipate that this 
contributes, in part, to their apparent additive rather than cooperative binding when 
studied as tandem system.  
1.3.1.3.2 Family 17 CBMs 
 This family of CBMs is represented by CcCBM17, the C-terminal domain of 
Clostridium cellulovorans Cel5A solved by Notenboom et al. [100]. As the only CBM17 
structure to date, CcCBM17 has been the subject of numerous biochemical studies. 
CcCBM17 appears to have optimal affinity towards cellohexaose, with a minimum 
ELQGLQJUHTXLUHPHQWRIFHOORWULRVH[97]. Although belonging to Type B, the binding site 
of CcCBM17 is barely recognizable as groove, with a shallow depth of 1-2 Å compared 
to the 4-6 Å of family 4 CBMs. The µsandwich¶ platform of CBM4s is also replaced by 
µtwisted¶ platform in CBM17s, such that two tryptophan residues are facing away from 
protein core to stack directly with the ligand pyranoside rings in addition to the polar 
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residue network running along WKH JURRYH¶V sides. Aromatic residues are of supreme 
importance in these CBMs, as their mutation to alanine destroyed affinity of CcCBM17 
for any tested ligand [100]. Up to 25-fold reductions in binding affinity with mutation of 
each polar residue also illustrates the crucial contribution of hydrogen bonding [100]. A 
computational alanine scan confirmed the importance, though not the role, of these polar 
residues [111]. This study also calculated ligand binding free energy of cellotetraose and 
cellohexaose bound to CcCBM17, but the accuracy of absolute binding free energies 
calculated using molecular mechanics/generalized Born surface area (00*%6$) are 
not reliable, and its application is typically restrained to relative ranking of binding 
affinities in pharmaceutical applications [112]. Here we use a robust, explicit solvent and 
enhanced sampling method, called as free energy perturbation with Hamiltonian replica 
exchange MD, recently used to calculate reliable and more accurate absolute binding free 
energies in relatively large protein-ligand system [113]. ,QLWLDOO\ ¨+ YDOXHV IURP WKH
thermodynamic study for cellotetraose binding in CcCBM17 suggest that it is an 
enthalpically-driven binding process, as they dominate over 7¨6+RZHYHUWKHSRVLWLYH
changes in both enthalpic and entropic terms with increasing length of bound cello-
ROLJRPHUZLWK¨¨+7¨¨6PHDQV LW LV UDWKHUHQWURSLFDOO\-driven. The large negative 
change in heat capacity values, by comparison to those from family 4, are consistent with 
burial of significant non-polar surface and solvent reorganization, which is strongly 
correlated with change in entropy [100]. Such entropy-driven binding was also observed 
in another family 17 member from Clostridium josui (CjCBM17) [102].  
 BspCBM17 is also included in this work given its occurrence in the 
biochemically-characterized tandem CBM from Bacillus sp. 1139 Cel5A, though no 
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structure is currently available. CcCBM17 has been used to draw parallels with 
BspCBM17, DV WKH\ VKDUH  VHTXHQFH VLPLODULW\ DQG  VWUXFWXUDO VLPLODULW\ DQG
ligand binding residues are thought to be conserved [64]. Here, we used homology 
modeling to construct BspCBM17 and investigate its binding functionality. Importantly, 
it has also been used to study characteristics of cello-oligomer binding in the tandem 
CBM, BspCBM17/CBM28. In spite of high fold similarity between family 17 and family 
4, mode of carbohydrate recognition appears to be different across the two CBM families. 
As we point out, the differences in topology of their binding sites and thermodynamics 
are likely the driving force behind variation in binding (Chapter 4). Nature has evolved 
these CBMs to recognize various architectural regions on the cellulosic substrate. 
1.3.1.3.3 Family 28 CBMs  
 The first representative of family 28 CBM was identified from Bacillus sp. 1139 
Cel5A, a C- terminal carbohydrate-binding module (BspCBM28) [96]. A second, related 
CBM from Clostridium josui Cel5A (CjCBM28) is also considered in this study. 
Structural studies for both the CBMs illustrate their differences from the other two Type 
B CBM families. The binding site for family 28 CBMs is also wide and shallow, similar 
to that of CcCBM17, with one face of the cello-oligomer stacking with tryptophans and 
the other face exposed to solvent [101, 106]. There is one additional aromatic residue in 
the binding site of CBM28s compared to that of CBM17s. According to ITC results, 
BspCBM28 binds to cellotetraose, cellopentaose, and cellohexaose in increasing order of 
binding affinity. Values for cellotetraose and cellopentaose suggest binding is driven 
enthalpically, but binding of cellohexaose exhibited a thermodynamic signature 
consistent with significant entropic contributions [96]. Contrasting with BspCBM28, 
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CjCBM28 is reported to bind cello-oligosaccharides enthalpically, despite the fact that 
the two structures are very similar; although, the study did not include binding with 
cellohexaose, limiting a complete comparison [102]. The recognition process depends 
upon key residues involved in binding of family 28 CBMs to cello-oligomers. However, 
no mutagenesis study of these proteins has been reported to date. Here, using a 
computational approach, we investigated the differences in oligosaccharide recognition 
for both family 28 CBMs and address many of the remaining TXHVWLRQV posed by the 
experimental studies. 
 Comparing CBMs from all three families, it is apparent that family 4 has deep 
binding groove, whereas both family 17 and 28 have relatively shallow but similar 
binding clefts. Why this difference evolved for structurally related CBMs of seemingly 
the same function, at a superficial level, will be addressed. Additionally, even if relative 
binding affinities for cello-oligosaccharides of family 28 and 17 imply similar 
carbohydrate recognition mechanisms, the amino acids involved in binding are poorly 
conserved in two families [64]. Ligand bound structural evidence for CBMs from both 
family 17 and 28 show carbohydrates occupying the binding site in opposite directions 
[101], and again despite the similarities, this kind of variation likely relates to functional 
differences between the members and should be better understood from the molecular 
level. 
1.3.1.4 Non-crystalline cellulose recognition by Type B CBMs 
 The interesting fact that these cellulose-specific Type B CBMs bind cello-
oligomers and can selectively bind various forms of non-crystalline/amorphous cellulose 
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is one of the primary reasons we initiated our study investigating these proteins and their 
molecular-level substrate interactions. Experimentalists commonly use different forms of 
purified cellulose like Avicel, regenerated amorphous cellulose (RAC), and phosphoric 
acid swollen cellulose (PASC) to imitate specific cellulose microstructures. Avicel, 
although being known as microcrystalline cellulose, contains partially decrystallized 
regions, as binding of both CfCBM4-1 and CfCBM4-2 to Avicel was confirmed in one of 
the first biochemical studies of Type B CBMs [114]. The latter two cellulose model 
substrates have been specifically used as representatives of non-crystalline/amorphous 
forms of cellulose. CfCBM4-1 was shown to bind 21-fold stronger to regenerated 
cellulose than to Avicel, although still with a higher affinity for cello-oligomers [98]. In 
contrast, the family 17 and 28 CBMs show a one order of magnitude affinity 
improvement towards Avicel and regenerated amorphous cellulose relative to cello-
oligomers [99, 100]. Langmuir isotherms were not sufficient to describe this latter 
binding affinity data for CcCBM17 and BspCBM28, and use of a two-binding-site model 
suggested both CBMs recognized two binding sites on the amorphous substrate differing 
in affinity, a high affinity site and a low affinity site [64]. Additionally, the CBMs did not 
compete for these two binding sites [64, 73], which is indicative of the presence of 
cellulose chains with structural features (e.g., conformation, proximity to other chains, or 
variations in solvation) that are distinguishable by the specific CBMs only. A recent 
study using fluorescent labels shows that two CBMs, one from each family 17 and family 
28, bound two different non-crystalline regions of sweet potato roots [65]. In a further 
study from Boraston et al., high and low affinity binding sites were again observed, 
where binding to each was defined as an enthalpically-driven process [115]. Notably, 
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there was less loss of configurational entropy in the low affinity sites, and we hypothesize 
that they correspond to less crystalline or somewhat oligomeric nature of the ligand 
[115]. Although all these studies confirm the important role these Type B CBMs play in 
ELRPDVVGHJUDGDWLRQ WKH\DOVRUDLVHIXQGDPHQWDOTXHVWLRQVDERXW the targeting function 
of CBMs based on type, architecture, and thermodynamics. In Chapter 4, we propose that 
carbohydrate recognition mechanisms for cello-oligomers closely mimic those of the 
identified low affinity binding sites on non-crystalline cellulose. Likewise, CBM 
carbohydrate recognition of high affinity non-crystalline cellulose binding sites will 
proceed through adapted mechanisms, allowing the CBMs to discriminate between 
regions on the non-crystalline cellulose surface. 
1.3.1.5 Carbohydrate recognition in tandem CBMs 
 Another confounding aspect of the Type B CBM carbohydrate recognition story 
is the evolutionary presence of tandem CBMs found in glycoside hydrolases. Both family 
4 CBMs are found in tandem arrangement, and one from each family 17 and 28 comprise 
cooperatively acting tandem system (Figure 1.2). We anticipate that the specific 
carbohydrate recognition mechanisms belonging to individual CBMs ultimately relate 
back to the biological implications behind the evolutionary presence of tandem CBMs. 
The contrasting examples of BspCBM17 and BspCBM28 connected together in tandem 
in Bacillus sp. 1139 Cel5A that enhanced affinity of the system for non-crystalline 
cellulose by 10–100 fold relative to their individual affinities [106], and tandem-linked 
family 4 CBMs from Cellulomonas fimi CenC that merely additively improved affinity 
relative to separate domains [98] have driven us to learn more about this. Other than these 
affinity comparisons and a proposed two-step mechanism [116], much remains to be 
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explored about structural or dynamical mechanisms involved in binding cooperativity and 
effects of avidity on hydrolysis. The biological significance of cooperative affinity 
enhancement in tandem CBMs is unclear, with such cooperativity used by hyper-
thermophilic organisms to overcome weak binding in high temperature environments 
[104] also being exhibited by CBMs from mesophiles [64]. A potential alternative 
function of tandem CBMs is that they may fine-tune the binding specificity, as binding 
models suggest that low affinity binding sites will only be bound when all high affinity 
sites are completely occupied [64]. Our computational approach provides an avenue to 
LQYHVWLJDWHVXFKTXHVWLRQV 
1.3.2 Mammalian glycoprotein YKL-40 
1.3.2.1 YKL-40: a biomarker 
 YKL-40, also known as chitinase 3-like 1 (CH3L1), is a mammalian glycoprotein 
implicated as a biomarker associated with progression, severity, and prognosis of chronic 
inflammatory diseases and a multitude of cancers [117-120]. The protein is 
overexpressed in many pathological conditions that involve connective tissue remodeling 
or increased deposition of connective tissue components. For example, increased levels 
of YKL-40 are reported in the blood serum of patients with rheumatoid and osteoarthritis, 
hepatic fibrosis, and asthma [121-125]. YKL-40 was first identified from the medium of 
KXPDQ RVWHRVDUFRPD FHOO OLQH0*-63 [126]. The first three N-terminal amino acids of 
this protein, Tyrosine (Y), Lysine (K) and Leucine (L), and the molecular mass of 40 kDa 
are the basis of the name YKL-40. Many different types of cells including synovial, 
endothelial, epithelial, smooth muscle, and tumor cells produce YKL-40 in vivo, likely in 
response to environmental cues [42, 127-129]. Speculation as to biological function of 
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YKL-40 varies from both inhibiting and antagonizing collagen fibril formation as a result 
of injury or disease [45], as well as conferring drug resistance and increasing cell 
migration leading to progression of cancer [119], and protection from chitin-containing 
pathogens [43]. Though the association of YKL-40 with physical maladies is well-
documented, identification of the physiological ligand of this lectin, and thus biological 
function, remains elusive. 
1.3.2.2 Known structural and functional properties of YKL-40 
 Mammalian YKL-40 is TXLWH VLPLODU WR family 18 glycoside hydrolases *+
EDVHG RQ KLJK VHTXHQFH KRPRORJ\ ZLWK WKLV ZHOO-conserved class of enzymes in the 
CAZy database [43, 44, 74] ,W DOVR KROGV   VHTXHQFH LGHQWLW\ ZLWK WKH KXPDQ
macrophage chitinase (HCHT) [130]. The crystal structure of human YKL-40, also 
occasionally referred as human cartilage glycoprotein- +&*3-39), was found to be 
similar to the crystal structure of human chito-triosidase [130], mouse YM1 [131],'*)-
2 from common fruit fly [132] and other family 18 *+V[133] (Figure 1.6.A). Structural 
analyses of YKL-40 and these enzymes reveal that they consist of a (ȕĮ)8 barrel (Figure 
1.6.C), and in some cases, an extra Į/ȕ domain is inserted in one of the barrel loops [43, 
44, 130]. Though very similar in binding site architecture to family 18 *+V, YKL-40 
lacks catalytic activity due to substitution of the glutamic acid and aspartic acid at the end 
of the conserved DXXDXDXE motif typical of catalytically-active family 18 *+V, 
rendering YKL-40 a lectin – a non-catalytic sugar-binding protein. YKL-40 exhibits an 
N-glycosylation site at Asn60, where a disaccharide of N-acetyl glucosamine is attached 
(Figure 1.6.C) [43, 44]. Structural evidence suggests YKL-40 exhibits at least two 
functional binding regions, the primary binding cleft has nine binding subsites lined with 
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aromatic residues compatible with carbohydrate binding (Figure 1.6.B), where chito-
oligomers have been shown to bind with YKL-40 [43]. A second putative heparin-
binding site, located within a surface loop, has also been suggested (Figure 1.6.B), though 
in vitro binding affinity studies have been unable to conclusively demonstrate this [44]. 
6HTXHQFH LGHQWLW\ DQDO\VLV DOVR VXJJHVW WKDW WKHUH DUH K\DOXURQDQ-binding sites on the 
external surface of folded YKL-40 [134]; however, the structural evidence of these 
binding sites, again, has not been observed in any structural studies. 
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Figure 1.6 (A) YKL-40 (gray cartoon) aligned with Serratia marcescens family 18 
Chitinase A (cyan cartoon) illustrating structural similarity and chito-oligomers (stick of 
respective color) binding similarity. (B) Surface representation of YKL-40 showing the 
binding cleft with a bound hexamer of chitin. Binding sites +2 through -4 are numbered. 
Sites -5, -6 and -7 have also been identified but are not shown. The putative heparin-
binding site is shown in marine blue. (C) Side view of the structure of YKL-40 (gray 
cartoon) illustrating the (ȕĮ)8 barrel fold and N-linked glycosylation (green sticks). 
Transparent surface rendering shows the overall µbean-shaped¶ nature of YKL-40.  
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1.3.2.3 Potential physiological ligands 
 Binding affinity and structural studies reveal that chito-oligosaccharides are a 
natural substrate [43, 44, 127]. In line with family 18 *+V, YKL-XQLTXHO\ELQGVVKRUW
and long chito-oligomers, indicating preferential site selection based on affinity [43]. 
Chitohexaose binding has also been purported to induce conformational changes in YKL-
40 [43], though this has not been observed in all structural studies [44]. Lectin binding 
niches are widely believed to be “pre-formed” with respect to the preferred ligand, 
exhibiting little conformational change upon binding [13, 135]. Despite the apparent 
affinity, chitin is not a natural biopolymer within mammalian or bacterial cells, and the 
presence of chitin or chito-oligosaccharides in mammals is likely related to fungal 
infection [136]. The noted up-regulation of YKL-40 in response to inflammation lends 
credence to the argument that YKL-40 functions as part of the innate immune response in 
recognition of self from non-self [12, 127]. Although, high expression levels of YKL- 40 
in carcinoma tissues suggest function beyond the innate immune response may also exist 
[137, 138]. The extracellular matrix is comprised of a mesh of proteoglycans (protein-
DWWDFKHG JO\FRVDPLQRJO\FDQV *$*V SRO\VDFFKDULGHV DQG ILEHUV, including collagen 
(Figure 1.7) [139]. An alternate theory to the pathogenic protection function is that a 
closely related polysaccharide, instead of chitin, plays the role of the physiological ligand 
in mediating cellular function [44]. 
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Figure 1.7 Molecular composition of extracellular matrix. The glycosaminoglycans are 
most likely found as highly glycosylated components of proteoglycans. Structural 
glycoproteins exhibit very little glycosylation.   
 The association of YKL-40 with ailments such as arthritis, fibrosis, and joint 
disease is suggestive of molecular-level interactions with connective tissue, and thus 
collagen [140-144]. Motivated by understanding the physiological role of YKL-40 in 
connective tissue remodeling and inflammation, Bigg et al. investigated association of 
YKL-40 with collagen types I, II, and III using affinity chromatography to confirm 
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binding to each type [45]. The authors report YKL-40 specifically binds to all three 
collagen types. Additionally, the authors used surface plasmon resonance (SPR) to 
confirm binding to Type I collagen. Unfortunately, the reported affinity constants were 
inconsistent across experiments as a result of aggregation. Nevertheless, the work clearly 
indicates YKL-40 is capable of binding collagen. With more than 28 types of collagen 
reported to exist in human body, it becomes critical to obtain molecular level insights to 
such protein-protein interactions, as it likely has profound physiological significance in 
understanding the functionality of YKL-40. However, this IXUWKHUFRQIRXQGVWKHTXHVWLRQ
of mechanism when considering physiological ligands, as YKL- 40 is capable of binding 
both carbohydrates and proteins.  
 Proper consideration of the structure and chemical nature of the ligand relative to 
the YKL-40 binding site(s) enables us to envision the chemical design of potent binding 
partners for a target (in lectin-mediated drug delivery) or potential approaches to block 
lectins of medical importance (in infection, tumor spread, or inflammation). With this 
goal in the mind, we approach the tasks of identifying the physiological ligands of YKL-
40 from a subset of six polysaccharides and glycosaminoglycans plus four triple helical 
collagen-like peptides and exploring the interactions characterizing the various aspects of 
functionality of this well-known, but mysterious lectin. 
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1.4 Outline of Dissertation 
 The overall theme of the dissertation is to identify and understand the interactions 
mediating protein-carbohydrate recognition at the molecular level. We examine these 
interactions in two different model protein-carbohydrate systems and address critical 
TXHVWLRQV pertaining to their structure-function relationships through dynamics and 
affinity data. The insights we obtained here can be utilized in future studies in a wide 
range of applications.  
As we study carbohydrate recognition in the Type B CBMs, we focus the investigation 
on two important objectives that highlight their story and role in nature:  
I. Cello-oligomer binding dynamics and bi-directional binding phenomenon in Type 
B CBMs (Chapter 3).  
II. Role of binding site architecture and high/low affinity binding on non-crystalline 
cellulose in Type B CBMs (Chapter 4). 
,Q WKH TXHVW WR identify the physiological ligand of the multi-functional mammalian 
glycoprotein YKL-40, we divided the study into two parts:  
I. Carbohydrate ligands of YKL-40: Binding mechanisms, thermodynamic 
preferences and surface binding ability (Chapter 5). 
II. Protein-protein interactions of YKL-40: Identification and characterization of 
collagen binding sites (Chapter 6). 
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Chapter 2  – Computational methods 
 Our computational investigation of complex protein-carbohydrate systems to 
XQGHUVWDQG DQG VROYH PDQ\ VFLHQWLILF TXHVWLRQV UHODWHG WR WKHLU SK\VLFDO VLJQLILFDQFH
ELRFKHPLFDOEHKDYLRU DQG WKHUPRG\QDPLF UHODWLRQVKLSV UHTXLUHGYDULRXVFRPSXWDWLRQDO
methods. Classical molecular dynamics (MD) simulations and free energy calculations 
are two important methods that are have been used in this study. Additionally, we have 
utilized tools prior to and after the primary, data-gathering calculations to build the 
models, run the simulations, and analyze the data. In this chapter, the theoretical 
background of these computational methods has been briefly explained to justify their 
application in this dissertation. Detailed protocols of implementation for methods used in 
a chapter have been described in respective methods section of each chapter. 
2.1 Pre-dynamics tasks 
 Classical MD simulations of biomolecules have been used over the last few 
decades to predict structural and dynamical properties, microscopic interactions, and 
ultimately, calculate free energy profiles. To build and run an MD simulation for a 
particular molecular system, one needs to have dependable initial atomic positions, like a 
crystallographic structure or reliable homology model, well-tested, compatible force-
ILHOGVDQGDVRIWZDUHSDFNDJHWRQXPHULFDOO\VROYH1HZWRQ¶VHTXDWLRQVRIPRWLRQ,QWKLV
dissertation, we used available structural data for CBMs and YKL-40 from the Protein 
Data Bank (PDB) in most cases; however, we needed to perform homology modeling in 
the case of the BspCBM17 structure and occasionally molecular docking to obtain the 
desired initial coordinates of the protein-carbohydrate and protein-protein complexes. 
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2.1.1 Homology modeling 
 As the term suggests, homology modeling, or comparative modeling, is a method 
to generate an atomic-resolution model of a target protein for which no structural data is 
DYDLODEOH EDVHG RQ WKH VHTXHQFHVWUXFWXUDO VLPLODULW\ZLWK D WHPSODWH SURWHLQ IRUZKLFK 
DWRPLFFRRUGLQDWHVDUHUHSRUWHGXVLQJH[SHULPHQWDOWHFKQLTXHVOLNH;-ray crystallography 
or NMR spectroscopy. Various applications of homology modeling in the drug-discovery 
process have been reported, yielding critical insights about structural and mechanistic 
properties of proteins that are experimentally difficult to purify or crystallize [145, 146], 
HJ*-protein-coupled receptors [147]. Out of all the proteins studied in this dissertation, 
we did not have the structural data for only one protein, BspCBM17. However, as 
described in Chapter 1, this CBM is an important part of this study as a representative of 
family 17 CBMs and as a component of the native tandem CBM construct of Cel5A from 
Bacillus sp. 1139.  
The general homology modeling protocol of a protein involves five general steps: 
1. Search, identify, and select the template protein structure. 
2. $OLJQWDUJHWVHTXHQFHZLWKWKHWHPSODWHVHTXHQFH. 
3. Build a preliminary model based on the structural information from the template. 
4. Check for errors. Atom-atom overlaps, missing segments, etc. 
5. Evaluate the model. Fold, ramachandran plot, stereochemistry, etc.   
 ,IWKHJHQHUDWHGKRPRORJ\PRGHOGRHVQRWVDWLVI\WKHUHTXLUHGTXDOLW\FULWHULDRQH
can go back to first step, choose the next best template and repeat steps 2 to 5. The 
detailed process of comparative protein modeling has been previously defined in the 
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literature [145]. We have used a fully automated protein structure homology-modeling 
server SWISS-02'(/WKDWSURYLGHVDOOWKHGDWDEDVHVIRUSURWHLQVHTXHQFHDQGVWUXFWXUH
DQG WRROV IRU WHPSODWHVHOHFWLRQPRGHOEXLOGLQJDQGVWUXFWXUHTXDOLW\HYDOXDWLRQwith a 
simplified user interface and workflow [148-150]. It uses Qualitative Model Energy 
Analysis (QMEAN), a composite scoring function based on four different geometrical 
properties that provides both global (i.e., for the entire structure) and local (i.e., per 
UHVLGXHDEVROXWHTXDOLW\HVWLPDWHV[151].  QMEAN4 < - LQGLFDWHVYHU\ORZTXDOLW\$
general overview of homology modeling of the BspCBM17 target structure from the 
CcCBM17 template structure (PDB ID – - KDYLQJ  VHTXHQFH LGHQWLW\ LV
illustrated in Figure 2.1. 
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Figure 2.1 Homology modeling of BspCBM17 using the SWISS-MODEL. The 
QMEAN4 for this model was – 2.34 suggestiQJDFFHSWDEOHTXDOLW\RIWKHPRGHO 
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2.1.2 Molecular Docking 
When two macromolecules, such as a protein and a carbohydrate, are known 
through biochemical studies to form a complex, docking of one molecule to another can 
be utilized to understand physical interactions, binding mechanisms, and binding affinity 
between those two molecules; this presumes there is either sufficient structural evidence 
of similar associations from which to model or biochemical evidence identifying the 
protein binding site. There are multiple approaches to docking, and we implement three 
different docking methods in this dissertation, each of which is appropriate to the 
available experimental data and binding scenario. Our docking cases include two cases 
where the binding site is clearly identified from structural evidence (bound docking) and 
one case wherein a biochemical association suggests a binding site (unbound docking).   
2.1.2.1 Docking of oligomeric ligands through pairwise alignment 
,QWKHFDVHRI7\SH%&%0VZHKDGDµERXQGGRFNLQJ¶situation where the cello-
oligomeric ligand was common and CBMs were different. The general assumption 
behind this docking approach is that, with very high structural and chemical similarity of 
binding sites in CBMs from same family the oligosaccharide ligands would occupy 
approximately same position in the binding sites. For CBMs with only apo structures 
available, we transferred the coordinates of the cello-oligomer from a holo structure of a 
highly homologous CBM from the same family after a pairwise alignment. We used the 
DALI pairwise comparison tool to obtain the aligned structures [152]. After the 
alignment, we copied the cello-oligomer into the binding site of the target CBM, which 
was followed by an extensive vacuum minimization protocol in the MD simulation setup 
process. This docking methodology was used in the cases of CfCBM4-2, BspCBM17 
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(apo structure obtained through homology modeling), and BspCBM28 where the cello-
oligomer was docked from the available holo structures of CfCBM4-1, CcCBM17, and 
CjCBM28, respectively. A general overview of this docking is shown in Figure 2.2.  
 
Figure 2.2 Docking of cello-oligomers through pairwise alignment. Illustrated here is an 
example of docking cellopentaose with apo BspCBM28 (PDB 1UWW) structure using 
the holo structure of CjCBM28 (PDB 3ACI).  
2.1.2.2 Oligosaccharide docking based on structural similarity 
 All the carbohydrate ligands considered in search of the potential physiological 
ligand of YKL-40 are composed of monomers with six-membered pyranose ring as the 
structural backbone. In contrast with CBMs, here we have a common protein with 
variable ligands. We utilized the structural similarity of the ligands to dock the 
monomeric units of the desired oligosaccharide at the most favorable positions based on 
the known coordinates of the bound chito-oligomer in the YKL-40 crystal structure. The 
chair conformation of six-membered pyranose ring, being mostly symmetrical, allows 
approximate positioning of the structurally similar monomer of the desired 
oligosaccharide. The sidechains of the ligand were then built by using the internal 
coordinate data (i.e., standard bond distances and angles for a given residue) provided in 
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the topology of the respective monomeric units. An example of cellohexaose docking 
based on chitohexaose coordinates is illustrated in Figure 2.3.  
 
Figure 2.3 Transition from chitohexaose (green-red sticks) to cellohexaose (cyan-red 
sticks) using structural similarity and sidechain rebuilding with internal coordinates from 
topology database. This procHGXUHLVORRVHO\UHIHUUHGWRDVµGRFNLQJ¶LQWKLVGLVVHUWDWLRQ 
2.1.2.3 Protein-protein docking with shape complementarity 
 To identify the surface-binding site on YKL-40 for relatively large ligands like 
the triple helical collagen peptides, we used a different aSSURDFKZLWKµXQERXQGGRFNLQJ¶
of rigid molecules. The binding affinity between two molecules depends upon non-
bonded interactions such as van der Waals and electrostatic contributions, but it is also 
necessary that their shapes are complementary to each other. Making the naïve 
assumption that the interacting molecules have rigid surfaces, matching local shape 
features, like local curvature maxima and minima, has been previously reported to 
correctly predict biomolecular association [153-155]. We implemented the shape 
  38 
complementarity docking method by using the algorithm called PatchDock, which was 
LQVSLUHG E\ REMHFW UHFRJQLWLRQ DQG LPDJH VHJPHQWDWLRQ WHFKQLTXHV XVHG LQ FRPSXWHU
vision [156].  
 
Figure 2.4 Surface representation of YKL-40 (gray) and collagen triple helix 
(multicolored) illustrating the concave and convex patches.  
The algorithm has three major stages [154], explained here in brief: 
1. Molecular Shape Representation – In this step, the molecular surface of the 
molecule is computed. Next, a segmentation algorithm is applied for detection of 
geometric patches (concave, convex and flat surface pieces). The patches are filtered, 
so that only pDWFKHVZLWK¶KRWVSRW¶UHVLGXHVDUHUHWDLQHG 
2. Surface Patch Matching – $K\EULGRI WKH*HRPHWULF+DVKLQJDQG3RVH-Clustering 
PDWFKLQJ WHFKQLTXHV DUH DSSOLHG WRPDWFK WKH SDWFKHV GHWHFWHG LQ WKH SUHYLRXV VWHS
Concave patches are matched with convex and flat patches with any type of patches. 
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3. Filtering and Scoring – The candidate complexes from the previous step are 
examined. All complexes with unacceptable penetrations of the atoms of the receptor 
to the atoms of the ligand are discarded. Finally, the remaining candidates are ranked 
according to a geometric shape complementarity score. 
2.2 Molecular dynamics (MD) Simulations 
 MD simulations implemented in this study are a computational approach to 
predicting atomic-level interactions in a system of molecules based on time-dependent 
calculation of atomic positions using classical mechanics and empirically-derived forces 
between all the atoms in the system (i.e., force fields) [157, 158]. When such calculations 
are performed with very small time-steps (i.e., 1-2 femptoseconds) consecutively over a 
period of time to obtain a trajectory, the statistical analysis of this large data set of atomic 
SRVLWLRQV LQ WLPH FDQ SURYLGH DQVZHUV WR TXHVWLRQV RI ELRORJLFDO LQWHUHVW VXFK DV QRQ-
catalytic protein-carbohydrate binding interactions. MD simulation of biomolecules has 
EHFRPH µD FRPSXWDWLRQDOPLFURVFRSH¶ LQPROHFXODU ELRORJ\ DQG LV H[SHFWHG WR KDYH D
significant impact on transformation of process of drug discovery [159, 160].  
 For N number of atoms in a system, the forces acting on each atom are governed 
by the potential energy function, U(rN), which is function of the position of each atom, rN. 
7KHWUDMHFWRU\RIWKHDWRPVLVGHWHUPLQHGXVLQJDQLQWHJUDWRUWRVROYH1HZWRQ¶VVHFRQG
ODZRIPRWLRQ(TXDWLRQVDQG7KHUHDUHYDULRXVYHUVLRQVRIWKH9HUOHW,QWHJUDWRU
[161, 162] µYHORFLW\ 9HUOHW¶ [163, 164] DQG D µOHDSIURJ IRUP¶ [165] being the most 
commonly used versions. 
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௜݂ = ݉௜ ߲ଶݎపሬԦ߲ݐଶ                                                                                                                            …ܧݍ 2.1 
௜݂ = െ ߲߲ݎ௜ ܷ(ݎଵ, ݎଵ, ݎଵ, ݎଵ, … … , ݎ୒)                                                                                   …ܧݍ 2.2 
where, ௜݂ is the force acting upon atom i, ݉௜ is the mass of the atom, ܽ௜ is the acceleration 
of the atom, and ݎ is the position vector of the atom. i =(1,2,3,…,N)  
  The sum of bonded and non-bonded contributions represents the total 
potential energy of the system as a function of atomic coordinates (TXDWLRQ7KH
ERQGHG WHUPV (TXDWLRQ  LQFOXGH FRQWULEXWLRQV IURP VWUHWFKLQJ RI ERQGV b) from 
HTXLOLEULXPERQGOHQJWKb0), where Kb is the force constant; bending of angles (ș) from 
WKHHTXLOLEULXPDQJOHș0), where Kș is the force constant; rotation of dihedral angles (ĳ) 
ZLWKDSKDVHVKLIWįZKHUHQLVWKHSHULRGLFLW\RIWKHGLKHGUDODQJOHDQGKĳ is the force 
constant; perturbation of improper angles (ȦIURPWKHHTXLOLEULXPLPSURSHUDQJOHȦ0), 
where KȦ is the force constant; the Urey-Bradley vibrational term (UB, S); and the 
backbone torsional correction factor (CMAP, ߮, ߰). The non-ERQGHG WHUPV (TXDWLRQ
2.5) include summation, over pairs of atoms, of Coulombic interactions between point 
atomic charges (qi and qj) and the Lennard-Jones (LJ) 6-12 term, where ߝ௜௝୫୧୬ represents 
the depth of the potential well, ܴ௜௝୫୧୬ is the distance at which the LJ potential reaches its 
minimum value, and rij is the interatomic distance between two atoms, i and j. The ݎ௜௝ିଵଶ 
term represents the short-range repulsive interaction, and the ݎ௜௝ି଺  term represents the 
long-range attractive/dispersive interaction of the LJ potential.  
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ܷ(ݎԦ) =  ܷୠ୭୬ୢୣୢ +  ܷ୬୭୬ିୠ୭୬ୢୣୢ                                                                                                    …ܧݍ 2.3 
ܷୠ୭୬ୢୣୢ = ෍ ܭ௕(ܾ െ ܾ଴)ଶ
ୠ୭୬ୢୱ
+ ෍ ܭఏ(ߠ െ ߠ଴)ଶ
ୟ୬୥୪ୣୱ
+ ෍ ܭఝ(1 + cos(݊߮ െ ߜ))
ୢ୧୦ୣୢ୰ୟ୪ୱ
 
              + ෍ ܭఠ(߱ െ ߱଴)ଶ
୧୫୮୰୭୮ୣ୰ୱ
+ ෍ ܭ୙୆(ܵ െ ܵ଴)ଶ
୙୰ୣ୷ି୆୰ୟୢ୪ୣ୷
+ ෍ ܷେ୑୅୔(߮,߰)
௥௘௦௜ௗ௨௘௦
…ܧݍ 2.4 
ܷ୬୭୬ିୠ୭୬ୢୣୢ = ෍ ߝ௜௝୫୧୬ ൥ቆܴ௜௝୫୧୬ݎ௜௝ ቇଵଶ െ 2 ቆܴ௜௝୫୧୬ݎ௜௝ ቇ଺൩୴ୟ୬ ୢୣ୰ ୛ୟୟ୪ୱ + ෍ ݍ௜ݍ௝4ߨߝ଴ߝݎ௜௝ୡ୭୳୪୭୫ୠ୧ୡ             …ܧݍ 2.5 
 The potential energy function, ܷ(ݎԦ) in (TXDWLRQV   DQG  [166], is the 
functional form of potential energy that can be used with the CHARMM36 all atom 
force-ILHOGZKHUHWKHHTXLOLEULXPYDOXHVDQGIRUFHFRQVWDQWVDUHLPSOHPHQWHGEDVHGRQ
TXDQWXPPHFKDQLFDO FDOFXODWLRQV RU H[SHULPHQWDO GDWD 'HWDLOHG LQIRUPDWLRQ DERXW the 
DOJRULWKPVWRQXPHULFDOO\VROYH WKHHTXDWLRQVRIPRWLRQDSSOLFDWLRQRIFRQVWUDLQWVDQG
periodic boundary conditions, and temperature and pressure control methods can be 
found in literature [167, 168]; also, details of our simulation protocols and parameter 
selections have been provided in the methods section of each chapter with corresponding 
references. In this dissertation, we have used CHARMM [166] and NAMD [169] as 
simulation software packages in association with VMD [170] and PyMOL [171] as 
molecular modeling and visualization tools. The latter two of which provide various 
modules to perform and analyze the MD simulations according to scientific needs.    
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2.3 Free energy calculations 
 While understanding the dynamic binding mechanisms of two biomolecules is 
important, knowing the free energy change associated with a binding event is also 
important, as it adds context to the characterization of ligand binding site dynamics and 
enables comparison of thermodynamic favorability in the case of multiple potential 
ligands. Free energy is a state function, and, although the difference in free energies of 
two states of a system is independent of the path chosen, one must pay attention to 
convergence and optimize use of computational resources. Here, we have used two 
enhanced-sampling free energy computation approaches to determine binding affinities.  
2.3.1 Free Energy Perturbation with Hamiltonian Replica Exchange Molecular 
'\QDPLFV)(3Ȝ-REMD) 
 )(3Ȝ-REMD LV DQ DOFKHPLFDO IUHH HQHUJ\ WHFKQLTXH ZLWK HQKDQFHG-sampling, 
i.e., replica exchange, to calculate relatively accurate absolute binding free energies of 
small molecules to proteins. A computationally inexpensive FEP simulation protocol was 
first developed by Deng and Roux, applicable to small ligands like benzene [172, 173]. 
With the availability of much faster and less expensive computational resources, Jiang et. 
al. [174, 175] modified this protocol by using FEP in association with Hamiltonian 
replica exchange MD to significantly improve the sampling and accelerate the 
convergence of computations, expanding application to a wider range of ligand 
molecules. The binding affinities of proteins for oligosaccharides calculated using this 
method are directly comparable to experimental binding free energies of the same 
systems measured using ITC.  
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Figure 2.5 The thermodynamic pathway implemented in )(3Ȝ-REMD to obtain ligand 
binding free energy. “Solv” refers to the solvated system and “Vac” refers to the vacuum. 
 The overall alchemical pathway used in this method (Figure 2.5) to calculate the 
DEVROXWHELQGLQJIUHHHQHUJ\¨*b) between protein and ligand includes two independent 
steps: i) decoupling of the ligand interactions from the protein-ligand complex in solution 
and ii) decoupling of the ligand interactions from the solvated ligand without the protein. 
7KHGLIIHUHQFHEHWZHHQ WKH IUHH HQHUJ\ FKDQJHVRI WKHVH WZR VWHSV JLYHV¨*b. In each 
step of this pathway, the free energy change is calculated by gathering contributions from 
WKH GLVWULEXWLRQ RI WKH SRWHQWLDO HQHUJ\ IXQFWLRQ (TXDWLRQ  LQWR QRQ-bonded 
interactions and restraints.  
ܷ = ܷ଴ + ߣ௥௘௣ ௥ܷ௘௣ + ߣௗ௜௦௣ܷௗ௜௦௣ + ߣ௘௟௘௖ ௘ܷ௟௘௖ + ߣ௥௦௧௥ ௥ܷ௦௧௥                                      …ܧݍ. 2.6 
where, ܷ଴ is the potential energy of the system with totally non-interacting ligand 
 Thermodynamic coupling parameters, Ȝrep, Ȝdisp, and Ȝelec WKDW YDU\ IURP µ¶ WR
µ¶UHSUHVHQWLQJWUDQVLWLRQIURPIXOOLQWHUDFWLRQWRIXOOGHFRXSOLQJRIUHSXOVLYHGLVSHUVLYH
and electrostatic interactions, respectively, are uniformly distributed over the number of 
replicas dedicated to the type of interaction. Figure 2.6 illustrates the implementation of 
replica distribution in which we used 128 replicas in total, with 72 repulsive, 32 
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dispersive, and 24 electrostatic replicas. Each replica from the set of replicas within a 
given type occupies multiple processors, in a parallel/parallel mode. The probability of 
whether WKHȜ-swap between the given two replicas will happen or not is calculated by a 
conventional Metropolis Monte Carlo algorithm [174]. In our study, the fourth 
contribution from restraints, usually having relatively little contribution (needed only in 
the 1st step to maintain the distance between the center of mass of protein and that of 
OLJDQGZDVQRWDSDUWRIWKHUHSOLFDH[FKDQJHSURWRFROWRUHGXFHUHTXLUHGFRPSXWDWLRQDO
time. Instead, MD simulations with Ȝrstr distributed over 13 consecutive windows of 0.1 
ns each, followed by numerical inWHJUDWLRQ ZLWK 6LPSVRQ¶V UXOH [173] were used to 
determine the contribution to free energy from added restraints. 
 
Figure 2.6 Scheme of replica distribution and exchange in )(3Ȝ-REMD, as 
implemented in this dissertation. Each box represents an individual MD simulation with 
specified conditions of Ȝ. The arrows represent the possible attempts of Ȝ-swap with 
neighboring replicas after each replica has completed the MD steps specified by replica 
H[FKDQJHIUHTXHQF\5HVWUDLQLQJFRQWULEXWLRQVZHUHQRWSDUWRI UHSOLFDH[FKDQJH LQRXU
case. The scheme has been adapted with permission from Jiang et. al. [175]. Copyright 
2010 American Chemical Society.  
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 For the three main contributions, we run these set of 128 replicas for 20 or more 
consecutive (but independent) windows of 0.1 ns each. After collecting the output 
potential energies from all the replicas and regrouping the values corresponding to Ȝ-
values for each type of interactions at the end of each window, multistate Bennett 
Acceptance Ratio (MBAR) method was used to determine the free energy changes for 
individual contributions along with their statistical uncertainties [176]. The convergence 
RI WKH FDOFXODWLRQVZDV DVVXUHG DV WKHZLQGRZVZHUH DQDO\]HG VHTXHQWLDOO\ WR SORW WKH
time progression of the total free energy change. The calculation was continued until we 
observed converged output for 1 ns where 20 windows of 0.1-ns each were sufficient in 
most cases in this study. The final free energy change was reported as the average of the 
last 1 ns data. The error of the averaged free energy change was reported as 1 standard 
deviation. More specifics of use of this method in this dissertation are provided in the 
methods section of respective chapters. This free energy calculation method can now be 
implemented through a dedicated module in the widely used simulation software 
package, NAMD (version 2.12) [169], while we used a developer version in NAMD 
provided by Wei Jiang, Argonne National Laboratory.  
2.3.2 Umbrella Sampling 
 In principle, umbrella sampling is merely several MD simulations conducted over 
the range of a pre-defined reaction coordinate (RC). A biasing potential term is added to 
the conventional potential energy function, directing the simulation to cross energy 
barriers and sample the conformational space typically inaccessible to unbiased classical 
MD [177, 178]. Umbrella sampling can be used to determine the free energy surface of 
the system, also referred to as potential of mean force (PMF), along that path of the 
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thermodynamic system from reference state to target state [179]. For calculation of the 
PMF, usually a harmonic restraint is used as the biasing potential, a function of reaction 
coordinate. This RC can be any observable like distance between protein and ligand 
ultimately defining the desired path between two states. Enhanced sampling is performed 
consecutively for windows covering the range of a selected RC that dictates the desired 
path. 
ܸ௎ௌ(ߟ(ݎԦ)) =  12 ܭ௎ௌ(ߟ(ݎԦ) െ ߟ଴)ଶ                                                                                   …ܧݍ. 2.7 
where, ܸ௎ௌ(ߟ)  is the biasing potential, ܭ௎ௌ  is the restraining force constant, ߟ  is the 
instantaneous RC, and ߟ଴ LVWKHHTXLOLEULXPYDOXHRI5&LQJLYHQZLQGRZ 
ܷ௎ௌ(ݎԦ) = ܷ(ݎԦ) +  ܸ௎ௌ൫ߟ(ݎԦ)൯                                                                                         … Eq. 2.8 
where, ܷ௎ௌ(ݎԦ) is new biased total potential energy function and ܷ(ݎԦ) is old unbiased 
potential energy function  
 The range of RC is divided into specific values (or windows), and MD 
simulations are run for each window, collecting the instantaneous values of RC. Either 
weighted histogram analysis method (WHAM) [180, 181] or multistate Bennett 
acceptance ratio (MBAR) [176] analysis can be used to estimate unbiased probability 
distribution and ultimately build the PMF profiles [182]. With WHAM, errors need to be 
computed separately, which is usually done by a standard bootstrapping method [181, 
183], while MBAR has a direct way to calculate errors [176]. The free energy of binding 
is then determined from the PMF by taking the difference between the free energy at RC 
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= 1 and RC = 0. For convergence and accuracy, two factors are closely observed, i) 
HTXLOLEUDWLRQRIDOOXPEUHOOD-sampling windows where initial sampling data is discarded 
ii) PMF profile near the ends of RC where minima/maxima/plateau is important for 
accurate difference in free energy. 
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Chapter 3  – Cello-oligomer binding dynamics and bi-directional binding 
phenomenon in Type B CBMs 
 As the title suggests, Chapter 3 reports the bi-directional ligand binding 
phenomenon in all three families (4, 17 and 28) of Type B CBMs and cellopentaose 
binding dynamics in two family 4 CBMs. Most of this chapter, i.e. experiments related to 
family 4 CBMs, has been adapted with permission from Kognole and Payne [184], 
Copyright © 2015, Oxford University Press. As the experiments related to family 17 and 
28 CBMs are going to be part of another journal article, we only add one subsection in 
this chapter to discuss the results relative to the topic of this chapter.  
3.1 Abstract 
 Carbohydrate binding modules (CBMs) play significant roles in modulating the 
function of cellulases, and understanding the protein-carbohydrate recognition 
mechanisms by which CBMs selectively bind substrate is critical to development of 
enhanced biomass conversion technology. CBMs exhibit a limited range of specificity 
and appear to bind polysaccharides in a directional fashion dictated by the position of the 
ring oxygen relative to the protein fold. The two family 4 CBMs of Cellulomonas fimi 
Cel9B (CfCBM4) are reported to preferentially bind cellulosic substrates. However, 
experimental evidence suggests these CBMs may not exhibit a thermodynamic 
preference for a particular orientation. We use molecular dynamics (MD) and free energy 
calculations to investigate protein-carbohydrate recognition mechanisms in CfCBM4-1 
and CfCBM4-2 and to elucidate preferential ligand binding orientation. For CfCBM4-1, 
we evaluate four cellopentaose orientations including that of the crystal structure and 
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three others suggested by NMR. These four orientations differ based on position of the 
ligand reducing end and pyranose ring orientations relative to the protein core. MD 
simulations indicate the plausible orientations reduce to two conformations. Calculated 
ligand binding IUHH HQHUJ\ GLVFHUQV HDFK RI WKH RULHQWDWLRQV LV HTXDOO\ IDYRUDEOH 7KH
calculated free energies are in excellent agreement with isothermal titration calorimetry 
measurements from literature. Through MD simulations we confirm the bi-directional 
binding of cellopentaose to four other Type B CBMs, two CBMs from family 17 and 28 
each. These MD simulations further reveal the approximate structural symmetry of the 
oligosaccharides relative to the amino acids along the binding cleft plays a role in the 
promiscuity of ligand binding. A survey of ligand-bound structures insinuates this 
phenomenon may be characteristic of the broader class of SURWHLQV EHORQJLQJ WR WKHȕ-
sandwich fold. 
3.2 Introduction 
 The multi-modular Cellulomonas fimi endoglucanase Cel9B (formerly CenC) 
exhibits tandem Type B, N-terminal CBMs, both of which belong to Family 4 [105]. The 
domains, CfCBM4-1 (formerly CBDN1) and CfCBM4-2 (formerly CBDN2), appear 
VHTXHQWLDOO\ DQG DGGLWLYHO\ ELQG DPRUSKRXV FHOOXORVH [98]. CfCBM4-1 is of historical 
significance as the first known soluble substrate-binding CBM, the discovery of which 
led to renewed interest in CBM function in general. Both CfCBM4-1 and CfCBM4-2 
bind cellotetraose and cellopentaose with increasing affinity [98, 110], suggesting each 
ELQGLQJFOHIWFRQVLVWVRIS\UDQRVHELQGLQJVXEVLWHV IRUPHGE\ WKHSDUDOOHOȕ-sheets of 
WKH ȕ-sandwich (Figure 3.1); this was later confirmed when Boraston et al. solved the 
cellopentaose bound CfCBM4-1 structure [62]. The affinity of CfCBM4-1 and CfCBM4-
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2 for cello-oligomers is roughly the same for a given length, and isothermal titration 
calorimetry suggests binding of cello-oligomers to both CBM4s is enthalpically driven 
[98, 110]. This latter observation is consistent with the large population of potential 
hydrogen-bonding polar residues lining the binding cleft [99], compared to those from 
planar binding sites of Type A CBMs [16]. Despite the apparent similarities in specificity 
DQG ELQGLQJ PRGH WKH WZR PRGXOHV H[KLELW RQO\  VHTXHQFH LGHQWLW\ ZLWK QRWDEOH
amino acid substitutions along the binding cleft. The binding cleft of CfCBM4-2 is also 
noticeably wider than CfCBM4-1 [62, 110]. We anticipated that direct comparison of the 
dynamics of cellopentaose-bound CfCBM4-1 and CfCBM4-2 will elucidate the 
IXQGDPHQWDO LQWHUDFWLRQV GULYLQJ ȕ-1,4-linked glucan specificity in Family 4 CBMs. 
Furthermore, these findings are likely to have broad applicability to other CBM families 
ZLWKȕ-sandwich folds. 
  51 
 
Figure 3.1 CfCBM4-1 and CfCBM4-2 ligand conformations considered in this study. 
CfCBM4-1 is shown in gray cartoon. CfCBM4-2 is shown in salmon cartoon, and 
cellopentaose is shown in green and red stick. (a) CfCBM4-1-RE represents the ligand 
orientation of the CfCBM4-VWUXFWXUH3'%*8ZLWKWKHUHGXFLQJHQG5(LQDOHIW- 
to-right fashion, and (b) CfCBM4-1- NRE illustrates the reverse, transverse axis 
transformation with the ligand oriented so the reducing end runs from right-to-left. (c) 
CfCBM4-1-5(¶UHSUHVHQWVWKHVWUXFWXUDOOLJDQGRULHQWDWLRQZLWKWKH5(IURPOHIW-to-right, 
but the cellopentaose has been rotated 180° about the length of the C1-C4 axis, locating 
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the hydroxymethyl groups out of register. (d) CfCBM4-1- 15(¶ UHSUHVHQWV ERWK WKH
transverse axis rotation and the 180° C1-C4 rotation of the cellopentaose in the binding 
cleft. (e) CfCBM4-2-RE represents the CfCBM4-1 structural ligand orientation (PDB 
*8ZLWK WKH UHGXFLQJ HQG RI WKH OLJDQG UXQQLQJ IURP OHIW-to-right. (f) CfCBM4-2- 
NRE represents the transverse axis transformation of cellopentaose so the reducing end 
runs from right-to-left. 
 NMR analysis of nitroxide spin-labeled cello-oligomer derivatives also put forth 
the intriguing, though somewhat controversial, hypothesis that CfCBM4-1 and CfCBM4-
2 are capable of binding a cello-oligomer in a multi-directional fashion [61]. Johnson et 
al. examined association of 2,2,6,6-tetramethylpiperidine-1-oxyl-4-yl (TEMPO) labeled 
cellotriose and cellotetraose with the individual CfCBM4-1 and CfCBM4-2 domains [61]. 
At the time of this study, structural resolution of a ligand bound CBM4 was unavailable, 
DQG 105 WHFKQLTXHV ZHUH D FRPSOHPHQWDU\ DSSURDFK WRZDrd understanding ligand 
binding in lieu of crystallographic evidence. Determination of 1H and 15N chemical shifts 
confirmed labeling did not significantly affect affinity, and paramagnetic relaxation 
studies further revealed the nitroxide label could lie at either end of the binding clefts. 
However, relative occupancies were not determined as a means to suggest a “more 
favorable” conformation. The multi-directional binding observation is interesting because 
it is counter to intuition. Polysaccharides exhibit a large dipole along the length of the 
polymer as a result of several factors including the parallel orientation of chains, the 
asymmetric pyranose ring oxygen atom, and the chemical polarity of the individual 
chains [185, 186]; for the cellopentaose ligand, the dipole moment is approximately 12 D. 
On the surface, it seems such a dipole would preclude multi-directional binding, as 
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proteins would likely evolve in such a way as to most effectively hydrogen bond with the 
oligomer in a given direction. Boraston et al. reached a similar conclusion upon solution 
of the cellopentaose-bound CfCBM4-1 structure in 2002 [62]. The structure captured the 
cellopentaose with one hydrophilic edge of the sugar pointed in toward the binding 
groove and the other edge exposed to solvent. Unambiguous electron density pointed to a 
single thermodynamically favorable conformation occupying the 5 subsites of the binding 
cleft. Nevertheless, the authors left open the possibility that serendipitous crystal packing 
interactions may have resulted in binding the least favorable cellopentaose orientation. Of 
course, the ability to multi-directionally bind of cello-oligomers would be significantly 
advantageous in engineered cellulase or cellulosomal constructs, allowing the CBMs to 
target amorphous cellulose from virtually any angle. Thus, determining whether this 
capability does in fact exist in a WKHUPRG\QDPLFDOO\HTXLYDOHQWFDSDFLW\DQGKRZPXOWL-
directional CBM4 substrate binding is accomplished promises to inform future 
biotechnological development. 
3.3 Methods 
3.3.1 Modeling of cello-oligomer in multiple orientations 
 We use molecular dynamics (MD) simulations to explicitly examine cello-
oligomer binding mechanisms in Family 4 CBMs. MD simulations of eight total systems 
representing the various ligand configurations of CfCBM4-1 and CfCBM4-2 were 
FRQGXFWHG IRU  ȝV 6L[ V\VWHPV UHSUHVHQWLQJ SRVVLEOe variations in binding cleft 
occupation were examined in addition to the two unbound proteins. Figure 3.1 illustrates 
the corresponding case/system abbreviation used throughout this study. The CfCBM4-1 
V\VWHPVZHUH FRQVWUXFWHGEDVHGRQ WKH*83URWHLQ'Dta Bank (PDB) structure [62], 
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and the CfCBM4-2 systems were constructed from the 1CX1 PDB structure [110]. As 
discussed above, the CfCBM4-1 structure features a bound cellopentaose ligand, which 
was used here as the basis for investigation of ligand dynamics and directionality 
preference. Four ligand orientations bound to CfCBM4-1 were considered representing: 
(1) the structural orientation (CfCBM4-1-RE); (2) a reversed ligand orientation where the 
non-reducing end of the cellopentaose occupies the original reducing end position of the 
structural conformation and symmetry of the glucopyranose side chains is maintained 
(CfCBM4-1-NRE); (3) a rotation of the structural cellopentaose conformation about C1-
C4 axis so the opposite hydrophilic edge faces inward to the protein, effectively locating 
a C5 hydroxymethyl group where the C3 hydroxyl previously existed (CfCBM4-1-5(¶
and (4) a transverse axis reversal along with the C1-C4 rotation (CfCBM4-1-15(¶$V
the CfCBM4-2 NMR structure does not contain a ligand, the bound CfCBM4-2 systems 
were prepared by aligning CfCBM4-2 to CfCBM4-1 protein backbones and docking the 
cellopentaose to the CfCBM4-2 structure. Two ligand orientations in CfCBM4-2 were 
FRQVLGHUHGUHSUHVHQWLQJ WKHRULHQWDWLRQRI WKH*8VWUXFWXUH CfCBM4-2-RE) and the 
transverse axis transformation (CfCBM4-2-NRE). The unbound CfCBM4-1 and 
CfCBM4-2 systems were also considered to understand the contributions of ligand 
binding to protein dynamics. A detailed description of simulation construction is 
provided ahead. 
3.3.2 MD simulation: Setup and parameters 
 All protein components of CfCBM4-1 and CfCBM4-2 simulations were 
constructed from crystal structures, manually docking the cellopentaose ligands as 
necessary through secondary structure alignment with crystal structure of CfCBM4-1 that 
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already exhibits bound cellopentaose. The CfCBM4-1 simulations were constructed from 
WKH*83'%VWUXFWXUH LQZKLFKCfCBM4-1 binds cellopentaose in the binding cleft. 
The nomenclature used in this study reflects the orientation of the ligand captured in 
*8 VWUXFWXUH [62]; we have defined this as the “reducing end” conformation of the 
bound ligand (CfCBM4-1-RE), numbering the pyranose moieties from 1 to 5 accordingly 
(Figure 3.2). The “non-reducing end” conformation (CfCBM4-1-NRE) was prepared 
from this same structure. To reverse the ligand direction, the coordinates of the heavy 
ring atoms were retained IURPWKH*8VWUXFWXUHDQGDWRPW\SHVZHUHUHDVVLJQHGVRDV
to locate the pyranose ring oxygen at the opposite end of the cleft (Figure 3.1). 
CHARMM was used to reconstruct the remaining hydrogens and primary alcohol groups 
from internal coordinate tables [166]. The reducing end and non-reducing end 
cellopentaose conformations bound to CfCBM4-2, CfCBM4-2-RE and CfCBM4-2-NRE, 
respectively, were constructed by docking the CfCBM4-1-RE and CfCBM-4-1-NRE 
ligands through structural alignment with the 1CX1 PDB structure [110]. To prepare the 
CfCBM4-1-5(¶ DQGCfCBM4-1-15(¶ FRQIRUPDWLRQV WKH FRRUGLQDWHV RI WKH S\UDQRVH
ring heavy atoms were again renamed such that the ligand was rotated along the 
longitudinal axis relative to CfCBM4-1-RE and CfCBM4-1-NRE, respectively. 
CHARMM was used to reconstruct remaining hydrogen and primary alcohol groups. 
Protonation states of the titratable residues were determined using H++ and manual 
inspection of the protein environment (i.e., possible salt bridge formation) [187-190]. 
PyMOL and VMD were used for structural alignment and visualization [170, 171]. 
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Figure 3.2 Binding site nomenclature for CfCBM4-1. The CBM binds cellopentaose 
aloQJILYH LQGLYLGXDOELQGLQJVXEVLWHVSHUSHQGLFXODU WR WKHȕ-sheets forming the protein 
core. These subsites are numbered from 1 to 5. Here, we define an additional “binding 
subsite,” 0, for discussion of MD simulations of CfCBM4-1-5(¶DQGCfCBM4-1-15(¶
Subsite 0 represents a completely solvent exposed pyranose ring of the cellopentaose 
chain. The bottom panel illustrates the symmetry of a cello-oligomer oriented in the 
opposite direction. The primary alcohol groups remain in approximately the same 
location regardless of direction. 
 All constructed systems were vacuum minimized, solvated with water, neutralized 
with sodium ions, and minimized again. The minimized systems were then heated to 300 
.DQGGHQVLW\HTXLOLEUDWHGLQ&+$500$IWHUHTXLOLEUDWLRQWKHV\stems were simulated 
for 250 ns at 300 K in the NVT ensemble using NAMD [169]. All simulations used the 
CHARMM36 force-field with CMAP correction for proteins [166, 191, 192], and the 
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CHARMM36 carbohydrate force-field for the cellopentaose ligands [193-195]. The 
modified TIP3P force-field was applied to water molecules [196, 197]. Analysis of the 
250 ns MD simulations included: determination of the RMSD and RMSF of the protein 
backbones, the RMSF of cellopentaose on a per binding subsite basis, the hydrogen 
bonding and interaction energies of each glucose residue with protein, and average 
solvation of the ligand on per binding subsite basis. 
3.3.3 )UHH(QHUJ\&DOFXODWLRQ)(3Ȝ-REMD 
 :H TXDQWLWDWLYHO\ H[DPLQHG WKHUPRG\QDPLF SUHIHUHQFH RI OLJDQG GLUHFWLRQDOLW\
through a computational determination of absolute binding free energy. An enhanced 
sampling free energy methodology, Free Energy Perturbation with Hamiltonian Replica 
([FKDQJH 0ROHFXODU '\QDPLFV )(3Ȝ-REMD), was used to calculate the affinity of 
cellopentaose to CfCBM4-1 [174]. We considered two cases representing the structural 
orientation and the transverse axis rotation, CfCBM4-1-RE and CfCBM4-1-NRE, 
respectively. The remaining two CfCBM4-1 ligand orientations, rotations about the C1-
C4 axis, were excluded from free energy calculations as the ligands significantly shifted 
DORQJWKHOHQJWKRIWKHELQGLQJFOHIWRYHUWKHFRXUVHRIWKH0'HTXLOLEUDWLRQVLPXODWLRQV
and no longer represented the intended conformational state. 
 This free energy calculation protocol couples free energy perturbation with 
Hamiltonian replica-exchange molecular dynamics to enhance Boltzmann sampling [173, 
174]. The calculations were performed by decoupling the potential energy into four 
separate contributions scaled according to coupling parameters, defined mathematically 
by Jiang et al [174]. In short, the contributions to overall free energy included the shifted 
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Weeks-&KDQGOHU $QGHUVRQ UHSXOVLYH DQG GLVSHUVLYH FRPSRQHQWV ǻ*repu DQG ǻ*disp, 
respectively, DQGWKHHOHFWURVWDWLFVFRQWULEXWLRQǻ*elec. Additionally, contributions from 
DQDSSOLHG UHVWUDLQLQJSRWHQWLDOZKHUHQHFHVVDU\ZHUHFRQVLGHUHGǻ*rstr. We used the 
thermodynamic cycle in Figure 3.3 to arrive at the free energy of binding a cellopentaose 
to CfCBM4-1. The cycle consisted of two separate sets of calculations: (1) decoupling the 
bound cellopentaose from the solvated CfCBM4-1 and (2) decoupling the solvated 
cellopentaose from solution. The difference between the two values is the standard 
bindLQJIUHHHQHUJ\ǻ*b. The restraining potential was used only in the first leg of the 
cycle, decoupling cellopentaose from CfCBM4-1.  
 
Figure 3.3 Thermodynamic cycle used to determine ligand binding free energy from 
)(3Ȝ- REMD. In this case, “CBM” is CfCBM4-1 and “ligand” is cellopentaose. The 
subscripts “solv” and “vac” refer to the solvated and vacuum (or decoupled) systems, 
respectively. 
 The free energy calculations were constructed from 4 ns snapshots from the 
explicitly solvated CfCBM4-1-RE and CfCBM4-1-NRE MD simulations. The absolute 
binding free energy was determined from 40 consecutive 0.1 ns calculations, where the 
first 1 ns data was discarGHGDVHTXLOLEUDWLRQ. The simulations used a set of 128 replicas 
(72 repulsive, 24 dispersive, and 32 elHFWURVWDWLFZLWKDQH[FKDQJH IUHTXHQF\RI
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steps (every 0.1 ps). The CfCBM4-1/cellopentaose systems included a positional restraint 
defined by the distance of the center of the mass of the ligand to the center of mass of the 
protein. This restraint bias during the decoupling of cellopentaose from the solvated 
FRPSOH[WRYDFXXPZDVGHWHUPLQHGE\QXPHULFDOLQWHJUDWLRQZLWK6LPSVRQV¶UXOH [173]. 
The output energies collected during simulation were post-processed using the Multistate 
Bennett Acceptance Ratio (MBAR) to calculate the free energies and statistical 
uncertainty of the individual repulsive, dispersive, and electrostatic contributions [176]. 
Finally, summation of all the four contributions gives total free energy change for each 
OHJ RI WKH WKHUPRG\QDPLF SDWKZD\ LH ǻ*1 DQG ǻ*2). The binding free energy of 
cellopentaose to CfCBM4-1 is the difference between the free energy of decoupling of 
solvated cellopentaose from solution and the free energy of decoupling of bound 
cellopentaose from CfCBM4-LHǻ*b  ǻ*2 – ǻ*1; Figure 3.3). As described above, 
the standard deviation of these values over the 3 ns data collection period, which were 
combined using error propagation rules, is reported as the final binding free energy error. 
Convergence was determined by monitoring the time evolution of the free energy 
calculations. Additional details are provided in Appendix 1. 
3.4 Results and Discussion 
3.4.1 Symmetry of the cellopentaose is critical to binding 
 Four possible cellopentaose conformations occupying the CfCBM4-1 binding 
groove were investigated as potential multi-directional binding forms. Two of these 
conformations, CfCBM4-1-5(¶DQGCfCBM4-1-15(¶ZHUHFRQVWUXFWHGVRDVWRWHVWWKH
suitability of the binding groove to accommodate larger carbohydrate side chain groups, 
such as the hydroxymethyl group, regardless of binding subsite. The nomenclature of 
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different binding subsites for CfCBM4-1 is illustrated in Figure 3.2. These two systems, 
constructed by rotating the ligand around its longitudinal axis (Figures 3.1c and 3.1d), 
place the cellopentaose off register by one binding subsite compared to the structurally 
ERXQG OLJDQG$FFHSWDQFHRI WKH ODWWHU WZR OLJDQGFRQIRUPDWLRQVZRXOGUHTXLUHHDFKRI
the binding subsites to consist of semi-redundant hydrogen bonding residues in every 
binding subsite. 
 MD simulations indicate the CfCBM4-1 binding groove will not accept the 
cellopentaose with the hydroxymethyl group arbitrarily located along the groove. This 
result is immediately evident from visualization of both the CfCBM4-1-5(¶ DQG
CfCBM4-1-15(¶WUDMHFWRULHVMovie 3.1 and 3.2). From the CfCBM4-1-15(¶WUDMHctory, 
we observe the cellopentaose shift longitudinally across the groove within 2 ns of the 250 
ns simulation (Figure 3.4, Movie 3.2). The displacement of the cellopentaose exposes a 
glucopyranose moiety to solvent, external to the binding groove, leaving only four 
moieties bound in the groove. For the purposes of describing ligand dynamics going 
forward, we have numbered this external “binding subsite” as “0” (Figure 3.2). An 
HTXLYDOHQW VKLIW RFFXUUHG DW  QV LQ WKH CfCBM4-1-5(¶ VLPXODWLRQ (Movie 3.1). As 
described in the Methods, each of these starting configurations was extensively 
minimized in a stepwise fashion, significantly reducing the possibility that unfavorable 
molecular contacts influenced the ability of the cellopentaose to occupy the alternative 
binding site. Additionally, each of these simulations was independently repeated varying 
the random number seed, and the same shift of the cellopentaose across the binding 
groove was observed. In the remaining two cellopentaose conformations, CfCBM4-1-RE 
and CfCBM4-1-NRE, this displacement was not observed. 
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Figure 3.4 Snapshots from the CfCBM4-1-15(¶VLPXODWLRQDWDQVDQGEQV7KH
protein is shown in gray surface, and the ligand is shown in green and red stick. The 
snapshots illustrate the ligand, initially out of register from the structurally bound 
position, naturally sliding to the more energetically favorable position, defined by the 
position of the hydroxymethyl side chain facing into the binding cleft. Schematic for this 
sliding is illustrated on the panels to right in comparison with CfCBM4-1-NRE. 
 Johnson et al. suggested that the approximate structural symmetry of 
oligosaccharides accounts for the ability of the protein to bind the cello-oligomer 
regardless of directionality [61]. That is to say, upon reversing the cellopentaose within 
the binding site, the hydroxymethyl group occupies roughly the same position as the 
hydroxyl group, which may allow for similar hydrogen bonding. Rotating the 
cellopentaose, as in the CfCBM4-1-5(¶DQGCfCBM4-1-15(¶FDVHVHIIHFWLYHO\GLVUXSWV
this structural symmetry. Positioning the ligand so that the hydrogen-bonding side chains 
are no longer occupying symmetrically similar locations, the cellopentaose is no longer 
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able to make the hydrogen bonds necessary to bind within the active site, as we will show 
through explicit characterization of hydrogen bonding. Naturally, the ligand was 
displaced by one glucopyranose moiety as it readjusted its side chains similar to 
CfCBM4-1-NRE or CfCBM4-1-5( $IWHU WKH FHOORSHQWDRVH UHDFKHG DQ HTXLOLEULXP
position, the CfCBM4-1-15(¶DQGCfCBM4-1-5(¶FDVHVZHUHDSSUR[LPDWHO\HTXLYDOHQW
to CfCBM4-1-NRE and CfCBM4-1-RE, respectively.  
 In the upcoming sections, we discuss the results of the CfCBM4-1-15(¶ DQG
CfCBM4-1-5(¶ E\ FRPSDULQJ WKH HTXLOLEULXP SRVLWLRQ RI WKH FHOORSHQWDRVHZLWK IRXU
protein-bound bound moieties and a singular “external” moiety in subsite 0. Furthermore, 
as the CfCBM4-1-5(¶ DQG CfCBM-4-1-15(¶ FDVHV DUH DSSUR[LPDWHO\ HTXLYDOent to 
CfCBM4-1-RE and CfCBM4-1-NRE, respectively, we did not perform free energy 
calculations on the former two cases.  
3.4.2 Thermodynamic preference of cello-oligomer orientation 
 $SULPDU\TXHVWLRQZHKDYHVRXJKWWRDGGUHVVE\WKLVVWXG\LVZKHWKHUCfCBM4-
1 has a thermodynamic preference for a given bound cello-oligomer conformation given 
WKH LQFRQFOXVLYH QDWXUH RI H[SHULPHQWDO DSSURDFKHV WR GDWH:H XVHG )(3Ȝ-REMD to 
calculate the free energy of binding a cellopentaose ligand to the CfCBM4-1 binding 
groove in two different orientations, CfCBM4-1-RE and CfCBM4-1-NRE, having 
narrowed down putative binding conformations using MD. The free energy of binding 
cellopentaose to CfCBM4-1 in either the CfCBM4-1-RE or CfCBM4-1-NRE 
FRQIRUPDWLRQZDVDSSUR[LPDWHO\HTXal. As shown in Table 3.1, the binding free energies 
ZHUHZLWKLQHUURUDWíNFDO mol-1 DQGí5.86 1.51 kcal mol-1 for CfCBM4-1-
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RE and CfCBM4-1-NRE, respectively. The repulsive, dispersive, electrostatics, and 
restraining potential contributions are provided individually. The free energies of each 
VWHS LQ WKH WKHUPRG\QDPLF F\FOH ǻ*1 DQG ǻ*2, were obtained by summing these 
contributions. Error calculation is explained ahead. 
Table 3.1 Binding free energies of cellopentaose to CfCBM4-1 in two ligand orientations 
representing bi-GLUHFWLRQDO ELQGLQJ7KH VROYDWLRQ IUHH HQHUJ\RI FHOORSHQWDRVHǻ*2, is 
also tabulated as its three contributions – repulsion, dispersion, and electrostatics.  
 
ǻ*b ǻ*repu ǻ*disp ǻ*elec ǻ*rstr 
 
(kcal mol-1) (kcal mol-1) (kcal mol-1) (kcal mol-1) (kcal mol-1) 
Cellopentaose -  í í - 
CfCBM4-1-RE í  í í í 
CfCBM4-1-NRE í  í í 0.06 
CfCBM4-1 
Experimentala. 
í - - - - 
a. Tomme, Creagh [98] 
 The corresponding error values represent standard deviations over the final 30 of 
40 intervals, i.e., the final 3 ns of 4 ns total. The free energy over the course of the 4 ns 
calculation, in 100 ps intervals, is given in Figure 3.5. The error of the binding free 
HQHUJ\ǻ*EZDVREWDLQHGE\WDNLQJWKHVTXDUHURRWRIWKHVXPRIWKHVTXDUHGVWDQGDUG 
deviations of the free energy of decoupling cellopentaose from CfCBM4-1 and the 
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FHOORSHQWDRVHVROYDWLRQIUHHHQHUJ\ǻ*1 DQGǻ*2. Error calculations based on statistical 
correlation of the data for each 100 ps interval are reported in the Supplementary Data 
(Figure 3.5). We have chosen to report the standard deviation here, as this represents the 
larger of the two values. Progress toward convergence was assessed by monitoring the 
time evolution of the free energy calculation (Figure 3.5). The effect of replica-exchange 
IUHTXHQF\ RQ WKH VDPSOLQJ DQG FRQYHUJHQFH RI WKH ELQGLQJ IUHH HQHUJ\ LQ WKH FDVH RI 
CfCBM4-1-RE was also considered (Details are provided in Appendix 1).  
 
Figure 3.5 &DOFXODWHG*LEEV IUHHHQHUJ\RYHUFRQVHFXWLYH-ns calculations using 
)(3Ȝ-REMD. The difference between the average value for either CfCBM4-1-RE or 
CfCBM4-1-NRE and the cellopentaose solvation free energy represents the binding free 
energy.  
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 The calculated binding free energies were in excellent agreement with a 
previously measured value obtained by isothermal titration calorimetry (ITC) at 35°C 
[98]. The reported value of cellopentaose binding to CfCBM4-1 in pure water at 35°C is 
– 5.24 0.91 kcal mol-1. As ITC does not provide structural-level resolution of ligand 
binding, the experimental binding free energy likely represents the ensemble of both 
putative binding conformations. Considering the accuracy of both ITC and free energy 
calculations [198, 199], the difference between the two is relatively insignificant. 
Calculated free energies of binding cellopentaose to CfCBM4-1 support the hypothesis 
that CfCBM4-1 possesses the ability to bi-directionally bind cello-oligomers. Our 
ILQGLQJVRIDSSUR[LPDWHWKHUPRG\QDPLFHTXDOLW\DUHLQOLQHZLth the original Johnson et 
al. study using TEMPO-labeled cello-oligomers coupled with NMR to observe ligand 
binding [61]. The crystallographic structure, later captured by Boraston, et al., temptingly 
suggests that CfCBM4-1 binds cellopentaose in a single, thermodynamically favorable 
orientation relative to the binding cleft [62]. Boraston et al. describe how the distance-
dependent nature of the NMR spin-labeling analysis prohibits calculation of relative 
occupancy of each of the ligand binding conformations, dismissing the possibility that bi-
directional binding represents anything more than a low-occupancy state. While free 
energy calculations also suffer from the inability to capture the statistical likelihood of a 
given orientation WKH HTXDOLW\RI WKH IUHH HQHUJ\RIELQGLQJFHOORSHQWDRVH LQ HLWKHU WKH
CfCBM4-1-RE or the CfCBM4-1-NRE conformation suggests occupancy of each state is 
HTXDOO\ OLNHO\ DQG WKH FDSWXUHG VWUXFWXUDO RULHQWDWLRQ ZDV D UHVXOW RI FLUFXPVWDQFH or 
experimental conditions of crystallography. 
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3.4.3 CfCBM4-1 hydrogen bonding  
 The cellopentaose ligand formed approximately the same number of hydrogen 
bonds in each binding subsite regardless of the direction of the ligand (Figure 3.6). VMD 
was used to determine the average number of hydrogen bonds formed per pyranose ring 
and side chain with the surrounding protein [170]. The criteria used to define a hydrogen 
bond was a 3.0 Å donor-acceptor distance and a 20° angle cutoff. The number of 
hydrogen bonds a ring formed was determined for each frame of the trajectory and 
averaged over the 250-ns length. Hydrogen bonding primarily occurred with subsites 1 
through 3, where $UJ*OQ*OQ$VQDQG$Vn81 were the primary residues 
participating in hydrogen bonding. 
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Figure 3.6 Hydrogen bonding partners (dashed lines) at each subsite between side chains 
of cellopentaose (green and red sticks) and amino acids of CfCBM4-1-RE (yellow, red, 
and blue sticks). The CfCBM4-1 backbone is shown in gray cartoon. To aid in viewing, 
the aromatic residues of binding cleft are shown in thin, marine blue lines. Binding 
subsites are numbered in balloons. Lower panel - Average number of hydrogen bonds (H-
bonds) formed between the pyranose ring and the surrounding protein of CfCBM4-1 
binding site. Error bars represent one standard deviation. 
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 Detailed analysis of hydrogen bonding over the course of MD simulations defined 
the primary hydrogen bonding partners in the CfCBM4-1 binding subsites responsible for 
acceptance of a bi-directionally bound cellopentaose (Figure 3.6). In subsite 1, Arg75 and 
*OQK\GURJHQERQGZLWKWKHVHFRQGDU\hydroxyl groupVRIWKHS\UDQRVHULQJ*OQ
generally bonds with the primary hydroxyl group of the pyranose ring in subsite 2, while 
occasionally hydrogen bonding with the secondary hydroxyl group of the subsite 3 
pyranose. Asn50 and Asn81 hydrogen bond with the secondary hydroxyl groups of the 
subsite 3 pyranose. The protein surrounding subsite 4 rarely participated in hydrogen 
bonding with the pyranose ring, but when a hydrogen bond was formed, Ala18 was the 
partner. This specificity for primary and secondary hydroxyl groups can only be fulfilled 
by the orientation of cellopentaose in CfCBM4-1-RE and CfCBM4-1-NRE, resulting 
from the symmetry of the ligands (Figure 3.2). When cellopentaose occupies the binding 
site as initialized in CfCBM4-1-5(¶ DQG CfCBM4-1-15(¶ WKHVH K\GURJHQ ERQGLQJ
partners were inaccessible, and thus, the ligand shift by one binding subsite 
accommodates formation of hydrogen bonds with the protein. The binding subsites of 
CfCBM4-1 do not appear to have redundant hydrogen bonding partners that would allow 
binding of the CfCBM4-1-5(¶DQGCfCBM4-1-15(¶OLJDQGFRQIRUPDWLRQV  
3.4.4 CfCBM4-1 dynamics 
 Molecular dynamics simulations further support the feasibility of bi-directional 
ligand binding. Examination of the five CfCBM4-1 and three CfCBM4-2 molecular 
dynamics simulations described above reveals remarkably similar dynamic behavior 
among the CfCBM4-1-RE and CfCBM4-1-NRE conformations and the CfCBM4-2-RE 
and CfCBM4-2-NRE conformations. Furthermore, the dynamics of the CfCBM4-1-5(¶
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and CfCBM4-1-15(¶FRQIRUPDWLRQVFRUUHVSRQGHGWRWKHCfCBM4-1-RE and CfCBM4-
1-NRE dynamics, respectively, following translocation as described above. To evaluate 
dynamic similarity, we applied a host of simulation trajectory analyses including: 
DQDO\VLV RI SURWHLQ DQG OLJDQG IOH[LELOLW\ PHDVXUHG WKURXJK WKH URRW PHDQ VTXDUH
deviation (RMSD) and root mean VTXDUH IOXFWXDWLRQ 506) QRQ-bonded interaction 
energy measurements, and degree of ligand solvation. 
 Evaluation of the RMSD of the protein backbone over the course the 250-ns 
simulation illustrates the relative stability of the CfCBM4-1-RE and CfCBM4-1-NRE 
conformations (Figure 3.7a). The RMSD was calculated for each of the five CfCBM4 
simulations, using the last coordinates of the 1-QV HTXLOLEUDWLRQ VLPXODWLRQ DV WKH
reference coordinates. The RMSD of the protein backbones in the CfCBM4-1-RE and 
CfCBM4-1-NRE simulations were extraordinarily well behaved, deviating little over the 
course of the simulation. This particular result suggests the opposite ligand conformation 
did not adversely affect the protein structure, and the binding site was capable of 
accommodating the ligand without a significant structural rearrangement. When the 
ligand was rotated around the longitudinal axis, as in the cases of CfCBM4-1-5(¶DQG
CfCBM4-1-15(¶WKHG\QDPLFVRIWKHSURWHLQEDFNERQHUHIOHFWHGWKHWUDQVORFDWLRQRIWKH
liJDQG WR WKH HTXLYDOHQW CfCBM4-1-RE and CfCBM4-1-NRE positions. The RMSD 
deviated significantly from that of the initial position as the protein rearranged the ligand, 
and the last glucose binding subsite remained unoccupied. The CfCBM4-1-5(¶ DQG
CfCBM4-1-N5(¶ VLPXODWLRQV HYHQWXDOO\ UHDFKHG DQ HTXLOLEULXP VLPLODU WR WKDW RI WKH
ligand free CfCBM4-1. 
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Figure 3.7 CfCBM4-1 hydrogen bonding behavior and protein-ligand dynamics from 
250-QV0' VLPXODWLRQV D 5RRW0HDQ 6TXDUH 'HYLDWLRQ 506' RI WKHCfCBM4-1 
protein backbone over the 250 ns simulation. The RMSD reference structure is the last 
frame of the 1-QVHTXLOLEUDWLRQVLPXODWLRQZKLFKLVZK\506'GRHVQRWVWDUWDWcDW
QV E5RRW0HDQ6TXDUH )OXFWXDWLRQ 506) RI WKH FHOORSHQWDRVH OLJDQG RQ WKH SHU-
binding-site basis. Error bars were determined from block averaging over 2.5 ns blocks of 
data. (c) Average total interaction energy (sum of van der Waals and electrostatic 
contributions) of each pyranose ring with the surrounding protein. Error bars represent 
one standard deviation. (d) The average number of water molecules within 3.5 Å of each 
binding subsite of CfCBM4-1. Error bars represent one standard deviation. 
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 Similarly, the RMSF of the protein backbones indicate the average protein 
structure of each ligand bound CfCBM4-1 was generally unaffected by the OLJDQG¶V
conformation (Figure 3.8a). In fact, the absence of ligand appeared to impact the protein 
more than any of the ligand conformations. Figure 3.8a illustrates that the aromatic 
residues along the binding cleft, Tyr43 and Tyr85, and key hydrogen bonding residues, 
Asn50 and Asn81, fluctuated significantly in the absence of a ligand. These fluctuations 
potentially contributed to the increase in RMSD of the apo structure, and gradually, the 
backbone of the apo CBM became more flexible. This may be a mechanism by which the 
CBM makes the binding site more accessible to ligands. In general, the N- and C-
terminal domain RMSF values were significantly higher than the core of the protein 
domain. While high terminal domain fluctuation is an expected behavior in nearly all 
proteins, we mention this to add the caveat that CfCBM4-1 has been simulated without a 
ERXQGFDOFLXPLRQ7KH*8VWUXFWXUHGRHVQRWFRQWDLQDUHVROYHGPHWDOLRQ [62], but 
Johnson et al. have reported that CfCBM4-1 coordinates calcium binding through 
UHVLGXHV 7KU *O\ DQG $VS ZKHUH 7KU DQG $VS FRPSULVH WKH 1- and C- 
terminus, respectively. This lack of coordinating bonds tying together the termini leads to 
higher relative fluctuation, as can be seen in the RMSD of the CfCBM4-1-apo at 70 ns 
(Figure 3.7a). However, the calcium ion and coordinating residues are located on the 
surface of CfCBM4-1, directly opposite the binding cleft, and the lack of a calcium ion 
has no affect on binding affinity [200]. Thus, we chose to simulate the protein without the 
calcium ion in accordance with the structure. 
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Figure 3.8 5RRWPHDQ VTXDUH IOXFWXDWLRQ 506) RI WKH SURWHLQ EDFNERQH IRU D ILYH
CfCBM4-1 systems and (b) three CfCBM4-2 systems over 250 ns. 
 The flexibility of the CfCBM4-1-RE and CfCBM4-1-NRE ligands, as measured 
E\506) RI WKH S\UDQRVH ULQJ DWRPV ZDV HTXLYDOHQW ZLWKLQ HUURU 7KH 506) RI WKH
ligand is a determination of the average position of the ring atoms over the course of the 
entire simulation and is delineated on a per-binding subsite basis (Figure 3.7a). As 
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previously described, the CfCBM4-1-5(¶ DQGCfCBM4-1-15(¶ OLJDQGV VKLIWHG RXW RI
register very early in the MD simulation to positions approximating the side chain and 
ring positioning of the CfCBM4-1-RE and CfCBM4-1-NRE ligands, respectively. The 
“0” binding subsite represents a solvent exposed pyranose ring, external to the cleft. 
Otherwise, the RMSF as a function of binding subsite (Figure 3.7aLOOXVWUDWHVHTXLYDOHQW
positions along the cleft, where CfCBM4-1-RE has the same ring and side chain 
orientation as CfCBM4-1-5(¶ $ORQJ WKH HQWLUHW\ RI WKH FOHIW WKHCfCBM4-1-RE and 
CfCBM4-1-NRE pyranose rings fluctuated within error of each other, suggesting the cleft 
accommodDWHVHDFKOLJDQGZLWKHTXDOIDYRUDELOLW\7KRXJKHTXLYDOHQWLQSRVLWLRQLQWKH
to 4 binding subsites, the CfCBM4-1-5(¶DQGCfCBM4-1-15(¶OLJDQGVIOXFWXDWHGPRUH
than the fully bound ligands. The solvent exposed pyranose rings had a much larger range 
of motion (Movies 3.1 and 3.2), uninhibited by the protein cleft, and this translated into 
increased fluctuation along the entirety of the four bound pyranose rings.  
 The degree of solvation within the binding cleft was unaffected by the ligand 
conformation (Figure 3.7d). For a given trajectory frame, the number of water molecules 
within 3.5 Å of the pyranose ring of binding subsite was determined. This value was 
averaged for each binding subsite over the entire 250-ns trajectory. The average value is a 
numerical estimate of the degree to which any pyranose ring is exposed to the water 
solvent. The degree of solvation of any given binding subsite was within one standard 
deviation of that of any of the various ligand conformations. This is consistent with the 
notion that CfCBM4-1 is capable of binding the cellopentaose ligand in both the 
CfCBM4-1-RE and CfCBM4-1-NRE directions.  
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 The total interaction energy of the protein with the pyranose rings of 
cellopentaose reveals aromatic stacking interactions were maintained with both faces of 
the pyranose rings along the cleft. Electrostatic and van der Waals components of the 
non-bonded interactions were calculated over the 250-ns MD simulations. The same non-
bonded interaction cutoffs used in producing the simulations were applied in the data 
analysis. For computational efficiency, the interaction energy analysis was conducted 
using a cuOOHG GDWDVHW  HTXDOO\-spaced frames rather than the 25,000 frames 
collected. The total interaction energy, the sum of the two components, was highest in 
binding subsites 1 through 3, reflecting the availability of hydrogen bonding partners and 
aromatic stacking interactions relative to subsites 4 and 5. As with other dynamic 
analyses, the total interaction energy was generally unaffected by the direction of the 
bound ligand (Figure 3.7c). The residues along the binding cleft maintained a similar 
degreH RI FRQWDFW ZLWK WKH S\UDQRVH ULQJV DQG ZHUH HTXDOO\ FDSDEOH RI PDLQWDLQLQJ
stacking interactions with either face of the pyranose ring. From perturbations of 1H 
chemical shifts upon cellotetraose binding, Johnson et al. reported that, despite the 
multitude of aromatic residues lining the binding cleft, only Tyr19 and Tyr85 were 
directly involved in aromatic stacking interactions [201]. From this determination of 
interaction energies, we endorse addition of Tyr43 to the list of stacking aromatic 
residues [62], as the interaction energy of Tyr43 with the ligand is of similar order as 
Tyr85.  
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3.4.5 CfCBM4-2 dynamics 
 Johnson et al. also made the case that CfCBM4-2 was capable of binding 
TEMPO-labeled cello-oligomers with the label at either end of the cleft [61]. To date, a 
ligand-bound structure of this homologous CBM4 structure has not been reported, though 
WKH VLPLODULW\ LQ IROG HQDEOHG GRFNLQJ RI WKH *8 FHOORSHQWDRVH DQG WKH PRGHOHG
CfCBM4-1-NRE cellopentaose to the CfCBM4-2 structure. MD simulations of the two 
conformations were performed to elucidate the molecular interactions governing ligand 
binding and the possibility of bi-directional binding. 
 CfCBM4-2 differs structurally from CfCBM4-1. The cleft of CfCBM4-2 appears 
to be wider and several ligand binding residues are substituted (e.g., CfCBM4-1 residues 
*O\ 7US +LV DQG 6HU DSSHDU DV $VQ 7\U *OQ DQG 9DO
respectively, in CfCBM4-2; Figure 3.9a) [110]. However, MD simulation suggests the 
apparent widened cleft of CfCBM4-2 may be an artifact of the structural study 
conditions. When CfCBM4-2 was docked with cellopentaose in the binding groove, the 
cleft width reduced, approximately matching that of CfCBM4-1 (Figure 3.10). The 
UHGXFWLRQLQFOHIWZLGWKRFFXUUHGTXLFNO\GXULQJHTXLOLEUDWLRQDQGWKHSURWHLQUHPDLQHG
in close contact with the ligand over the remainder of the simulation. The NMR structure 
captured CfCBM4-2 in its ligand-free state [110], and thus, the absence of ligand 
interactions is the likely reason behind the larger binding groove width relative to that of 
CfCBM4-1. The RMSD of the CfCBM4-2 protein backbone reflects the protein 
rearrangement that occurs when the binding cleft closes around the bound ligand, 
HYHQWXDOO\HTXLOLEUDWLQJDURXQGc)LJXUH3.9b). The ligand-free CfCBM4-2 exhibited 
a great deal more flexibility in the loops surrounding the cleft (Figure 3.8b), suggesting 
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flexibility in the cleft as aQDFTXLVLWLRQmechanism. The N-terminus of the CfCBM4-2-RE 
structure underwent a conformational change around 220 ns, as indicated by the change 
in RMSD, but this does not affect ligand binding.  
 
 Figure 3.9 (a) Comparison of binding site of CfCBM4-1 (gray) and CfCBM4-2 (salmon) 
illustrating substitutions of residues involved in cello-oligomer binding. CfCBM4-1 
residues are labeled in black letters, and residues in the same position in CfCBM4-2 are 
labeled in red. The binding subsites are numbered. (b) RMSD of the CfCBM4-2 protein 
backbone over the 250-ns simulation. The RMSD reference structure is the last frame of 
the 1-QVHTXLOLEUDWLRQVLPXODWLRQ 
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Figure 3.10 Comparison of CfCBM4-1 (gray surface) and CfCBM4-2 (salmon surface) 
binding groove width. The average distance between center of mass of side chains of two 
aromatic residues (blue sticks) forming sandwich platform in both CBMs was measured 
over 250 ns (25,000 frames). For CfCBM4-1, this average distance was 9.37 Å and for 
CfCBM4-2 this average distance was 8.58 Å. The < 1 Å difference between these 
averages is insignificant in context of groove width. The CfCBM4-2 binding groove 
width, measured from Tyr91 to Trp49, was 15.27Å in the apo structure, from which the 
simulation was initialized. 
 As with CfCBM4-1, dynamic measurement associated with ligand binding and 
hydrogen bond formation suggest CfCBM4-2 is capable of bi-directional binding. Again, 
we have compared the average number of hydrogen bonds formed between the protein 
and this pyranose rings of a given binding subsite, the RMSF of ligand along the cleft, 
and the total interaction energy of the ligand with the protein on a per-binding-site basis 
as function of ligand direction in the CfCBM4-2 cleft. All of these measures were 
expected to be the same for the two conformations, indicating both liJDQGVDUHHTXDOO\
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stable in the CfCBM4-FOHIW'HVSLWHWKHVLJQLILFDQWVHTXHQFHYDULDWLRQLQWKHWZRFOHIWV
the number of hydrogen bonds formed between a given pyranose ring and the CfCBM4-2 
binding site did not vary significantly upon reorientation of the ligand (Figure 3.11a). In 
general, each binding subsite formed one intermittent hydrogen bond with the protein 
over the course of the simulation. This is similar to the behavior of CfCBM4-1 (Figure 
3.6), implying the substituted residues play HTXLYDOHQW roles in ligand binding. The RMSF 
of the ligand was approximately the same in each binding subsite irrespective of where 
the reducing end resided (Figure 3.11b). The CfCBM4-2-NRE pyranose in binding 
subsite 5 was unable to maintain stable interactions with any surrounding protein 
residues, accounting for the slight deviation from the CfCBM4-2-RE ligand behavior. 
However, the total interaction energy of the pyranose ring in a given CfCBM4-2 binding 
subsite was the same regardless of ligand direction (Figure 3.11c). These dynamic 
measures support the hypothesis that the CfCBM4-2 can bind cello-oligomers in at least 
two different conformations. As we will describe, we further posit the ability to bi-
directionally bind carbohydrate oligomers may be common to thH ȕ-sandwich protein 
fold. 
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Figure 3.11 CfCBM4-2 ligand dynamic measurements. (a) Average number of hydrogen 
bonds formed between each of the five pyranose rings and side chains in each binding 
subsite with the surrounding protein (b) RMSF of ligand on a per binding subsite basis 
for CfCBM4-2 systems. Error bars were calculated using block averaging over 2.5 ns (c) 
Average total interaction energy of each pyranose with the surrounding protein. Error 
bars represent one standard deviation. (d) The average number of water molecules within 
3.5 Å of each binding subsite of CfCBM4-2. Error bars represent one standard deviation. 
3.4.6 Evidence of bi-directional binding beyond C. fimi CBM4s 
 Bi-directional cello-oligomer binding is likely a phenomenon common to CBM4s 
DQG WKH EURDGHU FODVV RI ȕ-sandwich CBMs. While structural resolution of cello-
oligomers in two different orientations of the same CBM4 binding cleft does not 
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currently exist, our computational results combined with the NMR studies from Johnson 
et al. strongly suggest both CfCBM4-1 and CfCBM4-2 demonstrate bi-directional 
binding capabilities, GHVSLWH VLJQLILFDQW GLIIHUHQFHV LQ VHTXHQFH VLPLODULW\ As further 
evidence of bi-directional binding in CBM4s, a computational docking study of a 
Clostridium thermocellum CBM4, part of the cellulosomal cellobiohydrolase A construct, 
found this particular CBM4 was likely to bind a cellohexaose in a direction opposite that 
of the cellobiose bound in the reported crystal structure (PDB ID 3K4Z) [202]. 
 CfCBM4-1 adoSWV D FKDUDFWHULVWLF ȕ-jelly roll fold, which belongs to the larger 
IDPLO\ RI ȕ-sandwich structures [16]. As CBMs are classified in the CAZy database 
(Carbohydrate Active Enzyme Database KWWSZZZFD]\RUJ DFFRUGLQJ WR VHTXHQFH
DQGVWUXFWXUDOVLPLODULW\DOO&%0VEHORQJWRWKHȕ-sandwich protein fold [74]. Further, 
WKH ȕ-sandwich fold is common among other CBM families and is noted for its broad 
specificity [16]. At the writing of this manuscript, 29 of the 69 CBM families 
GRFXPHQWHGLQ&$=\H[KLELWDIRUPRIWKHȕ-sandwich fold, with a remarkable relative 
GLYHUVLW\RIVHTXHQFH$FFRUGLQJO\ZHK\SRWKHVL]HGWKDWEL-directional binding has been 
previously observed in these structurally-related CBMs, but that it had perhaps not been 
recognized as such. In such a comparison, one must be cognizant that ȕ-sandwiches can 
KDYHWZRELQGLQJVLWHVRQHRQWKHIDFHRIWKHȕ-VKHHWVDQGWKHRWKHURQWKHHGJHRIWKHȕ-
sheets [16]. 2I WKH  ȕ-sandwich CBM families, 10 families had deposited structures 
with a glycan bound at the same binding site as that of CfCBM4-1-RE (i.e., on the face of 
the beta-sheets). A total of 34 glycan-bound CBM structures, representing 10 of the 29 ȕ-
sandwich CBM families, were available for examination (Table 3.2). Using the Dali Web 
Server (http://ekhidna.biocenter.helsinki.fi/dali_lite/start)[152] to structurally align the 34 
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structures with CfCBM4- 3'% FRGH *8 ZH H[DPLQHG WKH FRQIRUPDWLRQ RI WKH
ligands within the CBM binding clefts. 
Table 3.2 &%0VWUXFWXUHVZLWKȕ-sandwich fold compared with CfCBM4-1-RE (PDB ID 
*8µ6DPH¶UHIHUVWRWKHGLUHFWLRQRIOLJDQGWKDWLVHTXLYDOHQWWRWKDWLQ*8 
CBM Family PDB ID Protein Name Ligand Direction 
4 *8 endo-E-1,4-glucanase C (CenC) (Cel9B) Same 
4 2Y64 xylanase (Xynl;Xyn1;RmXyn10A)(Xyn10A) Same 
4 <* xylanase (Xynl;Xyn1;RmXyn10A)(Xyn10A) Same 
4 2Y6K xylanase (Xynl;Xyn1;RmXyn10A)(Xyn10A) Same 
4 2Y6L xylanase (Xynl;Xyn1;RmXyn10A)(Xyn10A) Same 
4 3K4Z cellobiohydrolase (CbhA;Cthe_0413) (Cbh9A) Same 
4 *8, laminarinase (Lam;TmLam;TM0024) (Lam16) Same 
6 1UY0 endo-E-1,4-glucanase B (CELB) (Cel5A; Cel5B) OPPOSITE 
6 1UYX endo-E-1,4-glucanase B (CELB) (Cel5A; Cel5B) OPPOSITE 
6 1UYY endo-E-1,4-glucanase B (CELB) (Cel5A; Cel5B) OPPOSITE 
6 1UZ0 endo-E-1,4-glucanase B (CELB) (Cel5A; Cel5B) OPPOSITE 
6 2CDO endo-E-agarase I / B (AgaB; Sde_1175) (Aga16B) Same 
6 2CDP endo-E-agarase I / B (AgaB; Sde_1175) (Aga16B) Same 
9 1I82 xylanase A (XynA;Tm0061) (Xyl10A) OPPOSITE 
15 *1< xylanase F / 10C (Xyl10C;CJA_3066) (Xyn10C) OPPOSITE 
15 1US2 xylanase F / 10C (Xyl10C;CJA_3066) (Xyn10C) OPPOSITE 
16 2ZEX E-mannanase A (ManA; CelA)(Man5A) Same 
16 2ZEY E-mannanase A (ManA; CelA)(Man5A) Same 
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16 3OEA E-mannanase A (ManA; CelA)(Man5A) Same 
16 3OEB E-mannanase A (ManA; CelA)(Man5A) Same 
17 1J84 endo-ș-1,4-glucanase 5A (EngF) (Cel5A) Same 
27 1PMH E-mannanase (ManA;CsMan26) Same 
27 1OF4 E-mannanase (ManB;TM1227) (Man5) Same 
27 1OH4 E-mannanase (ManB;TM1227) (Man5) Same 
28 $&* endo-E-1,4-glucanase 5A (CelA) (Cel5A) OPPOSITE 
28 3ACH endo-E-1,4-glucanase 5A (CelA) (Cel5A) OPPOSITE 
28 3ACI endo-E-1,4-glucanase 5A (CelA) (Cel5A) OPPOSITE 
29 *:/ non-catalytic protein 1 (Ncp1) Same 
29 *:0 non-catalytic protein 1 (Ncp1) Same 
29 1OH3 non-catalytic protein 1 (Ncp1) Same 
29 1W8T non-catalytic protein 1 (Ncp1) Same 
29 1W8U non-catalytic protein 1 (Ncp1) Same 
39 3AQX E-1,3-glucan UHFRJQLWLRQSURWHLQEHWD*53*QES OPPOSITE 
39 3AQZ E-1,3-glucan UHFRJQLWLRQSURWHLQ%*%3*QES OPPOSITE 
 Visualization of the glycan-ERXQG ȕ-sandwich fold CBM structures reveals 
apparent promiscuity in binding. The examined CBMs bind not only C6 sugars but also 
C5 sugars; the sugars were often bonded through a variety of glycosidic linkages as well. 
Further, multi-directional binding along the binding cleft appeared often across the 
REVHUYHG ȕ-sandwich CBM structures. Of the 34 structures examined, 22 displayed a 
OLJDQGLQWKHVDPHERXQGFRQIRUPDWLRQDVWKH*8VWUXFWXUHLHCfCBM4-1-RE); 12 
ligands appeared in the opposite conformation corresponding to the modeled CfCBM4-1-
NRE conformation. As an example of the latter, we illustrate a family 15 CBM derived 
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from Pseudomonas cellulosa [\ODQDVH ;\Q& 3'% FRGH *1<[203] aligned with 
CfCBM4- 3'% FRGH *8 LQ )LJXUH 3.12. Family 6 CBMs exhibit bi-directional 
ligand binding within the same family. %LQGLQJRIJO\FDQVLQȕ-sandwich CBMs makes 
use of standard aromatic stacking interactions common among carbohydrate binding 
proteins [204, 205], but we anticipate bi-GLUHFWLRQDO ELQGLQJ LV D FRQVHTXHQFH RI WKH
evolutionary diversity of the protein fold [206], resulting in conveniently-spaced 
hydrogen bonding partners along the cleft. While 34 structures is too small a sample to 
GUDZ FRQFOXVLRQV UHODWLYH WR IUHTXHQF\ RI FRQIRUPDWLRQDO RFFXSDQF\ WKLV HYDOXDWLRQ
indicates bi-directional bLQGLQJ RFFXUV PRUH IUHTXHQWO\ WKDQ DFNQRZOHGJHG DQG RIIHUV
new possibilities in the development of cellulosic biotechnology. 
 
Figure 3.12 Family 15 CBM derived from Pseudomonas cellulosa xylanase Xyn10C, 
PcCBM15 (purple cartoon), bound to xylopentaose (yellow and red sticks) aligned with 
CfCBM4-1-RE (gray cartoon) bound to cellopentaose (green and red sticks). 
  84 
3.4.7 Bi-directional binding extends to family 17 and 28 CBMs 
 We have found that family 4 CBMs showed no thermodynamic preference 
towards a given longitudinal orientation of cello-oligomers (i.e., the oligomers can bind 
µEL-GLUHFWLRQDOO\¶ZLWKWKHUHGXFLQJHQGRIWKHFKDLQDWHLWKHUHQGRIWKHFOHIWPRUHRYHU
structural comparison of all 29 available (as of June 2015) ligand-bound CBM structures 
exhibiting a ȕ-sandwich fold revealed ligand binding in opposite directions in many other 
E-sandwich CBM families [184]. We hypothesize bi-directional binding may be feature 
Type B CBMs developed as an evolutionary advantage, given that bi-directional binding 
could increase the probability of binding events up to 2-fold. Within the scope of this 
dissertation, we investigate this bi-directional binding phenomenon in family 17 and 28 
CBMs. According to Table 3.2, we already know that crystal structures of family 17 
CBMs show same orientation of ligands while crystal structures of family 28 CBMs 
exhibit the ligand in opposite orientation (Figure 3.13). Although there are architectural 
differences in binding sites of family 4 (Sandwich platform) and, family17 and 28 CBMs 
(Twisted platform; discussed in next chapter), the approximate symmetry of cello-
oligomeric ligands and redundancy of available hydrogen bonding partners in the cleft 
are the determining factors in bi-directionality, which is transferable over the 
architectures. To consider bi-directional binding within the twisted platform CBMs, we 
investigated the binding dynamics of four CBMs from families 17 and 28 (CcCBM17, 
BspCBM17, BspCBM28, and CjCBM28) with the cellopentaose ligand bound in both 
possible orientations in the binding grooves. The homology modeling was used to build 
BspCBM17 as its crystal structure is unavailable. Apo crystal structure was available to 
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build BspCBM28. Details of these methods and docking of cellopentaose in opposite 
direction for all CBMs has been discussed in the methods section of next chapter. 
 
Figure 3.13 Structural alignment of CcCBM17-RE (left; PDB 1J84) and CjCBM28-NRE 
(right; PDB 3ACI) with CfCBM4-1-5( 3'% *8 %RWK CcCBM17-RE and 
CjCBM28-NRE are shown in purple cartoon with cello-oligomer in yellow sticks. The 
common structure of CfCBM4-1-RE is shown in gray cartoon with cello-oligomer in 
green sticks.  
 In all eight simulation cases, the bound cellopentaose ligand maintained 
continuous interaction with the CBM binding surface over the entire 250-ns simulations, 
indicating that the binding sites of these family 17 and 28 CBMs can generally 
accommodate cello-oligomers bi-directionally. The RMSF of ligand in the binding site 
SURYLGHVDTXDQWLWDWLYHPHDVXUHRIVWability of the interactions (Fig. 6), and while all four 
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CBMs can accommodate the ligand bi-directionally, not all of them exhibit fully 
stabilized protein-ligand interactions. CcCBM17-RE, BspCBM28-NRE and CjCBM28-
NRE bind the cello-oligomer with relatively little fluctuation about the average (~1 Å). In 
the remaining five cases, though the cellopentaose ligands maintain contact with the 
CBM binding grooves, we observed sliding of the cellopentaose ligand along the binding 
site, which is reflected in the increased RMSF. We previously observed cellopentaose 
sliding within the CBM4 binding sites, however, the oligomers moved only a single 
subsite in either direction to rearrange the primary hydroxyl groups within the groove, as 
a result of the purposeful perturbation of ligand orientation (Section 3.4.1). The sliding 
observed in BspCBM17-RE, by two subsites or a cellobiose unit, maintains the primary 
and secondary hydroxyl group positions within a given subsite, which is suggestive of a 
functional mechanism rather than merely alleviation of steric hindrance. A cluster of 
snapshots (every 2.5 ns) from each simulation has been provided in Figure 3.15 
illustrating this phenomenon. In case of BspCBM17-NRE, between 85 ns to 100 ns, the 
cellopentaose is slides by one subsite, but an accompanying flip around the longitudinal 
axis maintains the original hydroxyl group orientation within the groove. Again, these 
results suggest the family 17 and 28 CBMs feature extended binding sites capable of 
binding cellohexaose or longer oligomers. These simulations provide sufficient evidence 
to support the hypothesis that cellulose specific CBMs from all three families hold the 
characteristics of a binding site that favors bi-directional binding to cello-
oligosaccharides irrespective of its overall architecture. On the other hand, this difference 
in binding site architecture, being evolved within the same type of CBMs, does play a 
role in recognition of substrate as discussed in the next chapter.  
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Figure 3.14 5RRW PHDQ VTXDUH IOXFWXDWLRQ 506) RI FHOORSHQWDRVH OLJDQG IURP LWV
average position over 250 ns trajectory calculated per binding subsite for all eight 
systems. The Error bars were calculated as a standard deviation of block averages of 
RMSFs with block size 2.5 ns each. 
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Figure 3.15 Snapshots of cellopentaose (lines) at every 2.5 ns in the binding site of each 
CBM (gray cartoon) over the 250-ns simulations. The position of cellopentaose at 0 ns is 
shown in thick cyan stick representation. The aromatic residues along the binding site are 
shown in dark blue stick representation. 
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 This section of MD simulations indicates that the modeling of protein-
carbohydrate complexes that involve homology modeled protein structures or has ligands 
docked based on structural alignment could use longer simulation times, most likely in 
microseconds, to get well-stabilized non-bonded protein-ligand interactions. We also 
FRQILUPHGWKDWH[WHQVLYHVWHSZLVHPLQLPL]DWLRQDQGHTXLOLEUDWLRQDUHKLJKO\HVVHQWLDOLQ
the simulation setup, as without it we observed dissociation of ligands from these open 
cleft binding sites at initial stages. 
3.5 Conclusions 
 MD simulations and free energy calculations have enabled us to investigate the 
molecular-level contributions to cellopentaose binding in protein-carbohydrate systems 
WKDWKDYHHOXGHGVWUXFWXUDOUHVROXWLRQWHFKQLTXHVOur results support the original Johnson 
et al. hypothesis that C. fimi CBM4s are capable of binding cello-oligomers with the 
reducing end of the pyranose at either end of the binding cleft. Free energy calculations 
are remarkably comparable to experimental ITC measurement and go beyond experiment 
in enabling delineation between conformational populations. MD simulations reveal 
abundant hydrogen bonding partners, in near 1:1 parity, exist along the binding cleft, so 
that regardless of direction, the pyranose ring primary and secondary alcohol are capable 
of maintaining a hydrogen bond with relevant partners from the interior of the cleft. MD 
simulations of CfCBM4-2 extend thHVH REVHUYDWLRQV WR ORRVHO\ UHODWHG  VHTXHQFH
similarity) familial representatives. Observation of the dynamic markers indicative of a 
stably-bound ligand again suggest that CfCBM4-2 is capable of binding cellopentaose in 
a bi-directional fashion. This observation appears to be not limited to CBM4s, but rather, 
many carbohydrate-ELQGLQJSURWHLQVEHDULQJWKHȕ-sandwich fold, which currently include 
  90 
29 additional CBM families, may bind pyranose rings irrespective of direction. Out of 
those 29 CBM families, we further confirm the bi-directional binding phenomenon for 
family 17 and 28 CBMs that have been categorized as Type B CBMs along with family 4 
CBMs but differ in shape of binding site. 
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Chapter 4  – Role of binding site architecture and recognition of non-crystalline 
cellulose in Type B Carbohydrate Binding Modules 
 Chapter 4 reports the characteristics of two different binding site platforms in 
Type B CBMs and non-crystalline cellulose binding in family 17 and 28 CBMs. 
Copyright © Abhishek A. Kognole 2017.  
4.1 Introduction 
 CBMs are structurally diverse proteins, binding with many different types of 
carbohydrate polymorphs and morphologies. To capture this diversity, CBMs have been 
divided into both famiOLHVDQGW\SHVEDVHGRQSURWHLQVHTXHQFHDQGIXQFWLRQDOVLPLODULW\
respectively [16, 75]. Currently, this nomenclature defines function as the ability to target 
particular substrate crystallinities, as CBMs appear to bind either crystalline or non-
crystalline/amorphous and oligomeric substrates. Type A CBMs are specific for 
crystalline substrates and exhibit a complementary planar binding site lined with aromatic 
residues [207, 208]. Type B and C CBMs are only subtly different from each other, with 
both types binding oligosaccharides and non-crystalline/amorphous substrates in clefts or 
grooves. Type C CBMs have been also shown to bind crystalline cellulose [59]. 
However, Type B CBMs are capable of binding at any point along the length of the 
substrate, and Type C CBMs are limited to the end of the oligomer. The underlying 
protein features enabling this distinction are difficult to define.  
 The most common protein fold among Type B CBMs is the ȕ-sandwich fold, the 
SURWHLQVRIZKLFKXQLTXHO\UHFRJQL]HQRWRQO\GLIIHUHQWNLQGVRIFDUERK\GUDWHVEXWDOVR
varying degrees of polymerization, from the smallest of oligosaccharides to amorphous 
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substrates [16]. This suggests the E-sandwich fold is a versatile architecture that allows 
UHODWLYHO\ PLQRU YDULDWLRQV LQ VHTXHQFH DQG DFFRUGLQJO\ FKHPLFal properties of the 
binding cleft/groove to determine carbohydrate binding specificity. Moreover, despite 
similar substrate specificities and, in some cases, similar measured affinities, some Type 
B CBMs appear to uncompetitively discriminate between binding sites on variable 
crystallinity surfaces [73, 208]. Attempts to experimentally characterize non-
crystalline/amorphous cellulose have revealed few details of specific structural 
properties, only that it is cellulose with a decreasing degree of polymerization and 
crystallinity index [92]. Non-crystalline/amorphous cellulose derived from pretreatment 
of native crystalline cellulose could be composed of anything from variable-length 
polysaccharide chains to only partially decrystallized substrate. Thus, the ability to 
recognize both soluble oligomers and non-crystalline/amorphous cellulose is a key aspect 
of Type B CBM functionality. 
 Cellulose-specific Type B CBMs, including those from families 4, 17, and 28, 
each with the ȕ-sandwich fold (Figure 4.1), have been shown to bind both soluble cello-
oligomers and non-crystalline cellulose [51-54, 56, 96-98]. Additionally, adsorption 
LVRWKHUPV VXJJHVW IDPLOLHV  DQG  LQGLYLGXDOO\ UHFRJQL]H µKLJK¶ DQG µORZ¶ DIILQLWy 
binding sites on representative non-crystalline cellulose substrates [64]. These studies 
also reveal that family 17 and 28 Type B CBMs exhibit higher affinities towards non-
crystalline cellulose than toward oligomeric substrates [64, 100]. Oligomeric substrates of 
Cellulomonas fimi CBM4-1 and CBM4-2 (CfCBM4-1 and CfCBM4-2, respectively) also 
appear to bind cello-oligomers bi-directionally, with the reducing end of the pyranose 
ring at either end of the cleft; there is positive, but limited, evidence of this phenomenon 
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being common among ȕ-sandwich CBMs [61, 184]. Collectively, the data imply that 
these Type B CBMs are discriminating between the various available binding sites on the 
non-crystalline carbohydrate surface, but there is not necessarily a directional preference 
within the binding site. 
 
 
Figure 4.1 CBMs (cartoon) from families 4, 17, and 28 with bound cello-oligomers 
(medium gray sticks). Binding site aromatic residues are shown in a dark gray stick 
representation. The structures, Cellulomonas fimi CBM4-1, Clostridium cellulovorans 
CBM17, and Clostridium josui CBM28, were obtained from crystal structures with PDB 
,'V*8 - DQG$&,, respectively. After structural alignment of the E-sandwich 
proteins, the family 4 and 17 CBM cello-oligomer is bound in same direction, with the 
reducing end toward the left of the figure, whereas the family 28 CBM¶VFHOOR-oligomer 
is oriented in the opposite direction. 
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 To gain a molecular-level understanding of how these three families of Type B 
CBMs discriminate between binding soluble oligomeric and non-crystalline/amorphous 
substrates, we implemented a computational approach to describe the differences in 
binding behavior and affinities within and among the CBM families. From molecular 
dynamics (MD) simulations, we explore the role of binding site architecture. Free energy 
perturbation with Hamiltonian replica exchange MD (FEP/O-REMD) and umbrella 
sampling MD was used to examine bidirectional ligand binding ability and apparent 
binding modes in non-crystalline substrate recognition. At each step of our study, we 
compare the computational results with available experimental data to assess the validity 
of our observations and to translate observations to practice.  
4.2 Methods and materials 
4.2.1 Modeling protein-carbohydrate complexes 
 Two representative CBMs from each of the three CBM families, 4,17, and 28, 
were selected to gain an understanding of the variations in protein-carbohydrate binding 
within and across the families. The selected representatives were Cellulomonas fimi 
CBM4-1 and CBM4-2 (CfCBM4-1 and CfCBM4-2), Clostridium cellulovorans CBM17 
(CcCBM17), Bacillus sp. 1139 CBM17 and CBM28 (BspCBM17 and BspCBM28), and 
Clostridium josui CBM28 (CjCBM28). The representatives were selected on the basis 
that they are characterized as cellulose-specific Type B CBMs and are shown to have 
affinity for both oligomeric and non-crystalline cellulose. CBMs with available structural 
GDWDZHUHSUHIHUUHGWREHDEOHWRVXFFHVVIXOO\DSSO\FRPSXWDWLRQDOWHFKQLTXHV 
The protein-carbohydrate systems were modeled in the following configurations 
(Figure 4.2): (A) CBMs with the cello-oligosaccharide bound in the orientation observed 
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in the crystallographic structure, (B) CBMs with the oligosaccharide bound in the 
opposite direction of the structural orientation (i.e., with the reducing end of the sugar 
longitudinally rotated to the opposite end of the groove), and (C) CBMs bound with a 
partially decrystallized cellulose microfibril, approximating non-crystalline cellulose, in 
both the structural and reverse orientations. Additionally, each of the CBM 
UHSUHVHQWDWLYHVZDVPRGHOHGZLWKRXWDERXQGOLJDQGIRUFRPSDULVRQWRWDOLQJXQLTXH
molecular models (Table 4.1).  
Table 4.1 List of all the MD simulations performed in this study with length of MD 
simulations and free energy calculation method.  
*URXS CBM Substrate System  
Simulation 
Time 
Free Energy 
Calculation 
Apo 
CcCBM17 - CcCBM17 250 ns - 
BspCBM17 - BspCBM17 250 ns - 
BspCBM28 - BspCBM28 250 ns - 
CjCBM28 - CjCBM28 250 ns - 
A 
CcCBM17 Cellopentaose CcCBM17-RE 250 ns FEP/O-REMD 
BspCBM17 Cellopentaose BspCBM17-RE 250 ns FEP/O-REMD 
BspCBM28 Cellopentaose BspCBM28-NRE 250 ns FEP/O-REMD 
CjCBM28 Cellopentaose CjCBM28-NRE 250 ns FEP/O-REMD 
B 
CcCBM17 Cellopentaose CcCBM17-NRE 250 ns - 
BspCBM17 Cellopentaose BspCBM17-NRE 250 ns - 
BspCBM28 Cellopentaose BspCBM28-RE 250 ns - 
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CjCBM28 Cellopentaose CjCBM28-RE 250 ns - 
C 
CcCBM17 
Cellulose 
microfibril 
CcCBM17-F 100 ns + 100 ns 
Umbrella 
Sampling 
CcCBM17 
Cellulose 
microfibril 
CcCBM17-R 100 ns + 100 ns 
Umbrella 
Sampling 
BspCBM17 
Cellulose 
microfibril 
BspCBM17-F 100 ns + 100 ns 
Umbrella 
Sampling 
BspCBM17 
Cellulose 
microfibril 
BspCBM17-R 100 ns + 100 ns 
Umbrella 
Sampling 
 Explicitly solvated models of each CBM were developed from Protein Data Bank 
(PDB) structures or via homology modeling. CfCBM4-1 and CfCBM4-2 models, in the 
apo and cellopentaose-bound states, were previously constructed [184]. CcCBM17 was 
constructed from the 1J84 PDB structure, which features cellotetraose bound in the 
groove [100]. Similarly, BspCBM28 was constructed from the 1UWW PDB structure, 
having no bound ligand [106], and CjCBM28 was constructed from the 3ACI PDB 
structure, featuring cellopentaose [101]. With no available crystal structure for 
BspCBM17, we used homology modeling, with CcCBM17 as a template, to build the 
protein model [148, 150] WKH WZR SURWHLQV DUH TXLWH VLPLODU KDYLQJ  VHTXHQFH
similarity and 70% structural similarity. For comparative purposes, we modeled the 
CBM-bound cello-oligomers as cellopentaose; an additional beta-D-glucose residue was 
constructed near the end of the CcCBM17 groove, and the cellopentaose ligand was 
docked with BspCBM17 and BspCBM28 by structural alignment with their homologous 
family member using Dali pairwise alignment tool [152]. These four systems represent 
the oligomer-bound CBMs exhibiting the structural orientation, CcCBM17-RE, 
BspCBM17-RE, BspCBM28-NRE, and CjCBM28-NRE (Figure 4.2A). 
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Figure 4.2 Cartoon illustration of the protein-carbohydrate complexes modeled in this 
study. CBMs from family 17 and 28 were modeled with cellopentaose bound in the (A) 
crystallographic structure orientation and (B) with the reducing end of the pyranose ring 
at the opposite end of the groove from the structural orientation. (C) CBMs were also bi-
directionally bound with partially decrystallized cellulose IE microfibrils, approximating 
non-crystalline cellulose substrates. RE = reducing end; NRE = non-reducing end.  
 To investigate the bi-directional binding phenomenon in family 17 and 28 CBMs 
(Figure 4.2B), we rotated the ligand from the structural orientation longitudinally along 
the ligand, as described for CfCBM4-1 and CfCBM4-1 [184].  
Cellopentaose was docked in the opposite direction of that captured in the crystal 
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structures by assuming the mean position of the pyranose ring heavy atoms must reside in 
approximately the same position regardless of direction. The approximate symmetry of 
the pyranose chair conformation enables this by merely exchanging the ring atom 
coordinates. CHARMM internal coordinate data was then used to establish the 
coordinates of the remaining sidechain atoms [193-195]. Extensive stepwise 
minimization of the ligand and the protein system was conducted before and after 
solvation to remove any deformation or bad contacts. These four systems, representing 
the “opposite” orientation, have been named CcCBM17-NRE, BspCBM17-NRE, 
BspCBM28-RE, and CjCBM28-RE for reference here.  
 We hypothesize high affinity CBM-binding occurs when the CBM associates with 
amorphous or non-crystalline cellulose via partially decrystallized oligomeric chains 
decorating the top layers of degraded cellulose microfibrils (i.e., whiskers). Here, the 
partially decrystallized microfibril model used to represent amorphous/non-crystalline 
cellulose was adapted from the three-layer cellulose Iȕ model used in previous cellulose 
decrystallization studies [209, 210]. The five-pyranose long decrystallized segment was 
DOLJQHGZLWKWKHFHOORSHQWDRVHIURPWKHHTXLOLEUDWHGROLJRPHULFV\VWHPVGHVFULEHGDERYH
using PyMOL (Figure 4.3). We docked two CBMs, a representative from both families 
17 and 28 selected based on the availability of experimental affinity data for later 
comparison, in both ligand orientations such that we explore both possible interactions 
between these CBMs and non-crystalline cellulose. When aligned with each other or with 
CfCBM4-1-RE (Figure 3.13), CcCBM17 and BspCBM28 appear to bind their cello-
oligomeric ligands in opposite orientations, relative to the directionality of the core E-
sheets. Assuming the structural orientations represent thermodynamically-preferred 
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recognition modes, we docked the CcCBM17 on the cellulose reducing end and 
BspCBM28 on the cellulose non-reducing end and refer to them as CcCBM17-F and 
BspCBM28-)LHµIRUZDUGELQGLQJPRGH¶ A second set of systems were prepared with 
WKH &%0V LQ WKH µUHYHUVH ELGLQJ PRGH¶ H[SORULQJ ERWK EL-directional binding and 
additional CBM-VXEVWUDWHUHFRJQLWLRQPHFKDQLVPV7KHVHµUHYHUVH¶V\VWHPVDUHUHIHUUHG
as CcCBM17-R and BspCBM28-R (Figure 4.2C). System construction was followed by 
extensive minimization and 1-ns of NPT HTXLOLEUDWLRQ WR HQVXUH WKH VWDELOLW\ RI WKH
modeled protein-carbohydrate interaction and reduce solvation effects. During heating, 
HTXLOLEUDWLRQ DQG SURGXFWLRQ 0' WKH ORZHU OD\HU Rf the cellulose microfibril was 
restrained by applying harmonic restraints to the pyranose ring atoms; the CBMs and all 
other atoms of the systems were free of restraints. Protein alignment and ligand docking 
by alignment was carried out using PyMOL [171] and Dali pairwise comparison version 
3.1 [152].  
 
 
 100 
 
Figure 4.3 Initial position of BspCBM28 in the forward orientation (after 500 ps of NPT 
HTXLOLEUDWLRQ RYHU WKH cellulose-,ȕ PLFURILEULO ZLWK a middle chain of the top layer 
occupying the binding cleft of the CBM. The front view (left) and left-side view (right) 
illustrate the CBM (gray cartoon), its aromatic residues in the shallow binding cleft (blue 
sticks with transparent surface), and the cellulose microfibril (green sticks with red 
oxygens). A similar setup approach was used for the other three cases. 
4.2.2 MD simulation parameters and protocols 
 The CHARMM36 force-field with CMAP corrections was used to simulate all 
proteins [191, 192], and carbohydrates were modeled with the CHARMM36 
carbohydrate force-field [193-195]. Water molecules were represented by the modified 
TIP3P force-field [196, 197]. Ions were modeled based on the force-field by Beglov and 
Roux [211]$IWHUDFTXLULQJWKHDWRPLFFRRUGLQDWHVIURPFU\VWDOVWUXFWXUHVCcCBM17 – 
1J84, BspCBM28 – 1UWW & CjCBM28 – 3ACI) and homology modeling 
(Bsp&%0WKHS.DYDOXHVRIWKH&%0V¶WLWUDWDEOHUHVLGXHVZHUHGHWHUPLQHGDWS+
using H++ web server [189]. Visual inspection revealed additional residues to be 
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protonated, including Asp200 in CcCBM17, Asp72 in BspCBM17, Asp184 in 
BspCBM28, and Asp198 in CjCBM28. Sixteen different molecular dynamics (MD) 
simulations were constructed using CHARMM [166]. The systems, containing CBMs, 
crystallographic waters, calcium ions, and ligands (cellopentaose or microfibril), were 
constructed in vacuum and minimized for 1000 steps of Steepest Descent (SD) and 1000 
steps of adopted basis Newton-Raphson (ABNR) with a tolerance of 0.01 for the average 
gradient. The vacuum-minimized systems were then solvated in explicit water, where the 
apo CBMs and CBMs bound with cellopentaose were solvated in a 70 Å × 70 Å × 70 Å 
cubic box (~35,000 atoms), and the CBMs bound with the cellulose microfibril were 
solvated in a 110 Å × 80 Å × 110 Å orthorhombic box. To neutralize the system charge, 
sodium or chloride ions were added by replacing random waters with the ions. The 
solvated systems were then subjected to extensive stepwise minimization: 2000 steps of 
SD with the protein and ligand fixed, 2000 steps of SD with only the protein heavy atoms 
fixed, and 10000 steps of SD and 10000 steps of ABNR (tolerance 0.01) with no 
restraints. The minimized systems were heated from 100 K to 300 K in 50 K increments 
over 20 ps, and then HTXLOLEUDWHGIRU 500 ps in the NPT ensemble at 300 K and 1 atm. The 
Nosé-Hoover thermostat and barostat were used to control temperature and pressure in 
CHARMM [212, 213].  
 For the data collection (production) MD, in the NVT ensemble, the apo and 
oligomeric systems were simulated for 250 ns seconds, while the CBM-microfibril 
systems were simulated twice (independently) for 100 ns each. These simulations were 
carried out at 300 K using NAMD 2.10 [169]. The Langevin thermostat was used to 
control temperature [214], and the SHAKE algorithm was used to fix the bond distances 
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of all hydrogen atoms [215]. Non-bonded interactions were truncated with a cutoff 
distance of 10 Å, a switching distance of 9 Å, and a non-bonded pair list distance of 12 
Å. Long range electrostatics were described using the Particle Mesh Ewald (PME) 
method with 6th order b-VSOLQH D *DXVVLDQ GLVWULEXWLRQ RI  c DQG D  c JULG
spacing [216]. The velocity Verlet multiple time-stepping integration scheme was used to 
evaluate non-bonded interactions every 1 time step, electrostatics every 3 time steps, and 
6 time steps between atom reassignments. All simulations used a 2-fs time step. 
4.2.3 Free energy calculations  
 We calculated the absolute free energies of binding cellopentaose to CBMs for all 
three families using an enhanced sampling free energy method, FEP/O-REMD. )(3Ȝ-
REMD is an enhanced sampling free energy methodology developed by Jiang, Hodoscek 
[174], which we have previously implemented for protein-carbohydrate systems 
obtaining good agreement with experimental data [113, 184, 217]. For two different 
systems, the CBM-cellopentaose complex in solvent and solvated cellopentaose, the non-
bonded interactions of cellopentaose with the rest of the system were systematically 
turned off to obtain the change in free energy. This free energy calculation protocol was 
implemented using dedicated module in NAMD [169]. The non-covalent interaction 
between the CBM and cellopentaose was distributed into repulsive, dispersive, 
electrostatic, and restraining components over 128 replicas. The total change in free 
HQHUJ\ RI ELQGLQJ ZDV WKHQ FDOFXODWHG DV WKH DJJUHJDWH RI ¨*repu ¨*disp ¨*elec, and 
¨*rstr7KHGLIIHUHQFHEHWZHHQ WKHIUHHHQHUJ\RI µGLVDSSHDULQJ¶FHOORSHQWDRVHIURPWKH
CBM groove into vacuum and the solvation free energy of cellopentaose gives the 
absolute free energy of binding a solvated ligand to a solvated protein. Convergence of 
 103 
the free energy values was determined by Multistate Bennett Acceptance Ratio (MBAR) 
analysis method [176]and can depend on whether the model was prepared from crystal 
structure or homology model. Free energy calculations using models implementing 
ligand docking or homology modeling included additional restraining forces to improve 
convergence. For direct comparison, the FEP/O-REMD calculations conducted here 
comply with the specifications outlined in our earlier study of family 4 CBMs [184]; 
accordingly, all methodological details are identical. 
 Umbrella sampling MD was used to determine the potential of mean force (PMF) 
of decoupling the CBM from the model non-crystalline surface into the solvent, from 
which we can estimate the free energy of binding. The distance between the projection of 
the center of mass of the CBM and the projection of center of mass of the lower layer of 
the cellulose microfibril on the Z-axis served as the reaction coordinate. This distance 
was gradually increased by 15 Å in 0.5 Å increments, or 31windows, until the non-
bonded interaction between the protein and substrate no longer existed. The biasing force 
along the reaction coordinate was applied using collective variables during the 10 ns MD 
of each window in NAMD [169]. To assist strictly perpendicular movement of the CBM 
relative to the microfibril surface, the distance between the same pair of projections on 
the X- and Y-axes was restrained as a constant. The harmonic restraint on the ring atoms 
of the lower layer of the microfibril was maintained throughout sampling. A force 
constant of 10 kcal/mol was used to maintain the collective variables to their specified 
values. In CcCBM17-F, the pyranose ring immediately prior to the decrystallized chain 
was harmonically restrained to the cellulose surface preventing further decrystallization 
as the CBM was pulled away. Last 5 ns data was used in construction of potential mean 
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IRUFH DW HDFK ZLQGRZ GLVFDUGLQJ ILUVW  QV WR DFFRXQW IRU HTXLOLEUDWLRQ 7KH UHDFWLRQ
coordinates were normalized to represent the change in distance (i.e. 0 Å to 15 Å). The 
calculation of potential mean force profile and error analysis was performed using 
MBAR analysis [176]. 
4.3 Results and discussion 
4.3.1 Role of binding site architecture in substrate recognition  
 The three CBM families, 4, 17, and 28, share the same ȕ-sandwich protein fold 
but exhibit key differences in binding site architectures/platforms. As they all belong to 
the Type B classification, the binding site generally conforms to either a cleft or groove 
capable of accommodating a single glycan chain. However, structural examine reveals 
the family 4 CBMs exhibit much deeper binding clefts relative to the more open grooves 
of family 17 and 28 CBMs, which we expect plays a critical role in substrate recognition 
mechanisms. Both CfCBM4-1 and CfCBM4-2 display aromatic residues lining the cleft 
and whose hydrophobic surfaces face each to sandwich the substrate pyranose rings 
between them (Figure 4.4). The oligomeric substrate is enveloped in a 4 to 5 Å-deep cleft 
with its pyranose ring perpendicular to the CBM surface [62]. Family 17 and 28 CBM 
binding grooves also display aromatic residues, although they are positioned side-by-side 
with their hydrophobic surfaces exposed to the solvent. Additionally, these aromatic 
residues are not exactly aligned in parallel planes, as in Type A CBMs, but, rather, 
FRPSULVH D VKDOORZ  WR  c JURRYHZLWK D µWZLVWHG¶ SRO\VDFFKDULGH-binding platform 
[100, 101].  
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Figure 4.4 Differences in the two binding site architectures of family 4, 17, and 28 
CBMs, as illustrated through hydrophobic interactions (dark blue sticks and transparent 
surface) and hydrogen bonding (red sticks) with the cellopentaose ligand (light green and 
red sticks). The front view (top left) and side view (top right) of the CfCBM4-1 binding 
site with bound cellopentaose clearly show the sandwich platform and deep cleft with 
one-sided hydrogen bonding of the ligand. The front view (bottom left) and side (bottom 
right) of the CjCBM28 binding site with bound cellopentaose show a twisted surface 
platform and shallow groove with hydrogen bonding partners available on both sides of 
ligand. 
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 The significance of individual hydrophobic aromatic residues and polar residues 
in both family 17 and 28 CBMs has been examined in prior experimental studies [100, 
102, 111]KRZHYHUELQGLQJDIILQLW\VWXGLHVVXJJHVWWKDWGHVSLWHVWUXFWXUDODQGVHTXHQFH
similarity, thermodynamic binding signatures are not always consistent within members 
of the same family [96, 101]. We have previously discussed the similarities and 
differences within the two family 4 CBMs for ligand binding dynamics and 
thermodynamic preference [184]. In this section, we focus on comparing and contrasting 
oligomeric ligand binding modes and affinity across the two different binding platforms 
RI&%0VDQG&%0DQGVµVDQGZLFK¶DQGµWZLVWHG¶UHVSHFWLYHO\ as well as within 
and across the three Type B CBM families. 
 Here, we select CfCBM4-1 and CfCBM4-2, having sandwich platforms, and 
CcCBM17-RE and CjCBM28-NRE, having twisted platforms for comparison, as 
experimental binding affinities and structures have been determined for each. Reported 
affinities for cellopentaose of each of the four CBMs are -NFDOPRO[98], -5.80 
  kcal/mol [110], -   NFDOPRO [100], and -   NFDOPRO [102], 
respectively. Additional cellopentaose affinities have been reported for several of these 
CBMs, though experimental conditions vary making direct comparison challenging [96, 
97, 218]. For the same four CBM·cellopentaose systems, we calculated binding affinity 
using FEP/O-REMD under conditions identical to experiment, at 300 K and pH 7.0. We 
found that CfCBM4-1 and CfCBM4-2 exhibited affinities for cellopentaose at -4.51 
1.30 kcal/mol [184] and    NFDOPRO. CcCBM17-RE and CjCBM28-NRE 
exhibited affinities for cellopentaose at -   NFDOPRO DQG -   NFDOPRO
respectively, and were more favorable than affinities of CBM4s. Detailed distribution of 
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free energy components, including charge, dispersion, van der Waals, and restraining 
contributions (Table 4.2), and illustration of calculation convergence (Figure 4.5) has 
been provided in Supplementary Material. These subtle thermodynamic preferences of 
different platforms are definitely one of the factors that play a role in building the 
recognition mechanisms targeted towards specific substrates. Further in this study, we 
address our hypothesis that this tighter binding in twisted platform is evolutionary feature 
of family 17 and 28 CBMs that allow them to preferably recognize non-crystalline 
cellulose over cello-oligomers. 
Table 4.2 'LVWULEXWLRQ RI IUHH HQHUJ\ FRPSRQHQWV RI FHOORSHQWDRVH * binding to 
&%0V DW . DQG S+  $OO YDOXHV DUH LQ NFDOPRO (UURUV IRU ¨*b° represent one 
standard deviation.  
System ¨*b° ¨*rep ¨*disp ¨*elec ¨*rstr 
a CfCBM4-* -4.51 1.30 73.54  0.19 
-78.87  
0.05 
-59.18  
0.15 0.29 
CfCBM4-* -5.41 1.38 81.19  0.33 
-81.01  
0.06 
-67.59  
0.17 
b 2.03 
Cc&%0* -6.94  0.91 76.09  0.19 
-77.27  
0.05 
-67.81  
0.18 
b 2.05 
Cj&%0* -6.26  0.74 75.74  0.19 
-72.55  
0.08 
-69.34  
0.17 -0.11 
a Data obtained from Kognole and Payne [184]  
b Harmonic restraints were applied to rings atoms of ligand. 
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Figure 4.5 Convergence of the free energy calculations of cellopentaose binding to 
CBMs over 20 consecutive windows of 0.1 ns using enhanced sampling method FEP/O-
REMD. 
  MD simulations provide additional insight into the binding free energy 
calculations, revealing that CcCBM17-RE and CjCBM28-NRE form more stable non-
covalent interactions with the cellopentaose ligand than either family 4 CBM. From the 
250-ns MD trajectories, we calculated the URRWPHDQ VTXDUH IOXFWXDWLRQ RMSF) of the 
ligand on a per-binding-subsite basis (Figure 4.6); error was estimated by block 
averaging over 2.5 ns blocks. This value describes how much a given pyranose ring 
fluctuates from its average position over the course of a simulation. Collectively, as well 
as in nearly every binding site, the pyranose rings within the CfCBM4-1 and CfCBM4-2 
binding cleft fluctuate more than that of either CcCBM17-RE or CjCBM28-NRE, 
indicating the latter two ligands form more protein-carbohydrate contacts and are, likely, 
more tightly bound as we will show below. Moreover, the lower RMSF combined with 
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higher binding affinity in the twisted platforms suggests that the unfavorable entropic 
penalty is compensated by enthalpic contributions, especially hydrogen bonding, as 
discussed ahead.  
 
Figure 4.6 5RRWPHDQ VTXDUH IOXFWXDWLRQ 506) RI the cellopentaose ligand from its 
average position in the clefts/grooves of representatives from family 4, 17, and 28 CBMs 
obtained from 250-ns MD simulation on a per-binding-subsite basis. Error was calculated 
from block averaging with block sizes of 2.5 ns. The binding site nomenclature with 
subsites 1 to 5 is assigned from reducing end to non-reducing end of cellopentaose; refer 
Figure 4.1.  
 There are three aromatic residues in the binding sites of the CBM4s and CBM28s, 
while CBM17s display only two, so the contribution to ligand binding from hydrophobic 
stacking interactions is not platform-dependent, varying by family. Rather, hydrogen 
bonding interactions appear to be a key determinant in affinity differences between the 
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two binding site architectures. The average number of hydrogen bonds formed between a 
given pyranose ring with the side chains of the surrounding protein was determined using 
VMD; detailed analysis of hydrogen bonding over the course of the MD simulations 
identified the primary hydrogen bonding partners in all the CBM-oligomer interactions. 
The average number of hydrogen bonds formed per binding site was calculated from the 
250-ns MD trajectories, where a hydrogen bond was defined as two polar atoms having a 
donor-acceptor distance of < 3.0 Å aQGDÛFXWRIIDQJOH. Table 4.3 shows the hydrogen 
bonding pairs from the calculations along with percent occupancy of each pair, where 
occupancy refers to the percent of the simulation during which the hydrogen bond was 
formed. While the CBMs with the same binding site architecture exhibit comparable 
hydrogen bonding, the total number of hydrogen bonds formed with the twisted platform 
was almost 100% higher than that of the sandwich platform. Total percent occupancy of 
100% indicates that at any given time of simulation there is, on average, at least one live 
hydrogen bond between the ligand and protein. Along the twisted platform, there are one 
or more additional hydrogen bonding partners, accounting for an additional 1-2 kcal/mol 
of binding free energy for the whole binding site [219, 220]. CcCBM17-RE and 
CjCBM28-NRE form more hydrogen bonds with cellopentaose than either CfCBM4-1 
and CfCBM4-2, fitting with our conjecture that the loss of conformational entropy in 
ligand binding is compensated with enthalpic contributions to free energy. This 
difference in hydrogen bonding can be justified by analysis of the positioning of partner 
amino acid residues along the binding site. In the sandwich platform, where the ligand is 
approximately perpendicular to protein surface, primary and secondary hydroxyl groups 
of only one edge of cellopentaose chain contact the CBM and the other edge is exposed 
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to solvent (Figure 4.4). In contrast, the cellopentaose bound in the twisted platform 
hydrogen bonds with partners on both sides of the groove. In CBM4s, there are relatively 
few hydrogen bonding partners available at binding subsite 5, but in the case of 
CcCBM17-RE and CjCBM28-NRE, each binding subsite exhibits at least one residue 
capable of hydrogen bonding.  
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Table 4.3 Percent occupancy of each hydrogen bond formed between the pyranose ring 
at each binding site and the surrounding protein residue over the 250 ns simulation. Data 
are shown in decreasing order of occupancy. Pairs with occupancy lower than 1% are not 
shown. %*&LVDQDFURQ\PIRUE-D-glucose. A hydrogen bond was defined as two polar 
atoms having a donor-acceptor distance of < 3.0 Å aQGDÛFXWRIIDQJOH 
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CfCBM4-1 CfCBM4-2 
Donor Acceptor Occupancy Donor Acceptor Occupancy 
$5*-Side %*&-Side 26.86% $5*-Side %*&-Side 43.83% 
%*&-Side ASN81-Side 25.70% %*&-Side */1-Side 40.02% 
%*&-Side ALA18-Main 25.14% HSE132-Side %*&-Side 26.11% 
%*&-Side TYR43-Main 16.61% %*&-Side LEU24-Main 7.83% 
%*&-Side */1-Side 15.37% %*&-Side SER23-Side 6.96% 
*/1-Side %*&-Side 6.54% %*&-Side SER23-Side 5.24% 
*/<-Main %*&-Side 5.11% ASN56-Side %*&-Side 3.98% 
*/1-Side %*&-Side 2.23% SER23-Side %*&-Side 3.27% 
%*&-Side ASN50-Side 1.90% SER23-Side %*&-Side 2.86% 
ASN50-Side %*&-Side 1.57% */1-Side %*&-Side 1.47% 
%*&-Side ASN81-Main 1.43% - - - 
%*&-Side */1-Side 1.11% - - - 
*/1-Side %*&-Side 1.04%    
Total 130.61% Total 141.57% 
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CcCBM17-RE CjCBM28-NRE 
Donor Acceptor Occupancy Donor Acceptor Occupancy 
%*&-Side ASP54-Side 63.20% $5*-Side %*&-Side 65.98% 
%*&-Side */1-Side 59.43% $5*-Side %*&-Side 54.69% 
$5*-Side %*&-Side 37.35% %*&-Side */1-Side 45.93% 
%*&-Side ASP54-Side 27.80% %*&-Side ASP76-Side 26.08% 
*/1-Side %*&-Side 20.06% %*&-Side */<-Main 23.77% 
ASN185-Side %*&-Side 15.67% */<-Main %*&-Side 7.54% 
ASN137-Side %*&-Side 14.64% %*&-Side ASP135-Side 3.14% 
ASN52-Side %*&-Side 9.25% %*&-Side ASP76-Side 2.68% 
THR184-Side %*&-Side 2.64% */1-Side %*&-Side 1.67% 
$5*-Side %*&-Side 2.15% TRP129-Side %*&-Side 1.57% 
%*&-Side THR184-Main 1.54% TRP78-Main %*&-Side 1.12% 
%*&-Side ASN137-Side 1.08% - - - 
Total 254.81% Total 234.17% 
 Average change in solvent accessible surface area (SASA) upon ligand binding 
(Figure 4.7) reveals that the sandwich platform buried more solvent exposed surface area 
upon binding than the twisted platform, though the latter was more solvent exposed 
initially. The average change in SASA was calculated over 2500 frames of MD 
simulation, taking the difference between summation of average SASA of apo CBMs and 
average SASA of solvated cellopentaose and average SASA of respective CBM- 
cellopentaose complexes (Figure 4.7). The mean change in SASA is lower for twisted 
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platform CBMs than sandwich platform CBMs, with less of a change in SASA observed 
for CjCBM28-NRE than CcCBM17-RE. The extra aromatic residue (Phe128) in the 
CjCBM28 binding groove, being the most obvious difference within the twisted 
platforms of family 17 and 28 CBMs, appears to contribute to this difference, but it also 
suggests that having an aromatic residue may not always contribute to higher change in 
SASA when compared to sandwich platform CBMs that also have three aromatic 
residues. Solvent-exposed residues along the twisted platforms do not appear to retain 
ordered water molecules proximal to the aromatic side chains when there is no bound 
ligand; upon ligand binding, additional water molecules were retained at the protein-
carbohydrate interface, as hydroxyl groups of cello-oligosaccharides enable solvent 
reorganization [101]. Thus, there is limitation to use of mean change in SASA, which is 
RQO\ D TXDQWLWDWLYHPHDVXUH DQG FDQQRW EH GLUHFWO\ FRUUHODWHG WR HQWURSLF FRQWULEXWLRQ
through solvent reorganization. However, the larger change in SASA for sandwich 
platform CBMs reflects a conformational change upon ligand binding. As observed in the 
MD simulations, the deep cleft of the two family 4 CBMs narrows over time as it 
sandwiches the cello-oligomer and excludes water from the hydrophobic core of the 
protein. The twisted platform on the other hand does not appear to implement this 
sandwiching mechanism and may, rather, prefer sliding along the polysaccharide chain 
more freely that would involve less change in SASA.  
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Figure 4.7 Average change in solvent accHVVLEOHVXUIDFHDUHD¨6$6$FDOFXODWHGXVLQJ
VMD over the 250 ns MD simulation trajectories of each CBM-cellopentaose system to 
compare the difference between sandwich (lined pattern) and twisted (dotted pattern) 
platforms. The error bars represent the standard deviation (SD) of the mean.  
 Overall, MD simulation results, especially hydrogen bonding patterns, suggest 
that the difference in cleft architecture (i.e., twisted vs. sandwich) greatly contributes to 
differences in affinity and, likely, protein-carbohydrate recognition mechanism. The 
recognition mechanism of the oligomeric ligand by these two different architectures is 
readily distinguishable based on the binding affinity and hydrogen-bonding pattern. It is 
tempting to suggest variations in molecular-level behavior, such as these, are a result of 
HYROXWLRQDU\ QHFHVVLW\ ZKHUH HDFK ELQGLQJ VLWH DUFKLWHFWXUH LV XQLTXHO\ VXLWHG IRU
targeting regional substrate features [64, 100].  
 To further differentiate oligomeric recognition mechanisms between CcCBM17 
and CjCBM28, we compared ligand binding dynamics at each binding subsite (Figure 
4.8). Despite the apparent similarity in binding site architecture, the two CBMs feature 
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cello-oligomers bound in opposite directions in their crystal structures (i.e., with the 
reducing end oriented at a different end of the groove when structurally aligned) [100, 
101]. To enable comparison, the binding subsites of the two CBMs were structurally 
aligned, and a letter-based subsite nomenclature was invoked based on the two common 
solvent-exposed Trp residues (Figure 4.8). The RMSF and hydrogen bonding evaluations 
reported above follow the numbered binding subsite nomenclature from crystal structure 
publications, as a cumulative comparison across the platforms. Alignment and renaming 
binding subsites (A to F), as previously implemented by Tsukimoto, Takada [101], 
reveals that four common binding subsites (B, C, D, and E) are occupied by 
cellopentaose in CcCBM17-RE (B to F) and CjCBM28-NRE (A to E).  
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Figure 4.8 Alignment of the twisted platform binding sites of CcCBM17-RE (top) and 
CjCBM28-NRE (bottom) with respect to the common pair of Trp residues (dark sticks). 
The new common naming of binding subsites (letters) is given in between the panel, and 
the original nomenclature (numbers) is given above and below the cartoon 
representations. (B) Average total interaction energy of the pyranose rings with the 
surrounding amino acid residues, on a per-subsite-basis, of CcCBM17-RE and 
CjCBM28-NRE calculated from the 250-ns trajectory. Error bars represent 1 SD. 
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 The average total interaction energy of protein with the cellopentaose ligand was 
determined from the 250-ns trajectory on a per-binding-subsite basis. The interaction 
energy distribution was very similar for CBM17 and CBM28, in the binding subsites B 
and C that reside along the hydrophobic face of pair of Trp residues common to both 
CBMs (Figure 4.8). Difference arises in the binding subsites as the extra aromatic residue 
in family 28 CBMs (Phe128 in CjCBM28 and Tyr118 in BspCBM28) that can provide 
hydrophobic stacking interaction at binding site E. Nevertheless, we observe little 
difference at subsites D and E in total interaction energy calculation that accounts for 
both van der Waals and electrostatic interactions. Based on overall analysis oligomeric 
binding affinities, collective nature of hydrogen bonding and total interaction energy at 
twisted platform, one can agree that these two families with same platforms exhibit very 
similar binding mechanisms for oligomeric ligands except the difference in mean change 
in SASA. CBM17s and CBM28s are reported to bind oligomers as long as cellohexaose 
[100] [96], and it is apparent that, for CBM17s, the sixth subsite would be A, while for 
CBM28s, the sixth sugar can be accommodated in either F or X. As CcCBM17 and 
CjCBM28 are known to bind non-crystalline substrates as well, it is possible there exist 
secondary binding subsites for chains even longer than cellohexaose. Accordingly, we 
docked cellohexaose with CjCBM28 in two orientations, occupying subsites A to F and 
X to E, and conducted 100-ns MD simulations; these simulations showed that both 
subsite X and F functionally interact with the ligand, although X had a higher interaction 
than subsite F (Figure 4.9). Extended binding sites may play a critical role in recognition 
of non-crystalline substrates, as we will discuss ahead. 
 119 
 
Figure 4.9 Average total interaction energy per binding subsite with the surrounding 
amino acid residues of CjCBM28 for a cellohexaose chain of the microfibril occupying 
the cleft in two different ways, A to F (red) and X to E (blue). Values were calculated 
over the entire 100-ns trajectory. The error bars represent one standard deviation. 
4.3.2 Differentiation of high and low affinity binding sites non-crystalline cellulose  
 Structural characterizations of many carbohydrate active enzymes focus strictly 
on the interactions occurring in the carbohydrate binding site or catalytic active sites, 
while protein surface residues or secondary binding sites may be just as important to 
functionality [221]. Type B CBMs are reported to bind both cello-oligomers and non-
crystalline/amorphous cellulose, covering a broad range of polymeric structural diversity 
and suggesting recognition processes may involve interactions beyond the primary 
binding site. Interestingly, CBMs from families 17 and 28 appear to bind non-crystalline 
cellulose with high and low binding affinities, as determined from isothermal titration 
calorimetry (ITC) data, and the two families do not compete with each other for 
 120 
carbohydrate binding sites [64, 65]. We further explore both the concept of bi-directional 
binding and the high/low binding affinity phenomena of family 17 and 28 CBMs on non-
crystalline cellulose by modeling representative Type B CBMs bound with a model non-
crystalline substrate in multiple orientations. At the nanoscale, we propose a partially 
decrystallized cellulose IE microfibril sufficiently represents the interaction of a CBM 
with non-crystalline cellulose, which retains a significant degree of crystallinity. 
Additionally, given our above insights into family 17 and 28 CBM members (i.e., that 
there is relatively little difference in oligomeric binding dynamics between members of 
the same family), we modeled only four representative CBM·microfibril systems: one 
&%0IURPHDFKIDPLO\DWWDFKHGWRWKHGHFU\VWDOOL]HGFKDLQRUµZKLVNHU¶LQWZRSRVVLEOH
orientations, forward and reverse. Details of this have been provided in methods section 
above. 
 Fully atomistic MD simulations were used to explore the primary modes of Type 
B carbohydrate recognition with respect to non-crystalline cellulose. All atomic 
interactions were unbiased except for the lower layer of the cellulose microfibril, which 
was harmonically restrained to prevent excessive fraying and further decrystallization. In 
all four cases, CcCBM17-F, CcCBM17-R, BspCBM28-F, and BspCBM28-R, the 
CBM·non-crystalline cellulose complexes stabilized in a global minimum state in each of 
the 100-ns MD simulations, illustrated by the rapid plateau in the protein backbone 
RMSD over time (Figure 4.10). Throughout the simulation, most CBMs bind all five 
pyranose moieties of the whisker along the twisted binding sites in the fully 
decrystallized state; in the case of BspCBM-F, the fifth pyranose ring closest to the 
cellulose surface partially re-annealed into the microfibril, which is not unexpected [222]. 
 121 
Comparing RMSF of the CBM backbone when bound to either an oligomer or non-
crystalline cellulose reveals that ligand binding stabilized the protein (lower RMSF); 
unbound CBM RMSFs exhibited larger fluctuations near binding site residues in both 
CBMs. Only BspCBM28-RE, bound with the rotated cellopentaose, showed large protein 
backbone fluctuations (Figure 4.11), resulting from ligand movement along the binding 
groove discussed in Chapter 3 (Figure 3.15).  
 
Figure 4.10 RMSD of the CBM backbone bound to the model non-crystalline cellulose 
microfibril over 100 ns of MD simulation (10000 frames captured at every 0.01 ns). 
RMSD was determined with respect to the coordinates of each respective CBM at 0 ns. 
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Figure 4.11 Root PHDQVTXDUHIOXFWXDWLRQ506)RIWKHEDFNERQHDWRPVRI&F&%0
(top) and BspCBM28 (bottom) in each ligand occupancy state. 
 Comparing these four simulations and the oligomer-bound simulations above, we 
identified molecular-level factors contributing to substrate recognition in each family 
with respect to variation in substrate and orientation. The interaction energy of each CBM 
residue with the substrate was determined by averaging the calculation over trajectories, 
for all CBM·substrate systems (Figure 4.12). For both family 17 and 28 CBMs, the 
average interaction of a given CBM residue with the substrate is independent of direction 
of cellopentaose ligand in the binding site, which is, again, consistent with bi-directional 
ligand binding. The hydrophobic-stacking aromatic residues and hydrogen bonding 
partners of the CBM·cellopentaose systems, as discussed above, produce substantial 
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favorable interaction energies  (< – 5 kcal/mol). These same residue·substrate interactions 
exist when the CBM is bound with non-crystalline cellulose. However, additional protein 
residues along the CBM surface also appear to be involved in binding non-crystalline 
cellulose (Figure 4.12), as revealed from the rather significant new interactions formed in 
regions where the CBM·cellopentaose systems produce no such interactions.  
 While it is clear that protein surface residues play an auxiliary role in non-
crystalline cellulose binding, each CBM and orientation relative to the cellulose surface 
UHVXOWV LQ D XQLTXH VHW RI SURWHLQāVubstrate interactions to amplify non-crystalline 
cellulose binding affinity over oligomeric affinity. In the case of CcCBM17-F, two 
peptide loops adjacent to the binding groove, residues 30-35 and 95-106, interact with 
cellulose as a result of their proximLW\ WR WKH FHOOXORVH VXUIDFH LQ WKLV µIRUZDUG¶
orientation. Most residues in these loops are polar residues, including Pro31, Lys32, 
$VS$VS*OQ6HU$VQDQG7\UDQGVHUYHWRDQFKRUWKH&%0RYHU
the microfibril through additional hydrogen bonding. In the case of CcCBM17-R, Asp81, 
Asn86, and Asn137 produce new, large electrostatic interactions between the CBM and 
substrate. Also, aromatic residues like Trp88 produced more favorable interaction 
energies in the reverse orientation, while interacting loops in the forward orientation 
played no role at all. Similarly, for BspCBM28-F, the family 28 CBM lost hydrogen bond 
LQWHUDFWLRQVEHWZHHQWKHOLJDQGDQG$UJLQWKHELQGLQJJURRYHVXEVLWHDQG*OQ
(subsite 4); however, new hydrogen bond interactions with residues in loop 65-68 were 
formed. The BspCBM28-R orientation exhibited more consistent interaction patterns, 
with no loss of affinity contributors and formation of additional favorable interactions 
between cellulose and residues in loops 66-68 and 115-130. Ultimately, it seems each 
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orientation of a given CBM relative to the cellulose surface produces a specific set of 
substrate interactions that enhance non-crystalline cellulose binding relative to oligomeric 
binding.  
 
Figure 4.12 Total interaction energy between the substrate and each protein residue, 
averaged over the length of the MD simulations. The CcCBM17 (top) and BspCBM28 
(bottom) residue numbers are shown along the x-axis. The simulation case label is given 
at left, four cases for each family 17 and 28 CBM. The magnitude of the interaction 
energy between a given residue and the bound ligand, as indicated in the case name, is 
shown in grayscale. Favorable interactions are more negative and, thus, darker. In 
cellopentaose binding, ligand direction does not affect CBM·cellopentaose interactions, 
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as redundant protein residues along the binding groove maintain association with 
cellopentaose. In non-crystalline cellulose binding, the CBM protein surface interacts 
with the surrounding carbohydrate, in both forward and reverse orientations, to enhance 
ELQGLQJDIILQLW\WKHQHZSURWHLQāFDUERK\GUDWHLQWHUDFWLRQVDUHXQLTXHIRUHDFK&%0DQG
each direction. 
 To thermodynamically characterize the effects of orientation and substrate 
crystallinity on family 17 and 28 binding, we calculated binding affinities from the 
SRWHQWLDO RIPHDQ IRUFH 30)RUZRUN UHTXLUHG WR VHSDUDWH WKH&%0V IURP WKHQRQ-
crystalline cellulose substrate. We used umbrella sampling MD to disassociate the CBM 
from non-crystalline cellulose, pulling the CBMs away from the substrate 
perpendicularly. Sampling simulations were started IURP HTXLOLEUDWHG -ns MD 
simulation snapshots of each CBM·non-crystalline cellulose complex. For all four cases, 
the corresponding PMFs indicate binding affinities are higher for non-crystalline 
cellulose than for oligomeric ligands in respective CBMs (Figure 4.13); this result aligns 
with our hypothesis that the higher affinity binding sites described in experimental 
binding studies corresponds to CBM·non-crystalline cellulose binding and lower affinity 
binding sites correspond to CBM binding in oligomeric or highly decrystallized regions.  
 7KH30)SURYLGHVERWKDELQGLQJIUHHHQHUJ\DQGDTXDQWLWDWLYHYLHZRIWKH&%0
dissociation process from a non-crystalline substrate (Figure 4.13). The free energy of 
binding non-crystalline cellulose is determined from the difference between the free 
energy at the beginning (0 Å) and end (15 Å) of the reaction coordinate. For both 
CcCBM17 and BspCBM28, the orientation of the CBM relative to the surface affects 
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binding affinity, favoring the forward orientation in CBM17 and the reverse orientation 
with CBM28. Additionally, there is a significant difference in affinity between the two 
high-affinity orientations of each CBM family; CcCBM17-F binds with the highest 
affinity, 23.0  1.1 kcal/mol, and BspCBM28-5ELQGVZLWKDQDIILQLW\HTXLYDOHQWWR
 0.8 kcal/mol. Combined with the knowledge that these two CBM families do not 
competitively bind non-crystalline cellulose [64], our results suggest that CBMs from 
these two families are capable of recognizing cellulose binding sites based on binding 
orientations relative to the substrate. The difference between the affinity of CBM17 and 
CBM28 for non-FU\VWDOOLQHFHOOXORVHPD\EHFRUUHODWHGWRWKHTXDOLWDWLYHGLIIHUHQFHLQWKH
surface interactions that contribute to the affinity as well as fortuitous compatibility of 
CBM17s than CBM28s with proposed non-FU\VWDOOLQHFHOOXORVHPRGHO*HQHUDOsurface 
topology around oligomeric binding site of CBM28 Decrystallized edge chain 
morphology could be one of the other cases of non-crystalline cellulose that are preferred 
by CBM28s over CBM17s. 
 The model non-crystalline substrate simulated in this study represents a subset of 
cellulose morphologies that are very close to crystalline substrate, and the calculated free 
energies correspond to association constants as high as 1012 mol-1, which are not 
detectable by experimental methods such as ITC. The reported high affinity cellulose 
binding sites for CcCBM17 and BspCBM28 on regenerated cellulose, from ITC, were -
8.41  0.32 and -8.28  0.35 kcal/mol, respectively [64] and while these values are much 
lower than those calculated from PMFs, it is plausible that the experimental affinities 
correspond to a range of other cellulose morphologies more amorphous in nature than the 
model non-crystalline substrate. Nevertheless, taken TXDOLWDWLYHO\ together with the 
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calculated and experimental values of cellopentaose binding to CcCBM17 and 
BspCBM28, our results offer promising evidence that high and low affinity non-
crystalline cellulose binding sites correspond to degree of substrate crystallinity. In other 
words, these family 17 and 28 CBMs appear to bind cellulose with a higher degree of 
crystallinity with greater affinity than small, oligomeric substrates.  
 
Figure 4.13 Potential of mean force (PMF) in uncoupling (A) CcCBM17 and (B) 
BspCBM28 from non-crystalline cellulose. Umbrella sampling MD was conducted over 
30 0.5-Å-windows using the projection of the distance vector on the z-axis as the reaction 
coordinate.  
 Finally, dissociation appears to occur in two separate events along the PMF 
profile (Figure 4.13), with an initial exertion of work to decouple the CBM from the 
substrate surface and a final extrication of the polymeric chain from the CBM binding 
groove. The CBM bound with non-crystalline cellulose must initially overcome the 
strong electrostatic interactions and hydrogen bonds formed between the CBM protein 
surface and the cellulose surface. After the exterior of the CBM was free of the cellulose 
surface, tKH ILQDO DPRXQW RIZRUN UHTXLUHG to dissociate the CBM was associated with 
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overcoming both van der Waals interactions between with the aromatic residues and 
pyranose rings and several hydrogen bonds formed with the substrate along the length of 
the groove. Combined with our MD simulation results above, the increase in affinity 
observed in binding CcCBM17 and BspCBM28 with non-crystalline cellulose with 
appears to be directly related to the additional protein·carbohydrate interactions mediated 
by residues exterior to the CBM binding groove. 
4.4 Conclusions 
 With better resolution of thermodynamic affinities and detailed analysis of 
protein-carbohydrate interactions like hydrogen bonding for two different binding 
platforms within same type of CBMs, it is evident that binding site architecture has 
profound effect on CBM functionality in recognizing carbohydrate substrates. 
Comparison of twisted platform in two different CBM families, 17 and 28, showed 
similarity in oligomeric ligand binding dynamics and certainly provided sufficient 
rationale towards their extenGHG ELQGLQJ VLWHV &RQVHTXHQWO\ ZH KDYH DGGUHVVHG WKH
PDQ\TXHVWLRQVUDLVHGE\%RUDVWRQHWDOLQUHJDUGVWRPHFKDQLVPVRI7\SH%&%0āQRQ-
crystalline cellulose binding, expanding upon experimental observations identifying 
enthalpic interactions as dominant in non-crystalline substrate recognition by CcCBM17 
and BspCBM28 [115]. Specifically, we identified individual contributions to 
thermodynamics parameters, revealing that the gain in enthalpy in binding non-
crystalline cellulose over oligomers results from direct contact of the CBM exterior with 
the cellulose substrate. We also provided insights into how family 17 and 28 CBMs could 
uncompetitively bind non-crystalline cellulose, despite having very similar binding 
VSHFLILFLWLHVDQGSURWHLQVWUXFWXUH7KHTXHVWLRQRIVSHFLILFDOO\DVVLJQLQJ&%0āFHOOXORVH
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binding affinities to non-crystalline substrate binding sites remains, hinging on future 
experimental efforts to structurally characterize non-crystalline cellulose of increasingly 
amorphous nature. This study also provides the basis for our future investigations of 
glycoside hydrolases linked with tandem CBMs, as the two family 4 CBMs (CfCBM4-1 
and CfCBM4-2) and the two Bacillus sp. 1139 family 17 and 28 CBMs (BspCBM17 and 
BspCBM28) are natural tandem constructs appended to E-1,4-endoglucanses. We 
anticipate the results toward understanding Type B CBM oligomeric and non-crystalline 
recognition mechanisms will advance our understanding of how protein-protein 
interactions and inter-module networking determines additive or cooperative binding in 
tandem systems and why organisms secret multi-modular enzymes with seemingly 
redundant CBM domains. 
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Chapter 5  – Carbohydrate ligands of YKL-40: Binding mechanisms, 
thermodynamic preferences and surface binding ability 
 In Chapter 5, we report molecular-level investigation of YKL-40s binding sites 
for carbohydrate ligands like chito-oligomer and determine the most likely physiological 
binding partner. This chapter has been adapted with permission from Kognole and Payne 
[223], Copyright © 2017, American Society for Biochemistry and Molecular Biology.  
5.1 Abstract 
 YKL-40 is a non-catalytic mammalian glycoprotein and biomarker associated 
with progression, severity, and prognosis of chronic inflammatory diseases and a 
multitude of cancers. Despite this well-documented association, conclusive identification 
RI WKH OHFWLQ¶V SK\VLRORJLFDO OLJDQG, and accordingly, biological function, has proven 
experimentally difficult. From experiments, YKL-40 has been shown to bind chito-
oligosaccharides; however, the natural production of chitin by the human body has not 
yet been documented. Possible alternative ligands include proteoglycans, 
polysaccharides, and fibers such as collagen, all of which make up the mesh comprising 
the extracellular matrix. It is likely that YKL-40 is interacting with these alternative 
polysaccharides or proteins within the body, extending its function to cell biological roles 
such as mediating cellular receptors and cell adhesion and migration. Here, we consider 
the feasibility of polysaccharides, including cello-oligosaccharides, hyaluronan, heparan 
sulfate, heparin, and chondroitin sulfate as potential physiological ligands for YKL-40. 
Molecular dynamics (MD) simulations resolve the molecular-level recognition 
mechanisms, as several of these potential ligands appear to bind YKL-40 in modes 
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analogous to chito-oligosaccharides. Further, we calculate the free energy of binding of 
the hypothesized ligands to YKL-40 to address thermodynamic preference relative to 
chito-oligosaccharides. Our results suggest that chitohexaose and hyaluronan 
preferentially bind to YKL-40, and hyaluronan is likely the preferred physiological 
ligand, as the negatively charged hyaluronan shows enhanced affinity for YKL-40 over 
neutral chitohexaose. Finally, heparin non-specifically binds at the surface of YKL-40, as 
predicted from structural studies. Overall, YKL-40 likely binds many natural ligands in 
vivo, but its concurrence with physical maladies may be related to associated increases in 
hyaluronan. 
5.2 Introduction 
 Significance of YKL-40 as a biomarker in various malignancies and structural 
properties of this chitinase-3-like-1 protein have been described in the general 
introduction (Section 1.3.2). In this chapter, we specifically focus on the polysaccharide 
binding sites of YKL-40 and exploring oligosaccharides of different glycosaminoglycans 
*$*V WKDW FDQ ELQG WR <./-40. Despite the structural similarity between chito-
ROLJRVDFFKDULGHV DQG WKH *$* PRQRPHUV OLWWOH HYLGHQFH RI SRO\VDFFKDULGH ELQGLQJ
beyond the original structural studies exists [43, 44]. In fact, we are aware of only one 
other study focusing on the molecular-level mechanism of carbohydrate binding in YKL-
40 [224]. From a bioinformatics and structural comparison of YKL-40 to a similar chi-
lectin, mammary gland protein-40, the authors propose an oligosaccharide binding 
mechanism that involves tryptophan-mediated gating of the primary carbohydrate 
binding site [224, 225]. Though in lieu of a dynamics-based investigation, little can be 
concluded about the binding mechanism of YKL-40 ligands other than chito-
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oligosaccharides, and conformational changes relative to binding are inaccessible. From 
SURWHLQ SXULILFDWLRQ WHFKQLTXHV QDPHO\ KHSDULQ-Sepharose chromatography, we also 
know that YKL-40 reversibly binds heparin [44, 128, 226]; however, affinity data for this 
interaction does not exist. Based on the interaction with heparin, it is reasonable to 
hypothesize heparan sulfate glycosaminoglycans, existing as part of the extracellular 
matrix construct, are a potential physiological ligand. Visual inspection of the protein 
structure initially suggested heparan sulfate fragments might be easier to accommodate 
within the carbohydrate binding site than heparin itself [44]. It follows that other 
structurally similar carbohydrate fragments would bind with similar affinity in a 
comparable mechanism.  
 Understanding the mechanism and affinity by which YKL-40 binds ligands is 
crucial to our comprehension of its physiological function. This knowledge will serve as 
a foundation for future campaigns toward rational development of a potent antagonists 
enabling cell biological study and addressing YKL-40 as a therapeutic target. To 
accomplish this goal, we must describe the molecular-level mechanisms governing the 
interaction of YKL-40 with polysaccharides DQGTXDQWLWDWLYHO\HYDOXDWHDIILQLW\. In this 
study, we used classical molecular dynamics (MD) simulations to differentiate modes of 
ligand recognition and specificity. Using free energy perturbation with replica exchange 
PROHFXODUG\QDPLFV)(3Ȝ-5(0'ZHTXDQWLWDWLYHO\determined affinities overcoming 
the experimental difficulties encountered thus far. As polysaccharide physiological 
ligands, we considered several options; provided below is a brief description of each 
carbohydrate ligand considered, as well as justification for consideration. 
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Figure 5.1 Monomeric units of the polysaccharides considered as potential physiological 
ligands of YKL- 40: cellohexaose, chitohexaose, heparan sulfate, heparin, hyaluronan, 
and chondroitin sulfate. The chito- ROLJRPHU LV D SRO\PHU RI ȕ-1,4-OLQNHG *OcNAc 
PRQRPHUV +HSDUDQ VXOIDWH ZDVPRGHOHG DV D ȕ- Į-1,4- OLQNHG FKDLQ RI *OF$ DQG
*OF1$F +HSDULQ ZDV UHSUHVHQWHG DV WKH ȕ- Į-1,4-OLQNHG ROLJRPHU RI *OF$ DQG
*OF16+\DOXURQDQDQGFKRQGURLWLQVXOIDWHDUHȕ-ȕ-1,4-linked oligomers; the former 
cRQVLVWVRI*OF$DQG*OF1$FDQGWKHODWWHUFRQVLVWVRI*OF$DQG*DO1$F*OF– ȕ-D-
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JOXFRVH*OF1$F– N-acetyl- Į-D-JOXFRVDPLQH*OF$– ȕ-D-glucuronic acid; IdoA – Į-
D-LGXURQLF DFLG *OF16 – N-sulfo-Į-D- JOXFRVDPLQH *DO1$F – N-acetyl-ȕ-D-
galactosamine. 
Chito-oligomer 
 After cellulose, chitin is the second most abundant naturally occurring biopolymer 
on earth [4], and is comprised of repeating N-acetyl-ȕ-D-JOXFRVDPLQH *OF1$F
PRQRPHULF XQLWV FRQQHFWHG E\ ȕ-1,4 glycosidic linkages (Figure 5.1). Based on the 
experimental evidence of in vitro binding to YKL-40 [43], the chito-oligomers were 
included as a control for comparison with other carbohydrates. Additionally, structural 
data is available for YKL-40 bound to chito-hexaose, which was used to as base in our 
computational modeling [43, 44].  
Cello-oligomer 
 The central ring of the monomer, a six-membered pyranose, is common to a 
number of carbohydrates including glucose, thH PRQRPHU RI FHOOXORVH *LYHQ WKLV
chemical similarity with chitin, as well as the general presence of glucose in mammalian 
cells as a form of energy, a hexameric cello-oligomer was also examined as a potential 
physiological ligand, despite its unlikely prHVHQFHDPRQJPDPPDOLDQ*$*V 
Heparan sulfate and heparin 
 As described earlier, YKL-40 binds heparin, and thus, likely also binds heparan 
sulfate. Heparan sulfate, a less sulfated form of heparin, is a polysaccharide found in 
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abundance in the ECM and at the cell surface [227]. Heparan sulfate is constructed from 
a repeating disaccharide of ȕ-D-glucuronic acid and N-acetyl-Į-D-glucosamine (Figure 
5.1). Of all the glycosaminoglycans, heparan sulfate is the most structurally complex. At 
least 24 different combinations of the disaccharide monomer exist, with differences 
arising as a result of variation in both isomer and degree of side chain sulfation [228]. 
Additionally, the heparan sulfate polysaccharide can exhibit both sulfated (NS) and 
XQVXOIDWHG 1$ GRPDLQV 3K\VLRORJLFDOO\ WKH XQVXOIDWHG GLVDFFKDULGH ȕ-D-glucuronic 
acid – (1,4) N-acetyl-Į-D-glucosamine is the most prevalent form of heparan sulfate 
[228]. Focusing on the most relevant physiological ligands, we examined the fully 
sulfated form heparin and the completely unsulfated form heparan sulfate. 
Chondroitin sulfate 
 Chondroitin sulfate is also a glycosaminoglycan prevalent in mammals reportedly 
known to have various functions as cell surface receptors, as extracellular signaling 
molecules, in sulfation-mediated neuronal plasticity, and in myogenic 
differentiation/regeneration [229]. The primary structural units of chondroitin sulfate are 
D UHSHDWLQJ ȕ-D-glucuronic acid and N-acetyl-Į-D-galactosamine disaccharides 
FRQQHFWHG E\ DOWHUQDWLQJ ȕ-1,3 and ȕ-1,4 glycosidic linkages (Figure 5.1). As with 
heparan sulfate, chondroitin sulfate exists in variably sulfated types along with its 
stereoisomer dermatan sulfate [229, 230]; we have selected the 4,6-O-GLVXOIDWHG*DO1$F
variant of chondroitin sulfate polysaccharide as our candidate based on its dominant 
existence over other forms in human aggrecan preparations isolated from knee cartilages 
[231]. 
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Hyaluronan 
 Hyaluronan is a particularly interesting glycosaminoglycan relative to this study 
because of two main reasons, first being the fact that chito-oligosaccharides are 
precursors to hyaluronan synthesis in vivo [232-234], and secondly it is seen that 
hyaluronan is also up-regulated in similar malignancies just like YKL-40 which we 
discuss the details ahead in this chapter. The structural relationship of these two 
molecules is such that binding mechanisms were expected to be similar at alternating 
ELQGLQJVLWHV+\DOXURQDQLVDSRO\VDFFKDULGHRIDUHSHDWLQJȕ-D-glucuronic acid and N-
acetyl-ȕ-D-glucosamine disaccharides conneFWHG E\ DOWHUQDWLQJ ȕ- DQG ȕ-1,4 
glycosidic linkages (Figure 5.1). As with heparan sulfate, hyaluronan is also a 
glycosaminoglycan comprising the extracellular matrix and plays critical role in 
stabilization of cartilage matrix [235]. At extracellular pH, the carboxyl groups of 
glucuronic acid are fully deprotonated giving the ligand an overall negative charge under 
typical physiological conditions [236, 237].  
5.3 Methods 
5.3.1 Molecular Dynamics Simulation 
 MD simulations were constructed starting from the chitohexaose-bound YKL-40 
structure deposited by Houston et al. (PDB ID 1HJW) [43]. The apo simulation simply 
removed the chito-oligomer from the primary binding cleft. As crystal structures of YKL-
40 bound to other polysaccharides are not available, we used the structural similarity of 
polysaccharides as the basis for modeling the remaining polysaccharides in this 
investigation. In the case of cellohexaose, hyaluronan, heparan sulfate, heparin, and 
chondroitin sulfate, we located the central ring atoms of the ligand backbone in the same 
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location as that of the original chitohexaose. Appropriate pyranose side chains and 
glycosidic linkages (Figure 5.1) were added using CHARMM internal coordinate tables 
to construct the remainder of the sugar residue [166]. All polysaccharides were described 
using the CHARMM36 carbohydrate force field [193-195]. The missing force-field 
parameters for N-VXOIDWHG JOXFRVDPLQH *OF16 in heparin were developed using the 
Force-field Toolkit (ffTK) plugin for VMD [170, 238]. More details of this force-field 
parameterization are provided in Appendix 2. 
 Protonation states of all the titratable residues were determined according to the 
corresponding pKa values calculated by the H++ web server [189]. The protein, 
structural waters, and ligands were constructed in a vacuum using CHARMM [166]. The 
system was minimized for 1000 steps in vacuum using the Steepest Descent (SD) 
algorithm followed by another 1000 steps of minimization with the adopted basis 
Newton-Raphson (ABNR) algorithm. This procedure reduces the number of bad contacts 
prior to solvation of the solute. The polysaccharide systems were solvated in 100 Å × 100 
Å × 100 Å cubic boxes. Sodium or chloride ions were added to the solution to ensure 
RYHUDOOFKDUJHQHXWUDOLW\)RUQHXWUDOOLJDQGVVL[FKORULGHLRQVZHUHUHTXLUHGWRQHXWUDOL]H
the charge of YKL-40 titratable residues. The charged ligands, hyaluronan (-3), heparan 
sulfate (-12), and chondroitin sulfate (-UHTXLUHGFKORULGHLRQVVRGLXPLRQVDQG
sodium ions for charge neutrality, respectively. After solvation, the systems were 
PLQLPL]HGDJDLQLQWKHIROORZLQJVHTXHQFHVWHSVRISD with the protein and ligand 
restrained, 1000 steps of SD with only the protein restrained, and 2000 steps of SD and 
2000 steps of ABNR with no harmonic restraints. Extensive minimization, up to 10000 
steps of SD, was carried out for systems bound to highly sulfated polysaccharides and 
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FROODJHQ7KHVROYDWHGDQGPLQLPL]HGV\VWHPVZHUHWKHQHTXLOLEUDWHGSULRUWRSURGXFWLRQ
MD simulations. The systems were heated from 100 K to 300 K in 50-K increments over 
SV LQ WKH FDQRQLFDO HQVHPEOH7KH V\VWHPGHQVLW\ZDV WKHQHTXLOLEUDWHG LQ WKHNPT 
ensemble at 300 K and 1 atm (101325 Pa) for 100 ps. The Nosé-Hoover thermostat and 
barostat were used to control temperature and pressure in CHARMM [212, 213].  
 Production MD simulations of 250 ns were performed in the canonical ensemble 
at 300 K using NAMD [169]. Temperature was controlled using Langevin thermostat 
[214]. The SHAKE algorithm was used to fix the bond distances to all hydrogen atoms 
[215]. Non-bonded interactions were truncated with a cutoff distance of 10 Å, a 
switching distance of 9 Å, and a non-bonded pair list distance of 12 Å. Long range 
electrostatics were described using the Particle Mesh Ewald method with a 6th order b-
VSOLQH D *DXVVLDQ GLVWULEXWLRQ ZLGWK RI  c DQG D  c JULG VSDFLQJ [216]. The 
velocity Verlet multiple time-stepping integration scheme was used to evaluate non-
bonded interactions every 1 time step, electrostatics every 3 time steps, and 6 time steps 
between atom reassignments. All simulations used a 2-fs time step. The CHARMM36 
force field with the CMAP correction [166, 191, 192] was used to describe YKL-40. The 
polysaccharides were described using the CHARMM36 carbohydrate force field [193-
195]. Water was modeled using the TIP3P force field [196, 197]. All simulations used 
explicit solvent. 
 A complete list of simulations and calculations performed to meet the objectives 
of this study is given in Table 5.1. The length of each MD simulation is also given, as not 
all simulation lengths were the same; several of the hypothesized ligands dissociated 
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from the binding cleft, and the simulation was halted to conserve computational 
resources. The free energy calculations performed are also indicated. If a ligand did not 
remain in the binding cleft throughout the entirety of the MD simulation, a free energy 
calculation was not performed. 
 In addition to these protein-carbohydrate complexes, oligo-saccharides were 
solvated in water separately, without YKL-40. These ligand-only simulations were 
UHTXLUHGDVLQSXWWRWKHIUHHHQHUJ\FDOFXODWLRQV6HYHUDODGGLWLRQDOV\VWHPFRQILJXUations 
beyond those originally proposed were also developed, as described below, in order to 
study the effect of ligand position on conformational changes and to understand the 
statistical significance of observed interactions with the putative heparin-binding subsite. 
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Table 5.1 Simulations and calculations performed in the investigation of the binding of 
polysaccharides ligands to YKL-40.  
Case No. System MD simulation 
Free Energy 
Calculation 
1 Apo YKL-40 250 ns -- 
2 YKL-40 + chitohexaose 250 ns )(3Ȝ-REMD 
3 YKL-40 + cellohexaose 250 ns )(3Ȝ-REMD 
4 YKL-40 + hyaluronan 250 ns )(3Ȝ-REMD 
5 a YKL-40 + heparin (fully sulfated) 50 ns -- 
6 YKL-40 + heparan sulfate (unsulfated) 50 ns -- 
7 YKL-40 + chondroitin sulfate 50 ns -- 
a  Four YKL-40 + heparin systems were constructed: two with heparin initially in the 
primary polysaccharide binding cleft and two with heparin initially located in bulk 
solution. 
5.3.2 )UHH(QHUJ\&DOFXODWLRQV)(3Ȝ-REMD 
 Free energy perturbation with Hamiltonian replica-exchange molecular dynamics 
(FEP/Ȝ-REMD) was used to calculate the absolute free energy of binding the 
polysaccharide ligands to YKL-40 [174, 175]. This protocol uses Hamiltonian replica-
exchange as a means of improving the Boltzmann sampling of free energy perturbation 
calculations. The parallel/parallel replica exchange MD algorithm in NAMD was 
implemented as recently described [113, 169]. The free energy calculations performed 
 141 
using this approach were accomplished through two separate sets of free energy 
calculations following the thermodynamic cycle illustrated in Figure 5.2. To obtain each 
ELQGLQJ IUHH HQHUJ\ ǻ* WKH ERXQG carbohydrate ligand was first decoupled from the 
solvated protein-carbohydrate complex WR GHWHUPLQH ǻ*1. The second calculation 
entailed decoupling the solvated oligosaccharide from solution into vacuum to obtain 
ǻ*27KHGLIIHUHQFHEHWZHHQWKHWZRYDOXHVǻ*2 – ǻ*1, gives the absolute free energy 
of binding the given ligand to YKL-40.  
 
Figure 5.2 7KHUPRG\QDPLF F\FOH XVHG WR GHWHUPLQH ¨* ZLWK )(3Ȝ-REMD method. 
µVROY¶UHIHUVWRWKHVROYDWHGVWDWHDQG µYDF¶UHIHUVWRWKHJDV-phase state. 
 In each free energy calculation, five separate terms contribute to the potential 
energy of the system: the non-interacting ligand potential energy, repulsive and 
dispersive contributions to the Lennard-Jones potential, electrostatic contributions, and 
the restraining potential. In each calculation, the ligand was decoupled from the system 
by thermodynamic coupling parameters controlling the non-bonded interaction of the 
ligand with the environment. The parameters decoupled the ligand in a four-stage 
process, wherein the coupling parameters defined replicas that were exchanged along the 
length of the alchemical pathway. This decoupling, as reported shortly ahead, has been 
described in detail previously [113]. A total of 128 FEP replicas were used (72 
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dispersive, 24 repulsive, and 32 electrostatic), and a conventional Metropolis Monte 
Carlo exchange criterion governed the swaps throughout the replica exchange process 
[175]. The free energy of binding was determined from 20 consecutive, 0.1-ns 
simulations of each corresponding system, where the first 1 ns of data was discarded as 
HTXLOLEUDWLRQ. The oligosaccharide ligands were restrained in the ligand-binding pose 
using a harmonic restraint on the distance between the center of mass of the protein and 
the center of mass of the ligand. The harmonic restraint force constant was 10 
kcal/mol/Å2. This restraint bias was removed from the free energy calculation according 
to the approach outlined by Deng and Roux [173]. Multistate Bennett Acceptance Ratio 
(MBAR) was used to determine electrostatic, repulsive, and dispersive contributions to 
free energy [176]. Standard deviation of the final 1 ns free energy values serves as the 
error estimate. All simulation parameters in the free energy calculations mimic those 
described in the MD simulations section. The progress towards the convergence of free 
energy calculations for cellohexaose, chitohexaose and hyaluronan systems are shown in 
Figure 5.3. 
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Figure 5.3 &RQYHUJHQFH RI ¨* RYHU  FRQVHFXWLYH -ns free energy perturbation 
calculations using the )(3Ȝ-REMD method.  
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5.4 Results and Discussion 
5.4.1 Protein-polysaccharide binding in YKL-40 
 MD simulation suggests that of the six polysaccharide oligomers investigated, 
only three bind in a stable fashion in the primary carbohydrate binding site of YKL-40. 
The three potential polysaccharide physiological ligands at this site include chitohexaose, 
cellohexaose, and hyaluronan. In the section that follows, we will describe the dynamics 
of chitohexaose, cellohexaose, and hyaluronan binding to YKL-40. The remaining three 
ligands – heparin, heparan sulfate, and chondroitin sulfate – were dislodged from the 
binding site over the course of MD simulations. 7KHĮ-1,4 glycosidic linkages in heparin 
DQG KHSDUDQ VXOIDWH LQVWHDG RI ȕ-1,4, modifies the relative orientation of disaccharide 
monomers from that of the chito-oligosaccharide. The NMR solution structure of heparin 
(PDB ID 1HPN) shows that the relaxed conformation is semi-helical [239], which cannot 
be feasibly accommodated in the conserved, narrow carbohydrate binding site of YKL-
40. Heparan sulfate suffers from similar steric constraints posed by the relaxation driving 
force. The bulky sulfated side chains of heparin introduce further steric hindrance, and in 
the case of heparin and chondroitin sulfate, unfavorably strong electrostatic interactions 
resulting from negatively charged moieties inconveniently located along the cleft (i.e., 
without a co-located, oppositely charged protein residue) eject the ligands from the cleft. 
In the cases of heparin, heparan sulfate, and chondroitin sulfate, the ligands 
TXLFNO\³UHOD[´IURPWKHLQLWLDOZLGH³9-shape” conformation as they are expelled from 
the cleft by charge- and steric-based effects. Relaxation of the sugar from the initial 
binding pose is sufficient to initiate loss of critical non-bonded interactions along with a 
VXEVHTXHQWUHGXFWLRQLQDIILQLW\)LJXUH:LWKLQQVKHSDULQKHSDUDQVXOIDWHDQG
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chondroitin sulfate were expelled from the cleft into bulk solution. Each of the three 
ligands capable of binding with the primary binding cleft maintained the -1 boat 
conformation over the entire simulation. Chitohexaose and cellohexaose remained in the 
binding cleft over the entire 250-ns MD simulation, while maintaining the initial wide 
“V-shape.” Hyaluronan developed a sharp “V-shape” within a few nanoseconds and 
maintained this conformation within the binding cleft for the remainder of the simulation 
(Figure 5.5); this is primarily due to variation in glycosidic linkage, where hyaluronan 
H[KLELWV D ȕ-1,3 OLQNDJHZLWKLQ WKHPRQRPHU LQVWHDGRI WKHȕ-1,4 linkage of cello- and 
chitohexaose. $OVRFRPSDULVRQRIWKHHTXLOLEUDWHGFKLWRKH[DRVH- and hyaluronan-bound 
structures disabuses one of the notion that similar binding mechanisms exist at alternate 
binding sites, as only the -1 site pyranose appears to maintain similar sidechain 
orientation. 
 
Figure 5.4 Relaxation of the polysaccharide ligands in the primary binding cleft of YKL-
40. Each ligand is shown after a 100-SVHTXLOLEUDWLRQLQDWKLFNVWLFNUHSUHVHQWDWLRQ)RU
comparison, the chito-ROLJRPHULQLWVHTXLOLEUDWHGFRQIRUPDWLRQLVVKRZQLQWKLQJUHHn 
lines behind each oligosaccharide. The YKL-40 protein has been aligned such that each 
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oligosaccharide is oriented in the same manner; though, YKL-40 is not shown for visual 
clarity. Heparan sulfate, heparin, and chondroitin sulfate relax significantly from the 
initial distorted conformation. 
 
Figure 5.5 Hyaluronan in YKL-40 binding site at 0 ns (left) and at 250 ns (right) 
illustrating difference between V-shape conformations of hyaluronan. 
The native distorted conformation is characteristic of glycoside hydrolase 
pyranose binding behavior in the -1 site (Figure 5.4) [80]. In solution, polysaccharide 
pyranose moieties adopt the energetically favorable chair conformation [240]; however 
when bound to an enzyme, the active sites of catalytically-active glycoside hydrolases 
distort the pyranose ring in the -1 binding subsite into a less energetically favorable 
conformation, such as a boat or skew conformation [241-244], priming the substrate for 
hydrolytic cleavage. Interestingly, the chitohexaose ligand bound in the primary binding 
site of YKL-40 exhibits a boat conformation despite not being catalytically active [43]. 
This suggests that the sugar distortion in the -1 binding site contributes to ligand binding 
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as well catalysis DV WKHUH LV QR HYROXWLRQDU\ UHTXLUHPHQW WR overcome an activation 
energy barrier in a catalytically-inactive lectins. A recent study of a homologous chitinase 
suggested that -1 pyranose relaxation reduces binding affinity and affords the ligand more 
flexibility and entropic freedom [245], which is consistent with our findings from the 
250-ns MD here.    
5.4.2 Putative heparin-binding site  
 Despite the fact that the heparin oligomer could not be accommodated by the 
YKL-40 binding cleft, MD simulations do suggest that the oligomer interacts with the 
surface of YKL-40 at a putative heparin-binding site (Figure 1.6B). After ejection from 
the primary binding site, the oligomer spontaneously binds to the YKL-40 heparin-
binding site (Movie 6.1). To address the significance of this unanticipated event, we 
performed three additional independent MD simulations of the YKL-40/heparin system: 
one with a new random number seed, though in the same configuration, and two 
additional simulations with the ligand randomly placed in solution (Movie 6.2). In each 
case, the heparin oligomers were capable of finding and binding to a group of charged 
residues at the surface of YKL-40 (Figure 5.6); these were the basic residues of a putative 
heparin-binding VLWH*55'.4+DWSRVLWLRQ-149. Interestingly, this domain follows 
DFRQVHQVXVSURWHLQVHTXHQFH– XBBXBX, where B is a basic residue and X is any non-
basic amino acid – that is noted for its ability to recognize polyanions like heparin [246]. 
In all four cases, heparin recognized the binding site within 25 ns of MD simulation 
(Figure 5.6), occasionally visiting other moderately basic surface locations before 
ORFDOL]LQJDURXQG WKH*55'.4+motif. The strong electrostatic interaction arose from 
the dynamic formation of salt-bridges between either the sulfate or the carboxyl groups of 
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the heparin oligosaccharide and the side chains of the basic amino acids. Coupled with 
experimental observation of heparin affinity, our MD simulations suggest a non-specific, 
surface-mediated binding interaction between YKL-40 and the extensively sulfated 
heparin oligomer [43, 44]. While the unsulfated variant, heparan sulfate, did not visit the 
heparin-binding site, chondroitin sulfate also attached to the putative heparin-binding site 
LQ D VLPLODU IDVKLRQ WR KHSDULQ *LYHQ WKH FKHPLFDO VLPLODULW\ RI WKHVH
glycosaminoglycans, i.e., highly sulfated and negatively charged, we anticipate the 
XBBXBX motif may also routinely appear in chondroitin-binding proteins. 
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Figure 5.6 Snapshots from four independent MD simulations of heparin (white stick) 
binding to a putative heparin-binding site (blue surface) of YKL-40 (gray surface). The 
primary oligosaccharide binding site of YKL-40 is marked by an aromatic residue shown 
in salmon surface representation. Transparent spheres illustrate the initial simulation 
positions of heparin. In two cases, (a) and (b), the heparin ligand was initially bound in 
the primary YKL-40 binding site. In both cases, the ligand was expelled from the primary 
binding site into solution and located the heparin-binding site through electrostatic 
interactions. Two additional simulations, (c) and (d), were initialized with the heparin 
ligand free in solution.  
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5.4.3 Polysaccharide ligand binding affinity 
 Each of the three polysaccharides maintaining contact with the primary binding 
site of YKL-40, cellohexaose (or likely any glucose derivative), chitohexaose, and 
hyaluronan, are feasible ligands. However, free energy calculations suggest that 
hyaluronan may preferentially bind with YKL-40 when chitin is not indicated as a 
foreign entity. The absolute free energies of binding cellohexaose, chitohexaose, and 
hyaluronan to YKL-40 were í3.01 0.88, í, and í 1.10 kcal/mol, 
respectively. Repulsive, dispersive, and electrostatic components of the free energy 
changes are tabulated in Table 5.2.  
Table 5.2 Energetic components of the free energy of ligand binding to YKL-40. All 
values are in kcal/mol.  
System ǻ*repu ǻ*disp ǻ*elec ǻ*rstr ǻ*Tot ǻ*b 
YKL-40 + 
Cellohexaose 
 í 
í
0.53 
í í 
í 
Cellohexaose  
í
0.31 
í
0.38 
0 í 
YKL-40 + 
Chitohexaose 
 
í
1.00 
í
1.79 
í í 
í 
Chitohexaose a 78.81 1.08 
í
0.72 
í
0.81 
0 í 
YKL-40 + 
Hyaluronan 

0.67 
í
0.36 
í
1.0 
í í 
í 
Hyaluronan 79.65 0.33 
í
0.31 
í
0.36 
0 í 
a Hamre, Jana [217] 
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The free energy of solvation for chitohexaose was previously calculated by our 
group as part of a study on family 18 chitinases [217]; this value has been used in our 
calculation of chitohexaose binding affinity to YKL-40 for computational efficiency. The 
methods used to calculate solvation free energy of chitohexaose were identical to those 
described here. Furthermore, the binding free energy of chitohexaose to YKL-40 is in 
good agreement with that of homologous family 18 chitinases, despite mutation of the 
catalytic motif in the lectin. 
Chitohexaose and cellohexaose are both neutral ligands but display a significant 
difference in binding affinity to YKL-40. Electrostatic interactions appear to be one of 
the more significant contributors to the enhanced affinity of chitohexaose over 
cellohexaose (Table 5.2). For cellohexaose, the change in the electrostatic component of 
ELQGLQJIUHHHQHUJ\ZDVXQIDYRUDEOHNFDOPROZKLOHWKHVDPHFRPSRQHQW
for chitohexaose was energetically favorable (í   NFDOPRO ,Q WKH FDVH RI
hyaluronan, electrostatic interactions play an even greater role in enhancing affinity of 
the ligand for YKL-40 (í   NFDOPRO 7KLV LQFUHDVLQJ HOHFWURVWDWLF
contribution is reflective of increasing number of electronegative atoms in the sidechains 
of carbohydrates as we go from cellopentaose to chitohexaose to hyaluronan. We observe 
no significant differences in cellohexaose, chitohexaose, or hyaluronan binding to YKL-
40 arising from Weeks-Chandler-Anderson (WCA) dispersion and repulsion (Table 5.2). 
This is largely a function of the molecular similarity of the pyranose rings comprising the 
monomeric units of three oligosaccharides (Figure 5.1). The pyranose rings of 
carbohydrates bound in the active sites of glycoside hydrolases, and by extension, the 
binding clefts of lectins, form carbohydrate-ʌ VWDFNLQJ LQWHUDFWLRQV ZLWK VXUURXQGLQJ
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aromatic residues along the clefts [247]. In YKL-40, these stacking interactions are 
formed in the -3 and -1 binding sites with residues Trp31 and Trp352, respectively. 
Naturally, any polysaccharide ligand capable of binding in the YKL-40 binding cleft will 
likely exhibit a similarly favorable WCA binding free energy component. In the 
following section, we expand upon the molecular-level interactions that contribute to 
polysaccharide binding affinity in YKL-40. 
Based on these results, it is unlikely that a cello-oligomer would bind in the cleft 
of YKL-40 over a chito-oligomer, and thus, while there is potential for YKL-40 to bind a 
cello-oligomer or glucose, it would not be inhibitory. Hyaluronan, on the other hand, 
likely competes with chito-oligomers in binding, which is due in large part to the 
HOHFWURVWDWLF IDYRUDELOLW\ RI K\DOXURQDQ¶V FKDUJHG VLGH FKDLQV LQ WKH <./-40 binding 
cleft. Clinical data supports hyaluronan as a biomarker for cancer prognosis and 
inflammation [236, 248], the same events in which YKL-40 appears at elevated serum 
levels [42]. To our knowledge, there are no studies evaluating the coexistence of YKL-40 
and hyaluronan. The cell receptor protein CD44 has been implicated in hyaluronan 
binding interactions and is also involved in confounding scenarios, both aggravating and 
improving inflammation [249]. 6HTXHnce alignment of YKL-40 with the hyaluronan-
binding domain of human CD44 [250], using BLASTP 2.3.0 [251], shows no homology, 
further suggesting that this YKL-40-hyaluronan binding is different from previously 
known hyaluronan-binding proteins [252].  
 153 
5.4.4 Polysaccharide Binding Dynamics 
 YKL-40 is highly homologous with carbohydrate-active enzymes found in 
glycoside hydrolase family 18 [74, 253]. Despite lacking catalytic ability, the primary 
polysaccharide binding site of YKL-40 exhibits remarkable similarity to these family 18 
chitinases. As such, one may reasonably expect that ligand binding within this family will 
demonstrate similar trends, regardless of evolutionary origin. Indeed, we observe that 
chitohexaose, cellohexaose, and hyaluronan binding in the primary binding site of YKL-
40 follow a general pattern common to carbohydrate-active enzymes. Namely, that ligand 
binding interactions are mediated by carbohydrate-ʌVWDFNLQJLQWHUDFWLRQVZLWKDURPDWLF
residues, and hydrogen bonding interactions are critical to overall ligand affinity and 
stability. We investigate WKHVH WUHQGV TXDQWLWDWLYHO\ WKURXJK DQDO\VLV RI WKH 0'
simulation trajectories, including root-mean-VTXDUH GHYLDWLRQ 506' RI WKH SURWHLQ
root-mean-VTXDUHIOXFWXDWLRQ506)) of both the protein and the ligands over the course 
of the simulation, hydrogen bonding analysis, degree of solvation of the ligand, and 
interaction energy of the ligand with the protein. 
 Cellohexaose, chitohexaose, and hyaluronan binding in the primary YKL-40 
binding site did not adversely affect protein dynamics. In each case, binding the 
polysaccharide ligand did not significantly disturb the protein backbone (i.e., protein 
fold), and the ligand remained relatively unperturbed over the course of the simulation. 
The RMSD of the protein (Figure 5.7a) is a measure of deviation over the course of the 
simulation from the initial configuration, which was the first frame of the simulation 
following NPT density HTXLOLEUDWLRQ 7KH UHODWLYHO\ FRQVLVWHQW 506' RI the protein 
backbones suggests the simulations reached a local HTXLOLEULXP7KHPDJQLWXGH RI WKH
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RMSD change over 250 ns is small given the significant chemical differences in the three 
ligands examined, which indicates the primary YKL-40 binding site is forgiving of small 
charged side chains such as the carboxylate of hyaluronan. The RMSF fluctuation of the 
protein backbone similarly describes fluctuation of a given protein residue from the 
average position over the course of the entire simulation. As with the RMSD calculation, 
the RMSF of the protein backbone suggests the binding of chitohexaose and cellohexaose 
does little to disturb the overall protein conformation (Figure 5.7b). In the case of 
hyaluronan binding, we observe increased fluctuation in residues 178-189, 225-235, and 
300-325 over that of cellohexaose and chitohexaose bound YKL-40. Both loops 225-235 
and 300-325 are located away from the primary carbohydrate-binding site; the increase in 
flexibility in these loops appears to be related to solvent exposed polar residues sampling 
bulk solution and is likely unrelated to hyaluronan binding. Segment 178-189, 
FRPSULVLQJSDUWRIDȕ-VKHHWDQGDVPDOOĮ-helix just beneath the +1 and +2 binding sites, 
becomes increasingly mobile as its interaction with hyaluronan is lost in the formation of 
the sharp V-shape. Despite localized increases in backbone flexibility, the overall protein 
structure largely remains in the same initial conformation, as evidenced by the similarity 
in RMSD (Figure 5.7a).  
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Figure 5.7 (a) Root-mean-VTXDUH GHYLDWLRQ RYHU -ns MD simulations and (b) root-
mean-VTXDUH IOXFWXDWLRQRI<./-40 without a ligand (apo) and bound to chitohexaose, 
cellohexaose, and hyaluronan. Binding of chitohexaose, cellohexaose, and hyaluronan do 
not significantly alter the dynamics of YKL-40. 
The RMSF of the ligand, averaged over 250 ns as a function of binding site, 
provides a measure of relative ligand stability. Error was estimated by block averaging 
over 2.5 ns blocks. Ligand stability over the course of the simulation suggests hyaluronan 
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is as stable, if not more so, as chitohexaose in the primary binding site (Figure 5.8a). 
Although, cellohexaose appears to be more stable relative to the two other ligands at the 
ends of the binding cleft. This latter finding is a function of the length of the side chains 
attached to the pyranose rings of each of the ligands. Of the three carbohydrates, the 
cello-oligomer has the shortest side chains, and thus, the ligand fluctuates less, as it does 
not need to rearrange as significantly to induce binding. As shown above, this does not 
necessarily correspond to the most thermodynamically preferential ligand and lower 
RMSF could also be interpreted hypothetically as loss of translational and conformational 
freedom, resulting in unfavorable entropic contribution. 
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Figure 5.8 (a) RMSF of the polysaccharide ligands on a per-binding-subsite basis. Error 
bars were calculated using block averaging over 2.5 ns. (b) Average number of water 
molecules within 3.5 Å of each ligand monomer. Error bars represent one standard 
deviation. 
 The hydrogen-bonding partners of chitohexaose, cellohexaose, and hyaluronan 
are TXLWHGLIIHUHQWODUJHO\DVDUHVXOWRIWKHFRQIRUPDWLRQal change of hyaluronan (Table 
5.3). Defining a hydrogen bond as a polar atom within 3.4 Å and 60° of a donor, we 
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identified the formation of donor-acceptor pairs and percent occupancy of these hydrogen 
bonds between the protein and each carbohydrate moiety over the course of the 250-ns 
MD simulations (Table 5.3). As described above, hyaluronan formed a sharp “V-shape” 
in the polysaccharide binding cleft, which minimized steric hindrance and in turn, 
modified accessible hydrogen bonding partners relative to chito- and cellohexaose. 
Hydrogen bonds at the +1 site, between glucuronic acid and Asp207, Arg263, and 
Tyr141, stabilized the hyaluronan conformation (Table 5.3). In the -1 subsite, 
chitohexaose primarily hydrogen bonds with the side chain of Tyr206 and the main chain 
of Trp99. In the cases of both cellohexaose and hyaluronan, the interaction with Tyr206 
was abolished, and instead, supplemented by Trp99 alone. In the -2 subsite, the oxygen of 
the chitohexaose acetyl forms a long-lived hydrogen bond with the indole nitrogen of the 
buried Trp352; neither hyaluronan nor cellohexaose interact with the -2 site through this 
tryptophan. Rather, Trp31, which stacks with the pyranose in the -3 subsite, acts as a 
hydrogen donor to the -2 subsite glucuronic acid side chain of hyaluronan. In the case of 
cellohexaose, the main chain of a solvent-exposed asparagine, Asn100, almost 
exclusively mediates hydrogen bonding in the -2 site. The +2, -3, and -4 binding subsites 
H[KLELW OHVVIUHTXHQWK\GURJHQERQGLQJEHWZHHQ the ligand and the protein, and there is 
little consistency in bonding partners across ligands. Certainly, these variations will 
manifest in enthalpic contributions to ligand binding, as even a single hydrogen bond 
may account for 1 – 7 kcal/mol of binding free energy in biological systems [219, 220]; 
such is likely the case for cellohexaose and chitohexaose binding to YKL-40, where the 
latter exhibits both greater hydrogen bonding capability and a more favorable binding 
free energy.
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Table 5.3 Hydrogen bonding pairs from polysaccharide-bound molecular dynamics simulations. A hydrogen bond was defined as a 
polar atom having a donor-acceptor distance of 3.4 Å and a 60° cutoff angle. Occupancy refers to the percent of the simulation during 
which the hydrogen bond was formed. Occupancies less than 10% have not been reported unless relevant in comparison. 
Binding 
Site 
Cellohexaose Chitohexaose Hyaluronan 
Donor Acceptor Occupancy Donor Acceptor Occupancy Donor Acceptor Occupancy 
-4
%*/&-SC */8-SC 56.28% 1$*-SC */8-SC 9.32% LYS289-SC *&8-SC 13.40% 
LYS289-SC 1$*-MC 8.48% *&8-SC TRP31-MC 12.55% 
-3
TRP69-SC %*/&-SC 53.32% 1$*-SC */8-SC 69.52% ASN100-SC 1$*-SC 35.71% 
%*/&-SC */8-SC 34.76% ASN100-SC 1$*-MC 67.68% TRP69-SC 1$*-SC 9.76% 
ASN100-SC %*/&-SC 21.80% 
-2
ASN100-MC %*/&-SC 87.40% TRP352-SC 1$*-MC 93.24% TRP31-SC *&8-SC 41.46% 
ASN100-MC 1$*-SC 66.00% ASN100-MC *&8-SC 22.27% 
1$*-SC */8-SC 30.32% TRP99-MC *&8-SC 16.03% 
1$*-SC ASN100-SC 13.44% ASN100-SC *&8-SC 13.60% 
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-1
TRP99-MC %*/&-SC 76.20% TYR206-SC 1$*-MC 75.16% TRP99-MC 1$*-MC 86.76% 
TRP99-MC 1$*-SC 39.56% 
TYR206-SC 1$*-SC 16.52% 
1$*-SC ASP207-SC 15.16% 
+1
%*/&-SC TYR141-SC 32.32% 1$*-MC ASP207-SC 74.08% *&8-SC ASP207-SC 96.19% 
%*/&-SC ASP207-SC 18.08% 1$*-SC TYR141-SC 17.00% $5*-SC *&8-SC 76.88% 
TYR141-SC %*/&-SC 13.52% TYR141-SC 1$*-SC 15.04% TYR141-SC *&8-SC 62.75% 
$5*-SC 1$*-MC 14.28% 
+2
TYR141-SC %*/&-SC 52.04% 1$*-MC TYR141-SC 45.68% TRP99-SC 1$*-SC 48.14% 
TYR141-SC 1$*-SC 18.88% 
TRP99-SC 1$*-SC 10.28% 
SC – Side chain; MC – 0DLQFKDLQ%*/&– ȕ-D-JOXFRVH1$*– N-acetyl-Į-D-JOXFRVDPLQH*&8– ȕ-D-glucuronic acid. 
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 Key aromatic residues – Trp31, Trp99, and Trp352 – play a significant role in 
binding all three oligosaccharides. Notably, these tryptophans are conserved in other 
OHFWLQV LQFOXGLQJPDPPDU\JODQGSURWHLQ 0*3-40) and mammalian lectin Ym1 [131, 
225]. According to previous structural studies, these aromatic residues form hydrophobic 
stacking interactions with pyranose moieties at the -3, +1, and -1 binding subsites, 
respectively [44]. As mentioned above, this carbohydrate-ʌVWDFNLQJ was observed across 
the three polysaccharide ligands as a result of the chemically similar carbohydrate 
“backbone” of pyranose rings. However, at the +1 site of hyaluronan, the stacking 
interaction with Trp99 was not maintained. Instead, prominent hydrogen bonding forces 
the +1 pyranose ring in an orientation that is perpendicular to aromatic Trp99 (Figure 
5.5). Nevertheless, the similarity in WCA contributions to binding free energy for all 
three polysaccharides suggests this +1 site stacking interaction weakly contributes to the 
overall binding free energy.   
 The degree to which the binding cleft of YKL-40 was accessible to water 
molecules did not change significantly with the bound polysaccharide. The degree of 
ligand solvation was determined by calculating the average number of water molecules 
within 3.5 Å of a given pyranose ring over the course of the simulations (Figure 5.8b); 
error is given as one standard deviation. Chitohexaose and cellohexaose display similar 
degrees of solvation across the length of the cleft. Hyaluronan allows a moderate increase 
in degree of solvation of the cleft by comparison to chitohexaose, across the -3 and +1 
subsites, where its sharp V-shape again contributes to variation in behavior. *LYHQ WKH
similarity in solvent accessibility within the binding cleft regardless of ligand, it is 
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unlikely that entropic contributions from solvation play a role in the observed differences 
in ligand binding free energy. 
5.4.5 Conformational changes in the YKL-40 binding site 
 Crystal structures of YKL-40 bound with chito-oligosaccharides suggest that 
YKL-40 undergoes a conformational change upon chitin ligand binding [43], contrary to 
suggestions that lectin binding sites, in general, are “pre-formed” to accommodate their 
natural substrates and undergo little change upon sugar binding [13]. Houston et al. 
reported that the residues forming a loop (residues 209 to 213) near the primary YKL-40 
binding cleft occupy an unusual conformation in apo YKL-40 when compared to the 
ligand bound YKL-40 structure, where Trp 212 lines the +2 and +3 subsites [43]. 
However, a second structural investigation published concurrently did not observe a 
similar conformation change in either of two crystal structures (1NWR and 1NWS), 
where no ligand occupied either the +2 or +3 subsites [44]. Additionally, the positioning 
of Trp99 at the +1 site in both apo structures of human YKL-40 (1HJX and 1NWR) and 
WKH KRPRORJRXV 0*3-40 (1LJY) differs from that of holo-YKL-40 and homologous 
mammalian lectin Ym1 (1E9L) [43, 44, 131, 225], with the tryptophan blocking the 
binding cleft in the apo form. This conformational variation as a function of binding site 
occupancy has been proposed as a tryptophan-mediated gating mechanism for ligand 
binding in chitolectins [224].  
 Based on MD simulations we did not observe data suggesting binding cleft 
rearrangement is important in polysaccharide binding to YKL-40. To investigate possible 
loop rearrangement upon ligand unbinding, the apo YKL-40 simulation was prepared by 
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undocking the bound chitin oligomer. One can reasonably expect that over the course of a 
250-ns MD simulation, the 5-amino acid residue loop would, at a minimum, sample a 
variety of conformations indicating flexibility in this region. However, in examining the 
trajectory of this loop with respect to its initial position, we did not observe the peptide 
loop returning to the unusual conformation even for a single frame (Figure 5.9). This 
suggests that the crystallographic apo conformation may have resulted from serendipitous 
crystal packing interactions and may not represent a typical conformational behavior. 
Additionally, the phenomenon of tryptophan mediated gating, according to which one 
would expect the Trp99 to return to the “pinched” conformation of the apo state, was not 
observed. Though, we note the likelihood of observing that the latter behavior, i.e., 
returning to a “pinched” conformation, in an unbiased MD simulation is low and may 
UHTXLUHRYHUFRPLQJDQHQHUJ\EDUULHUWKURugh enhanced sampling approaches. 
 
Figure 5.9. 5RRWPHDQVTXDUHGHYLDWLRQRIORRSRIUHVLGXHVWRIURPWKHXQXVXDO
configuration in apo YKL-40 crystal structure during 250-ns MD simulation of apo YKL-
40 prepared by removing the bound ligand from holo crystal structure. 
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5.5 Conclusions 
 We constructed polysaccharide-bound YKL-40 models understand the molecular-
level interactions of the protein with potential physiological ligands. MD simulations as 
well as free energy calculations overwhelmingly suggest polysaccharide ligands, in 
particular chito-oligomers and hyaluronan, are preferential physiological ligands of YKL-
40. The ability of YKL-40 to bind the polysaccharide ligands is related to the ability of 
the carbohydrate ligands to adopt the primary binding cleft. These ligands are able to 
form longer-lived hydrogen bonds deeper in the hydrophobic interior of the protein. 
Additionally, electrostatic interactions play a key role in ligand recognition and affinity to 
YKL-40. Improper alignment of side chains of heparan sulfate with the residues lining 
the YKL-40 cleft, additional large and highly charged side chains of heparin and 
chondroitin sulfate prohibit these ligands from binding in the primary binding cleft. 
However, the smaller, negatively charged side chain of hyaluronan interacts favorably in 
the primary binding cleft and contributes significantly to the affinity of this molecule. 
Additionally, we confirmed the non-specific interaction of heparin with the putative 
heparin-binding domain suggested from previous structural studies. The charged side 
chains repeatedly and spontaneously interact with charged residues at this secondary 
surface-binding site. Based on this study, we suggest that hyaluronan is a preferential 
physiological ligand of YKL-40, which may explain the pervasive association of YKL-40 
with the physical maladies in which hyaluronan has also been associated. These findings 
not only identify physiological ligands of YKL-40, they enable future efforts to rationally 
guide design of YKL-40 inhibitors, the design of which, is invaluable in the control of 
inflammation-based disorders and possibly several types of cancer. 
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Chapter 6  – Protein-protein interactions of YKL-40: Identification and 
characterization of collagen binding sites 
 This chapter focuses on how these carbohydrate-binding proteins can also be 
involved in surface interaction with other proteins as well. We worked on determining the 
unknown binding site for collagen on YKL-40, analysis of protein-protein binding 
abilities and calculation of relative binding affinities. This chapter has been adapted with 
permission from Kognole and Payne [223], Copyright © 2017, American Society for 
Biochemistry and Molecular Biology.  
6.1 Introduction 
 Till now, the clinical use of YKL-40 as a biomarker in various mammalian 
diseases and structural properties of this chitinase-3-like-1 lectin have been described in 
the general introduction (Section 1.3.2). In the previous chapter we reported the 
carbohydrate-binding abilities of YKL-40 with hyaluronan being thermodynamically 
most preferred polysaccharide and heparin finding the surface binding site, however the 
story of binding partners for YKL-40 does not stop there. As YKL-40 protein has been 
observed to be up-regulated in various diseases that involve connective tissue 
remodeling, and based on YKL-¶V QRWHG DIILQLW\ for various types of collagen and 
uncharted participation in collagen fibril formation [45], collagen has also been 
considered as a potential physiological ligand. Hence, in this chapter we specifically 
focus on identification and characterization of the collagen binding site of YKL-40 and 
exploring different surface properties that facilitate this protein-protein interaction. 
Collagen, unlike the other potential physiological ligands, is a macromolecular protein 
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triple helix structure (Figure 6.1); there are at least 27 distinct types of human collagen, 
forming a variety of biological networks, all of which are constructed of a basiF*O\-
Xxx-Yyy UHSHDWLQJDPLQRDFLGVHTXHQFH[254]*HQHUDOO\ WKHXQVSHFLILHGDPLQRDFLGV
Xxx and Yyy, are proline (P) and hydroxyproline (O), respectively (Figure 6.1).  
 
Figure 6.1 Triple helical structure of collagen from crystal structure (PDB ID – &$*
WKDWH[KLELWVVWUDQGVZLWKUHSHDWLQJDPLQRDFLGVHTXHQFHRI*O\-Pro-Hyp. Three strands 
DUH VKRZQ LQ WKUHH FRORUV 6WUXFWXUDO IRUPXODV RI JO\FLQH * SUROLQH 3 DQG
hydroxyproline (O) are also shown.    
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 Model collagen peptides have been observed in two different symmetries: the 
original Rich and Crick model with 10/3 symmetry, 10 units in 3 turns, and the 7/2 
symmetry of a more tightly symmetrical triple helix [255-257]. On the molecular scale, 
collagen type will have relatively little impact on binding to YKL-40. However, 
symmetry may have an impact on hydrogen bonding to the binding site, and thus overall 
affiniW\ZKLFKZLOOSURYLGHXQLTXHLQVLJKW LQWRSK\VLRORJLFDOUHOHYDQFH7RGDWHPRGHO
collagen peptides of a true 10/3 symmetry have not been reported. Rather, the peptides 
either have a 7/2 helical pitch or are somewhat “intermediate” in symmetry leading some 
to believe that the 7/2 symmetry is representative of the true collagen helical structure 
[258]. However, it is not known how universally true this hypothesis is, as the structures 
of model peptides capture just a small subsection of the larger macromolecular structure 
[259].  
 With a broad range of possible collagen architectures, we have selected four 
representative model collagen peptides whose structures are both available from 
crystallographic evidence and span the 10/3 and 7/2 symmetries to the greatest possible 
extent. The first collagen peptide considered is that of the basic collagen peptide model, 
3'%,'&$* [260]7KHUHSRUWHGcUHVROXWLRQVWUXFWXUHH[KLELWVDVLQJOH*O\WR$OD
substitution and 7/2 symmetry overall. Near the substitution site, the helix relaxes 
somewhat from 7/2 symmetry, though not so much as to change overall symmetry. The 
VHFRQGFROODJHQPRGHOSHSWLGHZHFRQVLGHULVDYDULDWLRQRIWKH&$*SHSWLGHZKHUHZH
reverted the alanine substitution to its native glycine. Minimization of this structure 
returns the helix to full 7/2 symmetryZHUHIHU WR WKLVSHSWLGHDV³QDWLYH&$*´KHUH. 
The third model represents a segment from type III homotrimer collagen with 
 168 
approximate 10/3 symmetry in the middle part of the helix (PDB ID 1BKV) [255]. This 
middle part of the 1BKV model peptide, also referred as the T3-785 peptide, has an 
imino acid-SRRUVHTXHQFHRI*,7*$5*/$Our fourth model, 1Q7D, is a triple helical 
collagen-OLNH SHSWLGH VHTXHQFH including a KH[DSHSWLGH *O\-Phe-Hyp-*O\-*OX-Arg 
*)2*(5) motif in the middle [261]; this motif is not sufficiently long to exhibit 10/3 
symmetry, exhibiting, rather, an intermediate degree of 7/2 helical symmetry. This 1Q7D 
model LV NQRZQ WR ELQG WKH LQWHJULQ Įȕ-I domain protein [262], and the *)2*(5
PRWLILVIRXQGLQWKHĮFKDLQRIW\SH,FROODJHQ. 
6.2 Methods 
6.2.1 Docking of collagen triple helix on YKL-40 
 As stated in Chapter 6, all MD simulations were constructed based on the 
chitohexaose-bound YKL-40 crystal structure deposited by Houston et al. (PDB ID 
1HJW) [43]. However, construction of the collagen-bound YKL- PRGHOV UHTXLUHG
docking calculations to appropriately position the ligand. The collagen peptides are 
significantly larger than any of the carbohydrate ligands; thus, it is unlikely that a 
collagen molecule occupies the primary YKL-40 binding site in the same manner as 
chito-oligomer. Standard affinity-based docking calculations, such as the ones performed 
in AutoDock, are not feasible for determination of an initial collagen-binding domain 
given the size and flexibility of the triple helix structures. Rather, the collagen peptides 
were docked on the basis of molecular shape complementarity using the online web 
server PatchDock Beta v.1.3 [154, 156]. In the case of each of the four collagen-like 
model peptides, PatchDock predicted two potential occupancies along the surface of 
YKL-40, site A and site B. Binding site A corresponds to the primary carbohydrate-
 169 
binding domain of YKL-40, though the collagen ligand was not as deeply entrenched in 
the cleft as chitohexaose. Binding site B is located on the opposite side of YKL-40 from 
the primary binding cleft. Thus for each collagen-like peptide, two MD simulations were 
constructed representing the two potential binding sites. Figure 6.2 illustrates results of 
the docking with predicted collagen binding sites A and B for the 1Q7D collagen-like 
model peptide.  
 
Figure 6.2 Molecular shape complementarity docking calculations predict collagen-like 
peptides will bind to YKL-40 in two possible orientations. (a) the front view of YKL-40 
(gray surface) with collagen docked in site A (green stick), (b) the back view where 
collagen is docked in site B (cyan stick), and (c) top view of YKL-40 illustrating relative 
positions of binding sites. The putative heparin-binding subsite is shown in blue surface 
to aid in visualization of relative orientation of the protein-protein complexes. This 
particular figure shows the integrin-binding collagen peptide, 1Q7D [261], in the 
predicted binding sites along the surface of YKL-40; similar docking was carried out for 
other collagen models. 
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6.2.2 Molecular Dynamics Simulation 
 Most of the simulation setup procedure and parameters were exactly the same as 
described in earlier chapter for YKL-40 with carbohydrate ligands. The only difference 
was that the simulation box size was larger in this case with collagen being a larger 
binding partner. The YKL-40 complex with collagen-like peptides was solvated in 120 
Å × 120 Å × 120 Å cubic boxes. The CHARMM36 force field with the CMAP correction 
[166, 191, 192] was used to describe YKL-40 and the collagen ligands. The parameters 
for hydroxyproline were determined using ParamChem, which determines force field 
SDUDPHWHUV EDVHG RQ DQDORJ\ZLWK&+$500*HQHUDO )RUFH )LHOG &*HQ)) SURJUDP
version 0.9.7 beta [263]. The CMAP corrections for hydroxyproline were adopted simply 
based on the analogy between proline and hydroxyproline residues. Water was modeled 
using the TIP3P force field [196, 197]. All simulations used explicit solvent. 
 A list of simulations and calculations performed to meet the objective of this 
study is given in Table 6.1. As described earlier, docking calculations of collagen-like 
peptides on YKL-40 indicated two potential binding surfaces; for these cases, the 
description in Table 6.1 lists both site and ligand. The free energy calculations performed 
are also indicated. Free energy calculations being highly expensive in terms of 
computational resources, only selective systems were included in this calculation. In 
addition to these protein-protein complexes, collagen-like peptide models were solvated 
in water separately, without YKL-40. However they were not used in any calculation or 
analysis as their only purpose was to preliminarily confirm weather the triple helical 
collagen-like peptides are eligible for dynamic studies and we have proper set of 
parameters to represent their chemical properties.  
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Table 6.1 Simulations and calculations performed in the investigation of the binding of 
collagen ligands to YKL-40.  
Case 
No. System 
MD 
simulation 
Free Energy 
Calculation 
8 & 9 YKL-40 + cROODJHQ&$*DWVLWH$	% 250 ns -- 
10 & 11 YKL-40 + cROODJHQQDWLYH&$*DWVLWH$	% 250 ns Umbrella Sampling 
12 & 13 YKL-40 + collagen (1BKV) at site A & B 250 ns -- 
14 & 15 YKL-40 + collagen (1Q7D) at site A & B 250 ns Umbrella Sampling 
 The constructed protein-ligand systems were minimized in vacuum and 
VXEVHTXHQWO\VROYDWHGZLWKZDWHUDQGVRGLXPLRQV8VLQJ&+$500[166], the solvated 
systems were extensively minimized and heated to 300 K for 20 ps, which was followed 
by MD simulation for 100 ps in the NPT ensemble. The coordinates following density 
HTXLOLEUDWLRQ ZHUH used as a starting point for 250 ns of MD simulation in the NVT 
ensemble at 300 K using NAMD [169]. Explicit procedural details were similar to the 
Chapter 6. 
6.2.3 Free Energy Calculations: Umbrella Sampling  
 Convergence challenges make )(3Ȝ-REMD inappropriate for determining the 
binding free energy of the much larger and more flexible collagen-like model peptides. 
Thus, umbrella sampling was used to determine thHZRUNUHTXLUHGWRdetach the collagen 
ligands from the shallow clefts of YKL-40. Over the entire reaction coordinate, this value 
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HTXDWHVWRELQGLQJDIILQLW\, enabling relative comparison of collagen peptide affinity. The 
MD umbrella sampling simulations used a native-contacts based reaction coordinate 
analogous to that defined by Sheinerman and Brooks and as implemented in recent 
cellulose decrystallization studies [209, 210, 264]. Here, a native contact was defined as 
YKL-40 protein residue within 12 Å of a collagen peptide residue; distance was defined 
by center of geometry of a given residue. The cutoff distance was selected to be larger 
than the non-bonded cutoff distance, ensuring that the collagen ligand was no longer 
interacting with YKL-40. Additionally, the water boxes of the collagen-YKL-40 systems 
were made bigger to accommodate the UHTXLUHGVHSDUDWLRQGLVWDQFH 
 The change in free energy was determined as a function of the reaction 
FRRUGLQDWHȡ IRUPulated as the weighted sum of the states of the native contacts. The 
initial coordinates of the bound systems were selected from 250-QV HTXLOLEUDWHG
snapshots. The initial number of native contacts and their weights were calculated from 
these snapshots. An initial reaction coordinate of 0 (normalized) corresponds to this 
initial condition, and a final reaction coordinate of 1 corresponds to all of the native 
contacts being outside the 12-Å cutoff (i.e., the ligand is decoupled and freely sampling 
the bulk). The reaction coordinate was divided into 20 windows evenly spaced along the 
reaction coordinate, and each window was sampled for 5 ns, where the reaction 
coordinate was maintained at the specified value using a harmonic biasing force with the 
force constant of 10000 kcal/mol. The potential of mean force profiles were calculated 
using the weighted histogram analysis method (WHAM), and error analysis was 
performed using bootstrapping [181]. 
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6.3 Results and Discussion 
6.3.1 Protein-protein binding in YKL-40 
 Based on biochemical characterization, it is clear that YKL-40 functionally 
interacts with collagen. For example, Bigg et al. uncovered the ability of YKL-40 to 
specifically bind types I, II, and III collagen fibers [45], and Iwata et al. recently 
discovered that YKL-40 secreted by adipose tissue inhibits degradation of type I collagen 
by matrix metalloproteinase-1 and further stimulates the rate of type I collagen formation 
[265]. However, a lack of structural evidence has precluded development of an 
understanding of the molecular nature of these interactions. Using molecular docking, 
MD simulation, and free energy calculations, we describe interactions of four collagen-
like peptides with two putative protein-binding sites along the surface of YKL-40. The 
selection of model peptides, as well as multiple binding sites, encompasses as many 
potential binding modes as feasible to describe protein-protein binding dynamics and 
relative affinity of YKL-40 for collagen. 
6.3.2 Ligand Binding Dynamics and Comparison of Model Collagen-like Peptides. 
  Dynamics of the collagen-like peptide ligands varies with both binding site and 
the pitch of the triple helix. Root-mean-VTXDUHGHYLDWLRQLOOXVWUDWHVWKHUHODWLYHVWDEility of 
each collagen peptide in each of the two binding sites, A and B (Figure 6.3). Although 
the molecular docking results in very close contacts between collagen and YKL-40 
(Figure 6.2), such that collagen appears to be almost buried in the primary carbohydrate-
binding site of YKL-40, minimization and MD simulation results in slight rise and shift 
in the position of collagen for every model at binding site A. Each of the four ligands 
maintains association with the binding site A over the course of 250 ns, though with 
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slightly different protein-protein contacts with YKL-40 (Figure 6.4). NDWLYH &$*
1BKV, and 1Q7D attained relative stability in a position not significantly different from 
WKH LQLWLDO GRFNHG SRVLWLRQ EXW WKH &$* SHSWLGH 0RYLH  ZLWK disrupted helical 
content resulting from tKH JO\FLQH WR DODQLQHPXWDWLRQ UHTXLUHG DQ DGMXVWPHQW LQ SLWFK
before associating with YKL-40. This relative change in position is shown in the RMSD 
of the peptides during first 50 to 100 ns before stabilization (Figure 6.3a). Binding site B 
accommodates helical pitches of 7/2 collagen SHSWLGHV DV QDWLYH &$* DQG 4'
associated with YKL-40 with very little change in orientation relative to the initial 
docked positions. TKH &$* OLJDQG was expelled from binding site B as was the 
somewhat imperfect 10/3 pitched-1BKV peptide. This suggests YKL-40 may avoid 
physiological interactions with certain collagen fibril domains, especially those having 
imperfect helical pitches. The integrin-binding collagen-like peptide 1Q7D demonstrated 
the greatest stability among collagen peptides in both binding sites (Figure 6.3) and 
formed more native contacts with YKL-40 than the other three collagen peptides at 
binding site A (Figure 6.4:HDQWLFLSDWHWKDWWKH*)2*(5PRWLISOD\VVXEstantial role 
in mediating the interaction of this collagen peptide with YKL-40. 
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Figure 6.3 Root-mean-VTXDUHGHYLDWLRQRIFROODJHQ-like peptides over the course of 250-
ns MD simulations at (a) collagen binding site A and (b) collagen binding site B. Each of 
the four collagen model peptides are shown. 
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Figure 6.4 Native contact analysis of each collagen-like peptide model binding to YKL-
40 at site A and at site B. The FRORU VFDOH UHSUHVHQWV WKH QRUPDOL]HG IUHTXHQF\ LH
fractional percentage of frames in which the contact was formed) of the respective YKL-
40 residue as a native contact. A native contact was defined as anytime a collagen residue 
was within 12 Å of a YKL-40 residue where distance was defined by center of geometry 
of a given residue. Only frames from the last 100 ns simulation, following the period of 
HTXLOLEUDWLRQZHUHFRQVLGHUHGLQWKLVDQDO\VLV  
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 Examining the number of native contacts between each collagen peptide and 
binding site A of YKL-40 reveals several common interaction sites mediate collagen 
binding and helps narrow down key regions of interest (Figure 6.4). YKL-40 residues 69 
to 71, 98 to 108, 205 to 215, and 230 to 235 interact with all four collagen peptides, and 
likely contribute to binding affinity, as we will discuss below. The region of YKL-40 
EHWZHHQUHVLGXHVDQGDVVRFLDWHVZLWKQDWLYH&$*%.9DQG4'EXWQRW
ZLWK WKH RULJLQDO &$* DV WKLV SHSWLGH ZLWK UHOD[HG V\PPHWU\ QHHGHG WR DGMXVW LWV
position from docked conformation to stabilize the interactions. The 1Q7D model formed 
the greatest number of interactions with YKL-40 residues relative to the other three 
models. Similar native contact analysis for binding site B shows that even N-terminal and 
C-terminal residues of YKL-40 are involved in collagen binding at binding site B (Figure 
6.4). It shows that, unlike binding site A, there is little difference in number of 
LQWHUDFWLRQVRIPRGHO4'DQGQDWLYH&$*FROODJHQSHSWLGHZLWKWKHELQGLQJVLWH%RI
YKL-40.  
 To better understand the interactions collagen makes with YKL-40, identified 
through the native contact analysis, we calculated electrostatic and van der Waals 
interaction energies of each YKL-40 residue with each collagen peptide over the 250-ns 
MD simulations (Table 6.2). Visual inspection of the simulations reveals aromatic 
residues in the binding sites, such as Trp212 and Trp99 in binding site A and Phe49 in 
binding site B, were involved in aromatic-proline stacking interactions with the collagen 
triple helices. Such interactions are favorable, occurring due to both hydrophobic effects 
DQGLQWHUDFWLRQEHWZHHQWKHʌDURPDWLFIDFHDQGWKHSRODUL]HG&-H bonds [266]. This is 
illustrated in the van der Waals component of the interaction energy, where at binding 
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site A, Trp69, Trp71, Trp99, Trp212 and Phe234 show substantial favorable interaction 
with collagen peptides, though the contribution varies with each collagen peptide (Table 
6.2). Additionally, acidic and basic residues of the integrin-ELQGLQJ*)2*(5PRWLI from 
collagen-like peptide 1Q7D form ionic interactions with the counter-ionic amino acids of 
YKL-40, also known as salt bridges. Specifically, 1Q7D forms three salt bridges at 
binding site A and one salt bridge at binding site B (Figure 6.5). At site A, Arg105, 
Asp207, and Arg263 of YKL-LQWHUDFWZLWK*OXD$UJFDQG*OXFRI4'
respectively, where the a, b, and c in the parenthesis corresponds to one of the three 
strands of the FROODJHQPRGHO1RWDEO\*OXD$UJFDQG*OXFEHORQJ WR WKH
*)2*(5LQWHJULQ-binding motif. At site B, Lys23 of YKL-40 forms a salt bridge with 
*OXDRI4'$V anticipated, WKH*)2*(5PRWLI SOD\ed a substantial role in the 
interaction of this collagen peptide with YKL-40, but its role was different from that of 
the integrin binding mechanism, which further involves coordination of a metal ion [262]. 
Nevertheless, salt-bridges and hydrophobic contacts are very important in both cases, 
significantly contributing to the electrostatic component of the binding affinity of this 
collagen peptide relative to collagen peptides lacking acidic or basic amino acids (e.g., 
QDWLYH &$* 7DEOH  7KH K\GUR[\O R[\JHQV RI K\GUR[\SUROLQHV IURP &$* DQG
QDWLYH &$* DSSHDU WR EH LQYROYHG LQ LRQLF LQWHUDFWLRQVZLWK DFLGLFYKL-40 residues 
(favorable electrostatic interaction energies, Table 6.2), though as a result of hydrogen 
bonding rather than salt-bridge formation. We note that the interaction energies of YKL-
40 residues with residues of each collagen model peptide are not conserved as a result of 
GLIIHUHQFHV LQ WKH FROODJHQ VHTXHQFHV SDUWLFXODUO\ LQ WKH PLGGOH UHJLRQV FRQVLVWLQJ RI
different imino-triplets. 
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Table 6.2 Interaction energies of YKL-40 residues with collagen peptides. The values are reported in terms 
of average interaction energy between major YKL-40 residues and collagen as a whole. van der Waals and 
electrostatic contributions are also provided separately. Residues with total average interaction energy 
greater than -4.18 kJ/mol have not been reported unless relevant to discussion. All the energies are in 
kJ/mol. 
 Residue # VdW-Avg Elec-Avg Total Avg  Residue # VdW-Avg Elec-Avg Total Avg 
1Q
7D
_A
 
$5* 0.079 -5.635 -5.557 
1
DW
LY
H
&$
*
B$
 
ASP232 0.000 -6.651 -6.651 
THR184 -0.270 -3.917 -4.188 TRP99 -3.250 -1.806 -5.056 
LYS182 -0.173 -3.992 -4.165 TRP212 -3.746 0.084 -3.662 
TRP212 -3.268 -0.468 -3.736 VAL183 -2.367 -0.387 -2.754 
ASP207 -0.175 -3.432 -3.607 PHE234 -2.445 -0.020 -2.465 
TYR141 -1.061 -2.314 -3.376 ASN100 -1.265 -0.606 -1.871 
*/8 0.010 -3.197 -3.187 */8 -0.166 -1.182 -1.348 
*/8 -0.809 -1.939 -2.748 THR184 -0.678 -0.588 -1.266 
$5* 0.033 -2.461 -2.428 */1 -0.525 -0.544 -1.068 
TYR34 -1.861 -0.195 -2.056 TYR141 -0.909 -0.092 -1.001 
ASN100 -1.631 -0.393 -2.024 ASP207 -0.158 -0.770 -0.928 
TRP99 -1.365 -0.552 -1.917     
PRO142 -0.091 -1.330 -1.421     
VAL183 -1.500 0.143 -1.357     
*/8 -0.347 -0.937 -1.283     
 Residue # VdW-Avg Elec-Avg Total Avg  Residue # VdW-Avg Elec-Avg Total Avg 
&
$
*
B$
 
*/8 -0.211 -5.383 -5.594 
1B
K
V
_A
 
ASP207 -0.970 -14.302 -15.272 
TRP99 -3.128 -0.966 -4.094 PHE208 -1.266 -3.398 -4.663 
*/8 -0.576 -2.309 -2.884 ALA180 -0.468 -4.172 -4.640 
ASN100 -1.971 -0.605 -2.576 TYR141 -1.302 -3.032 -4.334 
TRP69 -1.520 -0.763 -2.283 TRP99 -3.116 -1.091 -4.207 
TRP71 -2.146 -0.106 -2.252 HIS209 -1.763 -1.774 -3.537 
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&
$
*
B$
 
ALA211 -1.386 -0.670 -2.056 
1B
K
V
_A
 
TRP212 -1.972 -0.960 -2.931 
TRP212 -1.583 -0.300 -1.882 LYS182 -0.377 -2.365 -2.742 
ASP207 -0.074 -1.337 -1.411 SER179 -0.419 -2.309 -2.728 
TYR34 -1.309 0.178 -1.131 */8 -1.192 -1.388 -2.580 
TRP31 -0.803 -0.121 -0.924 $5* -0.433 -2.107 -2.540 
    TYR206 -0.247 -2.058 -2.305 
    */< -0.652 -1.647 -2.299 
    ALA211 -0.195 -1.887 -2.082 
    TYR34 -1.660 -0.298 -1.958 
    */8 -0.443 -1.035 -1.478 
    VAL183 -1.421 0.035 -1.386 
    ASN100 -0.947 -0.348 -1.296 
    TRP31 -1.096 -0.089 -1.184 
 Residue # VdW-Avg Elec-Avg Total Avg  Residue # VdW-Avg Elec-Avg Total Avg 
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7D
_B
 
LYS23 -0.190 -20.619 -20.809 
1
DW
LY
H
&$
*
B%
 
ASN89 -2.861 -6.322 -9.182 
TYR22 -1.145 -11.156 -12.301 LYS377 -1.703 -6.249 -7.952 
LYS91 0.011 -9.232 -9.221 ASP378 -1.224 -3.781 -5.004 
PHE49 -3.618 -0.449 -4.066 ALA381 -2.240 -0.846 -3.086 
ASP367 -0.062 -3.849 -3.912 */1 -1.533 -1.004 -2.536 
LYS377 -1.282 -2.186 -3.469 THR52 -1.952 -0.552 -2.504 
THR52 -0.760 -2.420 -3.179 */1 -1.526 -0.721 -2.247 
ASP47 -0.227 -1.987 -2.215 PHE49 -1.761 -0.218 -1.980 
LYS253 -0.280 -1.631 -1.911 TYR22 -1.055 -0.631 -1.686 
ASN89 -1.654 -0.172 -1.825 LYS91 -0.891 -0.689 -1.581 
ASP378 -0.225 -1.367 -1.592 LEU50 -0.677 -0.685 -1.362 
ALA381 -1.250 0.077 -1.174 HIS53 -0.669 -0.541 -1.210 
    ASP199 -0.130 -0.880 -1.010 
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Figure 6.5. Collagen binding with YKL-40. (a) Salt bridges formed between the 1Q7D 
collagen peptide (green cartoon) and binding site A (gray surface) (b) Salt bridge 
interactions of the 1Q7D collagen peptide (cyan cartoon) with binding site B (gray 
surface).  
From MD simulation, we observe substantial hydrogen bonding between the 
collagen peptides and YKL-40 across the length of each binding site, which contributes 
to overall stability and binding affinity. The hydrogen bonding analysis for the collagen-
YKL-40 systems was performed as described above for the polysaccharide ligands; pairs 
exhibiting greater than 10% occupancy over the simulation are reported individually in 
Table 6.3. The YKL-40 residues responsible for hydrogen bonding are not consistent 
across each collagen model (Table 6.3). In geQHUDO *OX 7US $VQ 7\U
182 
Arg145, Ser179, Lys182, Thr184, Asp207, Arg213, Phe218, Asp232, Arg263 in binding 
site A form hydrogen bonds with the peptides. Similarly at site B, Tyr22, Lys23, Asn87, 
Asn89, Lys91, Lys377, Asp378 are typically involved in hydrogen bonding. The 
variation in hydrogen bonding pairs between YKL-40 and the collagen peptides is a 
natural extension of the YDU\LQJDPLQRDFLGVDORQJWKHUHSHDWLQJ*O\-Xxx-<\\VHTXHQFH; 
there are many different potential donor and acceptor pairs in each case. Hydroxyproline 
residues play a crucial role both as donor and acceptor in most pairs, benefitting from the 
extra hydroxyl group relative to proline. Although all the collagen peptides maintain 
association with collagen-binding site A, the hydrogen-bonding characteristics are 
slightly different for each, which will in turn lead to affinity differences. The relaxed 
KHOLFDOSLWFKRIWKH&$*SHSWLGHeffectively disrupts hydrogen bonding, and affinity for 
the ligand is lost at binding site B. The 1BKV peptide model with 10/3 symmetry was 
also unable to remain associated with binding site B, suggesting that binding site B may 
be more sensitive to helical pitch and prefers 7/2 symmetrical helices. 
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Table 6.3 Hydrogen bonding pairs between YKL-40 and collagen model peptides at binding site A, 
including percentage occupancy, over 250-ns MD simulations. A hydrogen bond was considered to be a 
polar atom having a donor-acceptor distance of 3.4 Å and a 60° cutoff angle. Occupancies above 100% 
mean that the same pair was involved in more than one type of hydrogen bond. 
1Q7D_A 1DWLYH&$*B$ 
Donor Acceptor Occupancy Donor Acceptor Occupancy 
$5*-SC */8-SC 164.84% $5*-SC HYP8-SC 79.68% 
$5*-SC ASP207-SC 126.36% HYP8-SC ASP232-SC 76.56% 
$5*-SC THR184-SC 51.96% */1-MC HYP14-SC 19.60% 
$5*-SC ALA291-MC 26.76% SER103-MC HYP14-SC 16.24% 
HYP9-SC */8-SC 25.56% $5*-SC HYP2-SC 13.44% 
HYP6-SC */8-SC 18.80% HYP17-SC ASN100-SC 10.32% 
TYR141-SC */8-SC 17.28% other pairs 123.68% 
ASN100-SC HYP9-SC 14.56% 
$5*-SC SER179-SC 13.44% 
HYP6-SC TYR34-MC 13.24% 
$5*-SC ASP207-MC 12.04% 
other pairs 100.20% 
Total 585.04% Total 339.52% 
&$*B$ 1BKV_A 
Donor Acceptor Occupancy Donor Acceptor Occupancy 
HYP20-SC */8-SC 75.72% TRP99-SC ALA17-MC 64.92% 
ASN100-SC HYP17-MC 35.84% $5*-MC PHE218-MC 56.88% 
*/<-MC HYP5-MC 29.24% $5*-SC SER179-SC 54.08% 
$5*-SC HYP5-SC 26.20% LYS182-SC THR8-SC 45.60% 
HYP14-SC ALA291-MC 17.80% $5*-SC TYR141-SC 42.56% 
*/<-MC */<-MC 11.00% $5*-SC ALA180-MC 40.04% 
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other pairs 112.08% $5*-MC THR184-SC 33.00% 
$5*-SC ASP207-MC 28.64% 
$5*-SC ASP207-SC 21.56% 
$5*-SC THR11-MC 20.24% 
$5*-SC */<-MC 15.92% 
$5*-SC TYR206-MC 13.72% 
TYR141-SC */<-MC 13.04% 
TRP212-SC */<-MC 12.76% 
$5*-SC ALA211-MC 11.04% 
other pairs 80.28% 
Total 307.88% Total 554.28% 
1Q7D_B 1DWLYH&$*B% 
Donor Acceptor Occupancy Donor Acceptor Occupancy 
LYS23-SC */8-SC 120.84% ASN89-SC */<-MC 94.68% 
ASN87-SC HYP6-SC 61.20% HYP17-SC ASN89-MC 84.72% 
ASN89-SC HYP6-MC 55.32% LYS377-SC HYP20-MC 59.92% 
LYS91-SC HYP9-SC 23.80% ASN89-SC HYP17-MC 47.84% 
LYS377-SC HYP3-SC 21.12% HYP23-SC ASP378-SC 32.80% 
LYS91-SC */8-SC 18.68% LYS377-SC */<-MC 30.20% 
LYS377-SC */<-MC 16.52% */1-SC HYP8-MC 18.40% 
TYR22-MC */8-SC 15.48% HYP20-SC ALA381-MC 16.92% 
*/1-SC HYP15-SC 11.76% ASN87-SC HYP20-SC 15.68% 
*/1-SC HYP18-SC 11.16% HYP11-SC LYS169-MC 15.28% 
THR52-SC */8-SC 10.00% */1-SC HYP11-MC 15.04% 
other pairs 129.24% LYS91-SC HYP17-SC 12.80% 
other pairs 98.36% 
Total 495.12% Total 542.64% 
185 
6.3.3 Collagen-like peptide binding affinity 
The relative binding affinity of collagen-like peptides to YKL-40 was determined 
from umbrella sampling MD simulations. Here, we report the binding affinity of the 
1Q7D collagen-like peptide, which is the integrin binding peptide with an overall 7/2 
helical pitch [261, 262], at both sites A and B. We have also calculated binding affinity of 
QDWLYH &$* DW ELQGLQJ VLWH $ IRU FRPSDULVRQ RI ELQGLQJ DIILQLWLHV RI WZR GLIIHUHQW
collagen peptides having different residue substitutions and helical pitches. 
Unfortunately, in case of umbrella sampling for the native &$*SHSWLGHat site B, we 
were unable to obtain statistically reliable results, and thus, we will not discuss findings 
relative to affinity of this model.  
The umbrella sampling MD simulations of the 1Q7D collagen peptide at both 
sites A and B show that YKL-40 has similar affinity for 1Q7D at both sites; whereas, the 
QDWLYH&$*FROODJHQSHSWLGHDSSHDUVWRELQGZLWKDORZHUDIILQLW\WKDQ4'DWELQGLQJ
site A (Figure 6.6). We note that the last umbrella sampling window in case 1Q7D at 
binding site A shows a sudden, sharp increase in the PMF, which is an artifact of the use 
of native contacts as an umbrella sampling reaction coordinate. As the standard C-
terminals of three strands of collagen helix are negatively charged, they are attracted to 
the nearby, highly positively charged surface of heparin-binding site. As a result, the final 
window of the PMF overestimates the work to remove the 1Q7D peptide from binding 
site A exclusively (Figure 6.6). Removing this latter window from the calculation, the 
free energy of binding 1Q7D is í N-PROin site A and í10.26  kJ/mol 
in site B7KHIUHHHQHUJ\RIELQGLQJQDWLYH&$*LQVLWH$LVí kJ/mol. The 
relatively low statistical uncertainty at each window along the potential of mean force 
186 
suggests sampling of the system was sufficient, providing a meaningful estimate of 
binding affinity. 
Figure 6.6. Binding free energy obtained from umbrella sampling MD simulations of the 
YKL-40-collagen peptide systems, interpreted as negative of potential of mean force 
30) WR GHFRXSOH WKH SDUWQHUV 7KH FROODJHQ SHSWLGHV LQ TXHVWLRQ DUH 4' DW ERWK
VLWHVDQG&$*DWVLWH$RQO\7KHIUHHHQHUJ\LVVKRZQDVDIXQFWLRQRIQRUPDOL]HG
reaction coordinate, where the reaction coordinate is fraction of native contacts. 
The potential of mean force determined from umbrella sampling MD simulations 
GHWHUPLQHVWKHDPRXQWRIZRUNUHTXLUHGWRSXOOWKHFROODJHQOLJDQGIURPWKHELQGLQJVLWH
As free energy is a state function, the difference between the beginning and end state is 
the binding affinity, regardless of path taken, as reported above. The path can provide 
information as to barriers to unbinding; however, the collagen peptides are readily 
removed from the binding sites along a relatively smooth path. This suggests there is 
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OLWWOH FRQIRUPDWLRQDO UHDUUDQJHPHQW UHTXLUHG RI <./-40 in the release of the collagen 
ligand. 7KHGLIIHUHQFHEHWZHHQDIILQLW\IRU4'DQGQDWLYH&$*DWELQGLQJVLWH$LV
reflected in the total hydrogen bonding occupancy in those two cases (Table 6.3). 
Notably, the binding free energies of collagen to YKL-40 are approximately half that of 
the tighter binding polysaccharide ligands. This suggests that YKL-40 will bind both 
hyaluronan and chito-oligomers over collagen in the presence of all three. This does not 
rule out collagen as a physiological ligand, but strongly supports hyaluronan as a 
preferred physiological ligand of YKL-40. 
6.4 Conclusions 
 The docking of triple helical collagen-like peptide models on YKL-40 surface 
based on molecular shape complementarity at two surface binding sites again proves that 
H[WHULRUVRISURWHLQWKDQSULPDU\ELQGLQJVLWHDUHHTXDOO\VLJQLILFDQWLQLWVIXQFWLRQDOLW\
Analysis of protein-protein binding dynamics, compared over various collagen models, 
provides detailed characteristics of surface binding residues at both the proposed binding 
sites. Binding site A showed more adaptability towards different helical symmetries and 
mutant disruptions. Binding site B only accommodated collagen peptides with 7/2 
symmetry. Native contact analysis was very helpful in pointing out the most important 
residues/loops that were involved in protein-protein interaction. 1Q7D collagen-like 
SHSWLGH PRGHO ZLWK WKH *)2*(5-motif, appears to be the most favorable and stable 
binding partner at both the sites among the four cases studied. The affinity of surface 
binding of collagen was much less than the affinities for chitohexaose and hyaluronan in 
the primary binding cleft. The demonstrated ability of YKL-40 to bind collagen 
molecules with two surface binding sites adds another dimension to its functionality in 
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extracellular matrix, as it has already been experimentally shown to affect collagen fibril 
formation. However, further investigation of significance of this protein-protein 
interaction is needed and combined with experimental evaluation of hyaluronan binding, 
we could ultimately use this knowledge in order to utilize the mammalian glycoprotein in 
many roles than just biomarker. 
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Chapter 7  – Conclusions and future work 
 This dissertation has covered a crucial aspect of non-catalytic proteins having the 
XQLTXH DELOLWLHV WR ELQG QRW RQO\ YDULRXV PRUSKRORJLHV RI VXEVWUDWHV EXW DOVR PXOWLSOH
sugar codes, sometimes with the aid of surface-binding sites. As the underlying 
mechanisms of such substrate recognition abilities are important to various applications, 
we set out to develop a molecular-level understanding of interesting protein-carbohydrate 
binding sites, their adaptability for ligand orientations, dynamical differences in binding 
to various morphologies, and thermodynamic preferences to certain protein-carbohydrate 
pairs; such an investigation provides critical insights that are beneficial towards the 
development of biotechnological applications, for example better use of CBM diversity in 
developing enzyme cocktails for efficient enzymatic hydrolysis. In this chapter, we 
discuss how our work can impact the future directions of this research area. 
 Through our CBM studies, we reached two main conclusions about Type B 
CBMs, based on MD simulations and free energy calculations. In the first part of the 
study, Chapter 3, we not only confirmed the original Johnson, et al. [61] hypothesis that 
C. fimi CBM4s are capable of binding cello-oligomers with the reducing end of the 
pyranose at either end of the binding cleft, but also showed that this bi-directional 
binding phenomenon also holds true for four other Type B CBMs. From this, we 
hypothesize that all cellulose-specific CBMs with a ȕ-sandwich fold may exhibit this 
ability. This bi-directional binding ability of cellulose-specific CBMs suggests that multi-
modular enzymes are evolved to recognize the free glycan chains with higher efficiency. 
It is another indication nature has evolutionarily selected for proteins with mechanisms 
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like bi-directional substrate recognition in response to the structural features of cellulose, 
with the approximate symmetry of sidechains, as a means to break it down in faster ways 
to maintain the balance of the carbon cycle. Nonetheless, we have more to learn from 
nature to capitalize on it for industrial and developmental purposes. Accordingly, CBMs 
with their basic attributes being independently folding proteins, abundant and 
inexpensive matrix attachment regions, and compliant binding specificities have already 
been employed in many applications, for example high-capacity purification tags for 
protein isolation [35]. The bi-directional binding ability of Type B CBMs could be 
harnessed for applications in which a directional preference is not critical, for example 
targeting of functional molecules to materials containing cellulose. CBMs are already 
being used to probe for polysaccharides in plant cell walls [94], and knowing that the 
CBMs can bind bi-directionally necessitates considering additional factor in designing 
probes for differentiation of the substrate morphologies. The molecular-level knowledge 
of these Type B CBM binding clefts can be utilized to engineer proteins with more 
flexibility towards binding orientations where ligands can offer symmetric interactions.  
 In Chapter 4, the architectural features of CBM binding sites in three families 
from the same type of CBMs were studied, extensively illustrating various characteristic 
differences that facilitate the tighter oligomeric binding within twisted platforms. The 
investigation further leads to the fact that this difference in binding site, within same 
family, is evolved to target distinct regions of non-crystalline cellulose and not only 
single glycan chains. The study highlights an overlooked element in structural 
characterizations of proteins that, although the active site or ligand-binding site is of 
prime importance towards proteins functionality, the rest of the protein surface and, 
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specifically, the neighboring loops of the binding site may play a critical role in defining 
the larger aspect of protein functionality. We anticipate our work will motivate more in-
GHSWK µDFWLYH VLWH¶ FKDUDFWHUL]DWLRQV WKat extend beyond the immediate protein-
carbohydrate interface. Undoubtedly, MD simulations facilitate such investigations once  
structural data from either X-ray crystallography or NMR spectroscopy is available, but 
homology modeling is proving to be an increasingly reliable tool for structural biologists. 
We envision extension of this research would involve mutations in the exterior loops 
around the twisted binding platforms of family 17 and 28 CBMs, which would be tested 
across range of non-crystalline substrates; from this, we would be able to identify the true 
contributions to specificities. This information would also benefit development of refined 
CBM probes for probing plant cell wall architecture by enabling biotechnology with 
differential arrays of CBMs capable of recognizing specific morphologies on non-
crystalline substrates. Exact identification the composition of pretreated biomass in terms 
of crystalline, non-crystalline, and soluble substrate, with better resolution of non-
crystalline morphologies, allows design of complementary enzyme cocktails for efficient 
and faster hydrolysis. The different hydrogen bonding patterns across the two platforms 
pose a great example that even the small differences in binding site have evolved to 
provide the functional specificity.  
 As stated earlier, Section 1.3.1.5, there is more to the story of Type B CBMs, 
pertaining to the fact that, in nature, four out of six CBMs studied here are found in 
tandem. The tandem Type B CBM construction further confounds fundamental 
understanding, as the two tandem CBM systems, CfCBM4-1/CfCBM4-2 and 
BspCBM17/BspCBM28, differ in their binding abilities. There are two basic 
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dissimilarities in these tandems. First, both have either sandwich or twisted binding 
platforms in their individual CBMs, and second, there is significant difference in linker 
length. The BspCBM17/BspCBM28 tandem, having twisted platform CBMs and a longer 
peptide linker length, exhibits cooperative binding effects, with up to 100-fold higher rate 
of association over that of the individual CBMs [106]. The tandem CfCBMs have a very 
short linker in combination with sandwich platforms of both individuals, and show only 
additive affinity improvement relative to separate domains [98]. Using these tandems 
CfCBM4-1/CfCBM4-2 and BspCBM17/BspCBM28 as representative models, we plan 
IXWXUH VWXGLHV WR DGGUHVV WKH TXHVWLRQV DERXW FRRSHUDWLYH DQG DGGLWLYH FDUERK\GUDWH
binding. The relative orientation of two partners in the wild-type tandems, length of the 
linker region between the two, and relative presence of the bound glycan chains are 
parameters that may contribute to cooperativity. We have obtained preliminary results 
examining the wild-type tandems, where the individual CBMs were connected by 
modeling the linker peptide between them based on tKHGHSRVLWHGVHTXHQFHV[105, 267]. 
$IWHU DOORZLQJ D ORQJ HTXLOLEUDWLRQ EHIRUH SURGXFWLRQ 0' ZH REWDLQHG VKRUW -ns 
trajectories that we have analyzed through residue-residue cross-correlations (Figure 7.1) 
and principal component analysis (PCA) (Figure 7.2). In the case of tandem CfCBM4s 
with a short linker, a large amount of strong negative correlations were observed between 
the residues from the two different CBMs; while in tandem BspCBMs, correlation across 
the CBMs was relatively very low. Additionally, we observed a large network of strong, 
positive correlations in tandem BspCBMs between residues of the same CBM, and these 
two CBMs only interact through the linker. In contrast, the tandem CfCBMs show strong 
positive correlations that extend across the linker to connect residues of one CBM to that 
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of the partner CBM. This is a promising indication that short linkers induce highly 
interdependent motions of the CBMs, which may restrict co-cooperativity. The PCA 
analysis provides the essential dynamic information that allows us to describe the protein 
motions that contribute the most to conformational variation. Figure 7.2 shows that the 
tandem BspCBMs have highly scattered conformations in a trajectory along largest 
principal components (PC), while tandem CfCBMs have closely related groups of 
conformers. 
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Figure 7.1 Visualization of residue-residue cross-correlation of tandem CBMs calculated 
based on RMSD of the protein backbone (Į-carbon only). The linker length in BspCBMs 
is longer than that in CfCBMs. The blue lines represent strong negative correlation 
between a pair of residues, while the red lines represent strong positive correlation.  
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Figure 7.2 PCA analysis of preliminary MD simulation data. Left panels illustrate the 
clustering of conformers on a principle components 1 and 2 (PC1-PC2) space. A 
cRQWLQXRXVFRORUVFDOHIURPEOXHWRUHGLVXVHGWRIROORZWKHVHTXHQFHRIFRQIRUPHUVLQ
the trajectory. The rLJKW SDQHOV VKRZ WKH SHUFHQWDJH RI WKH WRWDO PHDQ VTXDUH
displacement (or variance) of atomic fluctuations captured in each dimension 
characterized by their corresponding eigenvalue. 
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 Through long-timescale MD simulations and post-process analysis, such as these 
above, future studies will address protein-protein networking in these tandem CBMs, 
comparing individual CBM dynamics and binding mechanisms. With variations in linker 
lengths, through swapping of the linkers between tandems, adding cello-oligomeric 
ligands in the binding sites of CBMs to consider possible allosteric effects, and further 
introduction of the catalytic module in the modeling, I expect to characterize the overall 
behavioral attributes of these multi-modular enzymes. 
 For the other non-catalytic protein, YKL-40, studied in this dissertation apart 
from CBMs we also arrive at remarkable conclusions. We have covered most of the ECM 
components having the potential to be a physiological ligand of this multi-functional 
protein. In Chapter 5, we modeled and analyzed the binding mechanism of YKL-40 for 
its known binding partner, chitohexaose, along with 5 different oligosaccharides, where 
chitohexaose, hyaluronan and cellohexaose could remain in the primary binding site; 
heparin was able to bind to a surface binding site. Moreover, in Chapter 5, the same 
mammalian glycoprotein was able to bind four different model collagen peptides through 
two different surface binding sites. The absolute thermodynamic favorability of YKL-40 
for hyaluronan over not only chitohexaose but also collagen model peptides calls for 
prompt experimental confirmation of this prediction. In vitro binding studies of YKL-40 
with hyaluronan and structural characterization of their interactions would provide further 
resolution of this novel interaction, which along with in vivo studies for expression levels 
of both the partners in various malignant tissues, will reveal a clear picture about the 
physiological significance of this strong biomolecular binding. Nonetheless, the details of 
these non-catalytic protein-carbohydrate interactions discussed in this dissertation can be 
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adapted to develop new inhibitory molecules/pathways for this lectin. The affinity of the 
YKL- VXUIDFH IRU KHSDULQ DQG RWKHU VLPLODU KLJKO\ QHJDWLYHO\ FKDUJHG *$*V DOVR
needs further attention, as this surface-binding site may play a role in cell-cell and cell-
matrix interactions. Heparin-Sepharose chromatography is used to purify YKL-40 [45]; a 
similar purification approach could also be developed for other proteins by modifying a 
surface patch with high positive charge density in the heparin-binding motif, 
*55'.4+ 7KH FROODJHQ ELQGLQJ VLWH LGHQWLILFDWLRQ DQG FKDUDFWHUL]DWLRQ UHYHDOV WKDW
YKL-KDVYHU\XQLTXHVXUIDFHUHVLGXHVWKDWFDQVSHFLILFDOO\UHFRJQL]HELQGLQJSDUWQHUV
of many types and symmetries of collagen triple helices. The significance of having two 
binding sites needs to be further analyzed, as it may play a crucial role in bringing the 
two helices together in fibril formation; however, the experimental evidence of YKL-¶V
involvement with collagen fibril formation is ambiguous and reports both inhibitory and 
stimulatory effects based on different forms of protein [45]. Study of this protein-protein 
relationship will clarify the higher expression levels of YKL-40 in inflammatory joint 
diseases like osteoarthritis. 
  In summary, this dissertation applies state-of-art computational approaches to 
gain molecular-level understanding of inconspicuous mechanisms and unidentified 
interactions in two studies of carbohydrate recognition by non-catalytic proteins namely, 
Type B CBMs, recognizing oligomeric and non-crystalline cellulose, and YKL-40, 
ELQGLQJ WR*$*V 7KH SURWHLQ-protein interactions, such as tandem CBMs or collagen 
binding of YKL-40, inevitably come into the picture, as many biological events are 
highly interdependent and often must be studied simultaneously for effective analysis of 
results. 
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Appendix 
A1   Supporting information related to CBMs 
 As the title suggests, Appendix A1 reports the additional details of simulation 
procedures. Also, some additional results about data analysis and free energy calculation 
methods that are not exactly related to actual theme of the dissertation are reported here. 
Information in this appendix has been adapted with permission from Kognole and Payne 
[184], Copyright © 2015, Oxford University Press. 
A1.1   Additional methods for Chapter 3 
 The CBM-ligand complex systems illustrated in Figure 3.1 were constructed 
using CHARMM as described in the manuscript [166]. Protonation states of the titratable 
residues were determined by H++ and manual inspection [187-190]. */8*/8DQG
ASP120 from CfCBM4-1 were protonated whereas no residues were protonated in 
CfCBM4-2. 
A1.1.1   Molecular Dynamics (MD) Simulation 
 The CBM-cellopentaose systems were minimized in vacuum in a stepwise fashion 
using the method of steepest descent. For 1000 steps, the ligand side-chains were 
minimized, holding all other atoms fixed. The entire ligand was minimized for an 
additional 1000 steps, with the protein held fixed. Finally, the protein and ligand were 
minimized for another 1000 steps with no constraints. An additional 1000 steps of 
minimization using Adopted Basis Newton-Raphson algorithm completed the vacuum 
minimization procedure. The minimized systems were then solvated; CfCBM4-1 systems 
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ZHUH VROYDWHG LQ  c VTXDUH-box (~27,300 atoms), and CfCBM4-2 systems were 
VROYDWHGLQcVTXDUH-box (~22,000 atoms). Sodium atoms, 13 for CfCBM4-1 and 13 
for CfCBM4-2, were added to neutralizHWKHV\VWHPFKDUJHDVUHTXLUHGIRUDSSOLFDWLRQRI
Particle Mesh Ewald electrostatic approximations. The solvated systems were re-
minimized in a stepwise fashion. Holding the protein and the ligand fixed, the water 
molecules were minimized for 1000 steps of steepest descent. The restraints on the ligand 
side chains were then removed, and the water and ligand side chains were minimized for 
1000 steps of steepest descent. The entire ligand and water molecules were then 
minimized for 1000 steps of steepest descent, and then, the entire solvated complex was 
minimized for 2000 steps of steepest descent and 2000 steps with adopted basis Newton-
Raphson method.  
 7KHQWKHV\VWHPVZHUHKHDWHGIURPWR.IRUSVDQGHTXLOLEUDWHGLQWKH
NPT ensemble for 100 ps. The Nosé-Hoover thermostat was used to control temperature 
in CHARMM [212, 213]. Shake was used to fix the distances to hydrogen atoms [215]. 
Non-bonded interactions were truncated with a 10-Å cutoff. The Particle Mesh Ewald 
method with a 6th order b-spline [216], D*DXVVLDQGLVWULEXWLRQZLGWKRIcDQGD
mesh size of 90 × 90 × 90 was used to describe the electrostatics. All simulations used a 
2-fs time step. The CHARMM36 force field with the CMAP correction was used to 
describe the protein [166, 191, 192], and the CHARMM36 carbohydrate force-field was 
used for the ligand [193-195]. Water was modeled using the modified TIP3P force field 
[196, 197]. Production MD simulations were performed using NAMD in the NVT 
ensemble at 300 K for 250 ns using a 2 fs time step [169]. Temperature was controlled 
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using Langevin thermostat in NAMD [214]. All other simulation parameters were the 
VDPHDVWKRVHGHVFULEHGDERYHIRUWKH&+$500HTXLOLEUDWLRQ 
A1.1.2   Free Energy Simulation 
 To determine the absolute binding free energy of the CfCBM4-1-RE and 
CfCBM4-1-NRE systems to cellopentaose per the defined thermodynamic pathway 
(Figure 3.3), the solvation free energy of the cellopentaose ligand must be determined. 
Accordingly, a solvated ligand system was constructed in a fashion similar to the protein-
ligand systems. The cellopentaose ligand was solvated in a 65-Å VTXDUH-box (~9,000 
ZDWHU PROHFXOHV UHTXLULQJ QR VRGLXP LRQ DGGLWLRQV 7KH VROYDWHG FHOORSHQWDRVH ZDV
minimized, heated, and HTXLOLEUDWHG XVLQJ WKH VDPH SURWRFRO DV RXWOLQHG DERYH )UHH
energy simulations were started from the 0.1-QV HTXLOLEUDWLRQ ZKLFK LV VXIILFLHQW IRU
effective diffusion of the highly mobile water molecules. 
 One hundred twenty-eight Free Energy PerturbatioQ)(3Ȝ-windows, treated as 
replicas, were run concurrently, obtaining an acceptance ratio of > 80% along the 
alchemical path. These 128 replicas were distributed into 72 repulsive, 24 dispersive, and 
32 electrostatic replicas. The MD simulations were performed using periodic boundary 
conditions in the NVT ensemble at 300K with a 1-fs time step. The systems were 
propagated with the multiple time step integration scheme and Langevin dynamics. Forty 
VHTXHQWLDOSVSURGXFWLRQUXQVZHUHSHUIRUPHGZLWKDUHSOLFDH[FKDQJHIUHTXHQF\RI
1/100 steps. The force field parameters were the same as described above for the MD 
simulations. Initial structures of the enzyme-ligand complexes were taken from the final 
FRRUGLQDWH VHW RI WKH HTXLOLEUDWLRQ WUDMHFWRU\  QV. Translational and rotational 
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restraining potentials were applied in the enzyme-ligand free energy calculations. The 
distance from the initial center of mass of the ligand to the initial center of mass of the 
protein was maintained through an applied 10 kcal/mol/Å2 harmonic restraint.  
 Energies collected from the MD simulations were used to determine repulsive, 
electrostatic, and dispersive contributions to the free energy of binding. The Multistate 
Bennett Acceptance Ratio (MBAR) was applied to determine free energy and statistical 
uncertainty associated with each 0.1 ns interval [176]. )URPWKHLQGHSHQGHQW)(3Ȝ-
REMD calculations (40 × 100 ps), the last 30 (3 ns) were used to obtain the average free 
energy of binding. The contribution of this restraint to the free energy was determined via 
QXPHULFDO LQWHJUDWLRQZLWK 6LPSVRQ¶V rule as described by Deng and Roux [173]. The 
error associated with the binding free energy was obtained from determining the standard 
deviation over the last 3 ns for each of the two sets of calculations and combining 
standard deviation using error propagation rules.  
A1.2   Additional results 
A1.2.1   The effect of replica-H[FKDQJHIUHTXHQF\RQWKHVDPSOLQJDQGFRQYHUJHQFH 
 The time progression of the 40 consecutive 0.1 ns FEP calculations is illustrated 
in Figure A.1a. The free energies reported in Chapter 3 (Table 3.1) were obtained from 
the final 3 ns. Statistical uncertainty of each point has been determined using MBAR. The 
HIIHFWRI UHSOLFDH[FKDQJH IUHTXHQF\RQVWDWLVWLFDOXQFHUWDLQW\DQGDFFHSWDQFHUDWLRZDV 
also considered. One gHQHUDOO\ H[SHFWV WKDW LQFUHDVLQJ WKH H[FKDQJH IUHTXHQF\ ZLOO
improve the statistical sampling, perhaps leading to faster convergence. The reported free 
energy YDOXHVZHUHREWDLQHGXVLQJDQH[FKDQJHIUHTXHQF\RIVWHSVRUHYHU\SV
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as described in WKH0HWKRGV:HDOVR H[DPLQHG H[FKDQJH IUHTXHQFLHVRI HYHU\
steps and 1/10 steps. All other parameters were identical. The binding free energies for 
CfCBM4-1-5(ZLWKH[FKDQJHIUHTXHQF\RIDQGZHUHí kJ mol-1 
DQG í   kJ mol-1, respectively (Figure A.1b). We found a moderate 
LPSURYHPHQW LQ XQFHUWDLQW\ ZLWK LQFUHDVHG H[FKDQJH IUHTXHQF\ KRZHYHU SURJUHVV
toward convergence did not appear to be affected (Figure A.E*LYHQWKHH[SRQHQWLDO
increase in computational expensH XVLQJ DQ H[FKDQJH IUHTXHQF\ RI  IRU WKH
CfCBM4-1-NRE free energy calculation was not warranted. 
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Figure A1.1 &DOFXODWHG*LEEVIUHHHQHUJ\RYHUFRQVHFXWLYH-ns calculations using 
)(3Ȝ-REMD. (a) The difference between the average value for either CfCBM4-1-RE or 
CfCBM4-1-NRE and the cellopentaose solvation free energy represents the binding free 
energy. (b) The free energy calculation for CfCBM4-1-RE system using different replica 
H[FKDQJH IUHTXHQFLHV LQ OHJHQGV I  IUHTXHQF\ RI  VWHSV  VWHSV DQG
steps. 
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A2   Supporting information related to YKL-40 
 Appendix A2 reports the details of force-ILHOGGHYHORSPHQWUHTXLUHGWRVHWXSWKH
MD simulation. Information in this appendix has been adapted with permission from 
Kognole and Payne [223], Copyright © 2017, American Society for Biochemistry and 
Molecular Biology.  
A2.1   Force-field parameterization for modeling heparin 
 Modeling of hHSDULQ LQ WKLV VWXG\ UHTXLUHG GHYHORSment of new force-field 
parameters for a sugar, where the acetyl group in N-acetyl glucosamine was replaced by 
SO3-1 (Figure A2.1). ParamChem was used to obtain an initial set of parameters based on 
analogy with available data [263, 268]. As the sulfamate anions were not explicitly 
supported, parameters obtained for –NHSO3 group by analogy UHTXLUHG optimization. 
The Force Field Toolkit (ffTK) Plugin Version 1.0 in VMD [238] was used to optimize 
the partial charges, bonds, angles, and dihedrals as described in the reference publication 
and provided examples. Parameters obtained using this approach are given in Table S2. 
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Figure A2.1 Atom labels of N-sulfo-D-D-glucosamine structure used for optimization of 
missing force-field parameters. The only missing parameters were the ones around N-S1 
bond as documented in Table S2. 
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Table A2.1 CHARMM-additive SDUDPHWHUV IRU*OF16optimized using the ffTK v.1.0 
plugin in VMD. The atom labels are as illustrated in Figure A2.1.  
Bonds Kb b0 
C2 – N 271.158 1.464 
N – S1 332.175 1.823 
N – HN 440.214 1.029 
S1 – O2 540.346 1.452 
Angles Ktheta Theta0 
C1/C3 – C2 –N  91.721 112.507 
N – C2 –H2  114.884 111.824 
C2 – N – S1 124.591 117.44 
C2 – N – HN 79.624 107.895 
S1 – N – HN 74.629 129.979 
N – S1 – O2 152.857 109.282 
O2 – S1 – O7  103.66 105.957 
Dihedrals Kchi n Delta 
N – C2 – C1 – O5 0.2 3 0 
N – C2 – C3 – O3 0.2 3 0 
N – C2 – C1 – O1 0.2 3 0 
C4 – C3 – C2 – N 0.2 3 0 
N – C2 – C3 – H3 0.2 3 0 
N – C2 – C1 – H1 0.2 3 0 
C1/C3 – C2 – N – S1 1.12 3 180 
H2 – C2 – N – HN 0.527 3 180 
H2 – C2 – N – S1 2.994 3 0 
C2 – N – S1 – O2 1.048 3 180 
NH – N – S1 – O2 0.831 3 0 
C1/C3 – C2 – N – HN 1.575 1 0 
O4* – C1 – C2 – N  0.2 3 0 
*this O4 is from the glycosidic linkage this residue will be involved in. 
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